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“Science is the attempt to make the chaotic 
diversity of our sense experience correspond 
to a logically uniform system of thought.” 
 
Albert Einstein (1879-1955) 
 
 
 
 
 
 
 
 
 
 
 
This thesis is dedicated to those who  
live in fear and anxiety…... 
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General Introduction 
 “Fear produces an agony and anxiety about the heart not to be 
described; and it may be said to paralyze the soul in such a manner, that 
it becomes insensible to everything but to its own misery…..When the 
effects of fear operate powerfully, without any mixture of hope, these 
passive impressions are predominant but where there is a possibility of 
escape, the mind reacts with wonderful energy…enabling the sufferer to 
precipitate his flight, by exertions that would have been impracticable in a 
more composed state of mind” 
T. Cogan, On the Passions (1802) 
 
 
Defensive behaviour is a form of behavioural and neuropsychological response to 
fear or anxiety condition due to avoidable and unavoidable threat stimuli. It plays an 
important role to protect an organism from potentially dangerous conditions where 
animals learn to escape from and avoid places where they have been attacked or hurt 
(Blanchard and Blanchard 1972; Panksepp 1998). The characteristic of stimuli is based 
on the presence of elements of either fear and/or threat, which may be real or perceived to 
be a threat stimulus as defined in both human and animal studies (Anders et al 2008; 
LeDoux 1993). Defensive behaviour is commonly categorized into flight, fight, and 
freeze responses. In rodents, subjects usually fear of high-illuminated areas and the smell 
of potential predators such as cat odor (Blanchard et al 1990; Dielenberg et al 1999). In 
humans defensive behaviour is associated with a number of complicated cognitive and 
emotional states including anxiety, horror, panic, and fearful sensation (Goossens et al 
2007; Lobue and DeLoache 2008; Teachman et al 2008). Different types of fear can be 
observed across different animal species. The fear response is initiated and controlled by 
the defense system, which runs from the cortex to the periaqueductal gray (PAG) (Davis 
1996; LeDoux 1993; McNaughton and Corr 2004).  
  
Studies using electrical deep brain stimulation (DBS) to explore the function of 
brain areas have revealed the existence of a coherent operating fear system in the brain. 
When this system is activated by an internal stimulus such as electrical stimulation of the 
PAG, animals show a variety of defensive behaviours, ranging from a freezing response 
to escape (flight) reactions (Carrive 1993; Jenck et al 1995; Lim et al 2008a). These 
reflect the different types of fear responses which are similar to the behaviour of animals 
that have perceived a predator at a far or near distance. Even though animals show escape 
reaction when this fear system is stimulated, they cannot learn to avoid the electrical 
brain stimulation induced fearful behaviour (Bandler and Shipley 1994; Bittencourt et al 
2005; Jenck et al 1995). It is noteworthy that electrical stimulation of the dorsolateral 
PAG (dlPAG) evokes a typical reaction which is generally regarded as escape or 
defensive behaviour (Bandler and Shipley 1994; De Oca et al 1998). This behaviour 
consists of a spontaneous flight reaction characterized by wild running, galloping, and 
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jumping accompanied by hypertension, tachycardia, tachypnoea, freezing, and fear-like 
responses (Bittencourt et al 2005; Hogg et al 2006; Lim et al 2008a). In humans, it has 
been reported that electrical stimulation of the PAG can produce intense emotional fear 
sensation, with remarkable autonomic changes, which are features of a typical panic 
attack (PA) (Amano et al 1978; Mobbs et al 2007; Nashold et al 1969). 
CURRENT PROBLEM 
Panic disorder (PD) is one of the most frequently encountered anxiety disorder, 
and one out of every seventy five people worldwide experiences a panic attack (PA) once 
in their lives (NIH 1991). PAs are characterized by an acute moment of intense fear or 
psychologically distress with a sudden onset rapidly building to a peak level and are 
usually accompanied by somatic and psychological symptoms associated with a sense of 
impending danger and an urge to escape from the susceptible risk condition (Craske and 
Waters 2005; Griez and Schruers 1998; Klerman et al 1993). PA is recognized as a 
disabling condition and its treatment includes pharmacologic and behavioural therapies as 
well as combinations of these strategies (American-Psychiatric-Association. 2000; 
Barlow et al 2000; Goisman et al 1999). In some cases, patients do not respond to these 
treatments and experience a chronic course of disease burden, usually together with their 
families (Fleet et al 1996; Reiman et al 1984; Roy-Byrne et al 1999).  
 
Besides, many clinical reports have demonstrated that PD is closely associated 
with agoraphobia, a distinguishing feature of fear in having a PA at a place from which 
escape is difficult (Kessler et al 2006; Marchand et al 2008; Roberge et al 2008). This 
psychopathology is generally followed by agoraphobia which develops from an intrinsic 
mechanism after a person has experienced an episode or several series of PAs (Kessler et 
al 2006; Marchand et al 2008; Roberge et al 2008). Such a person usually associates the 
panic with the location or environment where it occurred, and therefore this place is 
considered no longer secure. Patients usually experience this as a high state of anxiety 
with fear of losing control and social embarrassment (Goisman et al 1994; Vincelli et al 
2000; Wittchen et al 2008). 
 
Many studies in which the effects of the PAG stimulation have been investigated 
in combination with psychopharmacological challenge showed that the PAG is involved 
in panic or anxiety-like behaviour. Thus, the use of electrical stimulation of the PAG as 
an animal model can be used in the development of novel panicolytic, anxiolytic, and 
phobiolytic drugs. 
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AIM OF THE PRESENT STUDY 
Investigating the defensive behaviour induced by electrical stimulation of the 
dlPAG is one of the main topics of this thesis. We have specifically chosen this animal 
model to gain more knowledge about the functional anatomy and behavioural phenotype 
of defensive behaviour. At present, we are still in the early stages of understanding 
fearful emotion and cognitive behaviour and the exact role of the PAG in these 
behaviours. Nevertheless, recent developments in neuroscience will gradually reveal the 
nature and complexities of emotionality of defensive behaviour in our phylogenetically 
old brain structure – the PAG.  
  
The aim of the studies presented in this thesis was to investigate the possibilities to 
modulate the activity of the dlPAG in order to induce or attenuate fear responses in the 
rat. This modulation was achieved by state-of-art deep brain stimulation (DBS) of the 
dlPAG and treatment with serotonin (5-HT) drugs. The purposes and results of 
experiments are described in the following chapters.   
 
In Chapter 2, we provide an extensive review on the histology, anatomy, and 
chemistry of the PAG. In addition, we outline the involvement of different PAG parts in 
different behaviours. In Chapter 3, we present an overview of the neural activation (c-
Fos immunoreactivity) in the different neuroanatomical structures following escape 
behaviour induced by electrical stimulation of the dlPAG. Chapter 4 aims to find a 
behavioural model with high and low fear in which we could test the effects of dlPAG 
stimulation. This study provides further evidence of the effects of buspirone on different 
levels of anxiety which were evaluated in two different conditions of the open-field. 
Following this, Chapter 5 tests the hypothesis that electrical stimulation of the dlPAG at 
higher frequencies (>100Hz) could be used to inhibit escape or panic-like behaviour. This 
was based on findings in which high frequency DBS of the subthalamic nucleus inhibited 
the output of this structure. Likewise, we would expect an inhibition of the output of the 
dlPAG which may prevent the fear response. In Chapter 6, we investigate the change in 
neuronal activities within the different regions of the PAG using buspirone (a 5-HT1A 
partial agonist) in the treatment of generalized anxiety disorder. Chapter 7 addresses the 
main hypothesis whether the fear-like behaviour could be attenuated by acute and chronic 
administration of buspirone or the SSRI escitalopram. Additionally, the levels of blood 
corticosterone were also explored with respect to the different experimental conditions. 
Finally, in Chapter 8, we provide an overall conclusion of our experimental findings and 
translate this to the clinical setting.  
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CHAPTER 2 
 
The Periaqueductal Gray:  
From longitudinal columns to defensive behaviour 
 
Lee Wei Lim, Arjan Blokland, Veerle Visser-Vandewalle,  
Harry Steinbusch, and Yasin Temel 
 
 
 
 
Abstract 
Recent findings on the different functional properties of the neuroanatomical 
columnar subdivision of the Periaqueductal Gray (PAG) have provided a fundamental 
understanding for the pathophysiology of panic and anxiety disorder. In this review, we 
focus mainly on the prominent role of the PAG in defensive behaviour by combining 
both the behavioural and neuroanatomical data. We have applied the theoretical model of 
the “two dimensional defence system” by McNaughton and Corr (2004), and thereby 
constituted an organizational structure on the neuronal circuitry of the different brain 
regions in relation with this panic- and fear-like behaviour. It has become clear that the 
dorsal and lateral PAG are involved in the active emotional coping (fight and flight 
reaction), whereas the ventrolateral PAG is responsible for the passive emotional coping 
(quiescence/freezing). In this regard, the PAG and other related brain structures are 
working in concert with different neurotransmitters providing animals with defensive 
strategies in response to predatory threats. The functional roles of the PAG in these 
behaviours as characterized in animals warrants further translational studies in humans 
which may eventually lead to novel approaches in anxiety- and panic-related disorders. 
 
 
(Submitted) 
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1. Introduction 
1.1 Background 
Panic attack is characterized by an acute moment of intense fear and psychological 
distress with a sudden onset and rapidly building to a peak level. It is frequently followed 
by somatic and psychological symptoms associated with a sense of impending danger and 
an urge to escape from the susceptible risk condition (Griez and Schruers 1998; Griez et 
al 2001). Besides, panic attack is regarded as the central pathological feature of panic 
disorder with physical symptoms such as shortness of breath, sweating, palpitations, 
trembling, feeling of choking, chest pain or discomfort, nausea or abdominal distress, 
feeling dizzy or unsteady, derealisation, fear of losing control, fear of dying, paresthesia, 
and chills or hot flushes (American-Psychiatric-Association 2000). The percentage of 
lifetime prevalence of panic attack in the United States range 3-5.6% and 1.5-5% for 
panic disorder (American-Psychiatric-Association 1998 May); and in Europe, the 
prevalence has been reported as 1.8% for panic disorder (Goodwin et al 2005). This 
disorder does not only cause functional disability but also affects the quality of life and 
related socio-economic conditions and interpersonal relationships (Abbar 1996; Klerman 
et al 1991; Wittchen 1988).  
 
To study the neurobiology underlying panic animal models have been developed 
in which animals display panic-like behaviour. A widely used and highly reproducible 
rodent model for panic and related behaviours is the electrical stimulation of the 
periaqueductal gray (PAG). This technique involves the implantation of an electrode to 
stimulate specific parts of the PAG. Electrical PAG stimulation evokes a typical escape 
behaviour, which is also referred as defensive behaviour or panic-like behaviour. This 
behaviour is characterized by fight, flight & freezing responses involving increased 
locomotor activity, galloping and jumps (Bandler et al 1985b; Brandao et al 1999; 
Brandao et al 1982; Brandao et al 2003). The defensive behaviour has been proposed to 
reflect aversive responses since they are very similar to escape reactions induced by 
natural aversive stimuli, such as the exposure to a proximal predator (Blanchard et al 
1988; Blanchard and Blanchard 1989a; Blanchard and Blanchard 1989b). Interestingly, 
two types of behaviour can be observed during electrical stimulation of the PAG. It has 
been found that sub-threshold stimulation resulted in freezing and stimulation at the 
threshold or above induced escape reaction. Following the post-stimulation period, the 
animals displayed highly immobile, indicative of fear response (Lim et al 2008a; Vianna 
et al 2001c).  
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In humans, stimulation of the PAG was originally applied for pain relief 
(Richardson and Akil 1977a; Richardson and Akil 1977b; Young et al 1985). Some 
studies also reported other findings after PAG stimulation. For example, in 1915 it was 
described by Brown that the PAG was a site for eliciting vocalization or “laughter” when 
stimulated with electrical current (Brown 1915). Twenty years later, Kabat and co-
workers demonstrated that PAG stimulation increased the respiratory rate and blood 
pressure (Kabat et al 1935). Many other studies have demonstrated that PAG stimulation 
produced intense emotional fear sensation, impending death with remarkable autonomic 
changes as characterized by the typical feature of panic attack (Amano et al 1978; Mobbs 
et al 2007; Nashold et al 1969). Recently, clinical reports have also shown that the 
reduction of pain and blood pressure were achieved by stimulating the rostral PAG and 
this is possibly mediated by a reduction in the central sympathetic system (Green et al 
2007; Green et al 2006).  
 
In the search for novel drugs and surgical therapies in panic disorders the PAG 
seems to be an interesting target. In 1990 Depaulis and Bandler provided an overview of 
the anatomical and neurochemical properties of the PAG and its role in defensive 
behaviour. In this review, we have applied the theoretical model of the “two dimensional 
defence system” by McNaughton and Corr (McNaughton and Corr 2004) and constituted 
an organizational structure for PAG regions in relation with this defensive behaviour. The 
two dimensional defensive behaviour is categorized into “defensive direction” and 
“defensive distance” based on the concept of Gray’s “Neuropsychology of Anxiety” 
(Gray 1982). The first dimension describes the two systems of defensive behaviour 
associated particularly with the PAG in controlling defensive avoidance (fear) and 
defensive approach (anxiety) (See Figure 1 and 2). The second dimension illustrates an 
important hierarchical neural organization of defensive behaviour with respect to the 
different levels of neuroanatomical structures. 
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Figure 1, Schematic illustration of the main upstream connections of the PAG based on 
the McNaughton and Corr’s two-dimensional defence system of “defensive avoidance” 
for panic and fear behaviour (McNaughton and Corr 2004). PFC= Prefrontal cortex 
(ventral stream), Ant. Cg= Anterior Cingulate, Amyg= nuclei of Amygdaloid complex, 
Hypo= Hypothalamus, and PAG= Periaqueductal Gray.  
 
 
 
 
Figure 2, Schematic illustration of the main upstream connections of the PAG based on 
the McNaughton and Corr’s two-dimensional defence system of “defensive approach” 
for anxiety related behaviour (McNaughton and Corr 2004). PFC= Prefrontal cortex, 
Post. Cg= Posterior Cingulate, Amyg= nuclei of Amygdaloid complex, Septo-Hipp= 
Septo-Hippocampal system, Hypo= Hypothalamus, and PAG= Periaqueductal Gray. 
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1.2. Organisation of the review 
We will first describe the intrinsic organization of the PAG including the specific 
cell types and the anatomical and functional separation into longitudinal columns, 
followed by a brief description of the regional anatomy in Section 2. In Section 3, the 
upstream and downstream connections of the PAG and its subdivisions will be discussed 
in detail. We will mainly focus on the functional and anatomical interconnections. 
Subsequently, in Section 4 we will review the neurochemical properties of the PAG 
including their behaviour correlates. In Section 5, we will discuss the role of the PAG in 
defensive behaviour in the light of behavioural and neuroanatomical data. Finally, we 
will discuss the use of animal models in which the PAG is stimulated and how this 
research may contribute to a promising future in treating neuropsychiatric disorders. 
2. Intrinsic organization of the PAG 
The PAG, also called the “substantia grisea centralis” or "central gray", surrounds 
the cerebral aqueduct of Sylvius from the midbrain to the brain stem. At the level of 
individual cells, three main types of neurons can be found. At the level of the PAG 
structure, cells are organized in longitudinal columns.  
2.1 Cell types  
Examination at the cellular level shows that the PAG consists of diffuse collection 
of neurons and fibers surrounding the cerebral aqueduct and the reticular formation, 
which are both important relay centers for ascending and descending sensorimotor 
pathways to and from the spinal cord (Jordan et al 1992; Zieglgansberger and Puil 1973). 
The morphology of the population of the majority of the neurons in the PAG comprises 
three major cell types: vertical cells, stellate cells, and horizontal cells (Laemle 1979). In 
general, the neurons of the PAG are all relatively small, ranging in size from 8 to 30 µm 
in diameter. Based on the Golgi-Cos study, these neurons can be divided into three 
different types, Class I (Ia & Ib), II  and III cells (IIIa, IIIb, IIIc, and IIId), according to 
their size and cytological characteristic (Hamilton 1973a; Hamilton 1973b; Liu and 
Hamilton 1980). 
 
 (a) Class I (Ia & Ib) neurons are approximately 18 µm in length and 8 µm in 
diameter. They are the smallest of the three types and have the shape of spindle bipolar 
neurons with one straight dendritic process. The nucleus is rather large, oval in shape and 
stains slightly lighter than the surrounding cytoplasm with the Nissl staining. The cells 
are generally darkly stained and have typically axons projecting from one end of the cell. 
The nucleus is located in the center and takes up the entire width of the cell. Nissl 
substances are uniformly distributed and are not found in clumps. Class I neurons are 
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usually found in the medial regions of the PAG. The type Ia is smaller than the type Ib 
and they are found particularly in the medial PAG.  
 
(b) Class II neurons are approximately 11 µm in length and 12 µm in diameter and 
are slightly larger with a fusiform or spherical shape. Triangular shaped neurons can also 
be found and have an apical dendrite that traverses a long distance within the PAG. The 
nucleus in this cell type is usually irregularly shaped. The axons of these cells are located 
in the central region, not at a pole as in class I neurons. Class II neurons generally have 
several dendrites. The Nissl substance is arranged in clumps which are evenly distributed 
in the cytoplasm. Class II neurons can be found in the area just dorsal to the cerebral 
aqueduct (the dorsal parts of the PAG) along with a large number of glial cells. 
 
(c) Class III (IIIa, IIIb, IIIc, and IIId) neurons are pleomorphic multipolar neurons, 
approximately 19 µm in length and 15 µm in diameter. They are the largest of the three 
types with a fusiform, spherical, or triangular shape and have a sparse amount of Nissl 
substance in their cytoplasm. In Golgi staining, type IIIa has a rhomboid-shaped soma 
and dichotomically branching dendrites, whereas type IIIb has a spheroidal soma and 
short axons. Type IIIc has a piriform soma and spiny dendrites, while the type IIId has 
the largest soma and structure resembles an undifferentiated motor neuron of the CNS. 
Due to the latter, these cells stain very lightly and usually only axons and dendrites can 
be identified. The nucleus is large in class III neurons, it is round, centrally located, and 
darkly staining. These cells (types IIIc and IIId) are found only in the lateral parts of the 
PAG along with a large number of glial cells. Axons of the types IIIa and IIId with strong 
branching characteristic are axonal projecting in nature, whereas the other types are 
found mostly in the lateral and dorsal parts of the PAG. 
2.2 Longitudinal columns  
The most frequently used subdivision system of the PAG is the separation into 
four major longitudinal columns according to their cytoarchitectural features (Figs. 3a, 3b, 
3c, 3d, and 3e; and Fig. 4). These subdivisions are cell-rich and serve as distinct 
anatomical modules for specific functions. They are generally classified as the 
dorsomedial- (dmPAG), dorsolateral- (dlPAG), lateral- (lPAG) and ventrolateral (vlPAG) 
PAG (Bandler and Shipley 1994; Carrive and Bandler 1991; Herrera et al 1987; Olszewki 
and Baxter 1954). The functions of these major subdivisions are discussed later. In 
addition, the intermediate part of the lPAG (ilPAG), which is a minor subdivision, has 
been found to contain dense NOS-staining fibers without NOS-staining neurons. This 
region in particular is thought to play a role in the modulation of cardiovascular functions 
including systemic arterial blood pressure and heart rate (Wang et al 2001). 
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Figure 3, A: lateral view, B: posterior-oblique vi 
ew, C: internal sagittal view, D: coronal section 
view – rostral PAG, and E: coronal section view.  
These 3-D reconstructions of the subdivisions of 
the PAG longitudinal columns were created based 
on the 1998 George Paxinos and Charles Watson 
rat’s Atlas 4th Edition (from Bregma -4.80mm till 
-8.80mm) using the Computer Aided Design 
(CAD) Environment software (Ontario, Canada) 
according to the anatomical and functional 
differentiation. Abbreviations: 1= dorsomedial 
PAG, 2= dorsolateral PAG, 3=lateral PAG, 4= 
ventrolateral PAG, and 5= aqueduct. A= anterior, 
P= posterior, D= dorsal, and V= ventral.   
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Figure 4, Bright-field photomicrographs showing a low-magnification overview of the PAG in 
sagittal section (Fig. 4A), horizontal section (Fig. 4C), and coronal section (Fig. 4E), stained by 
NADPH-diaphorase histochemistry and visualized with DAB-immunohistochemistry in the normal 
rat brain. The detailed information of the boxed areas in A, C, and E are shown in 40X high-
magnification photomicrographs of B, D, and F, respectively. Abbreviations: Aq= Aqueduct, cic= 
commissure of the inferior colliculus, csc= commissure of the superior colliculus, c-PAG= caudal 
periaqueductal gray, dlPAG= dorsolateral periaqueductal gray, dmPAG= dorsomedial 
periaqueductal gray, DpG= deep gray layer of the superior colliculus, DpMe= deep mesencephalic 
nucleus, DRN= dorsal raphe nucleus, DRVL= dorsal raphe ventrolateral, EW= Edinger Westphal 
nucleus, IMLF= interstitial nucleus of the medial longitudinal fasciculus, lPAG= lateral 
periaqueductal gray, NADPH= nicotinamide adenine dinucleotide phosphate-oxidase, 5-HT= 5-
hydroxytryptamine, Op= optic nerve layer of the superior colliculus, pc= posterior commissure, r-
PAG= rostral periaqueductal gray, and SuG= superficial gray layer of the superior colliculus. 
vlPAG= ventrolateral periaqueductal gray. 
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The dlPAG has a wedge-shaped form located most part in the rostral and 
intermediate two thirds region of the PAG. The dmPAG is located medially to the 
dorsolateral columns and is separated by an imaginary midline. The regions of lPAG and 
vlPAG columns are located in between the anterior boundaries of the dlPAG and the 
border of dorsal raphe nucleus (DRN). The boundary between the lateral and 
ventrolateral columns has been inferred from functional and connectional studies. There 
is no known specific histochemical marker that can be used to distinguish lPAG from 
vlPAG columns. However, a constant and useful identifying feature of the vlPAG is the 
presence of a number of prominent blood vessels (Bandler and Keay 1996; Bandler and 
Shipley 1994; Bandler and Tork 1987; Clement et al 1996).  
2.3 Regional anatomy of the PAG  
The PAG is located inferiorly to the reticular formation and its inferior border is 
bounded by the tegmentum (back of the pons), the nucleus fastigius of the cerebellum 
and medulla’s reticular area. Ventral to the PAG, close to the midline, is located the 
oculomotor nucleus (and associated Edinger-Westphal nucleus), and the medial 
longitudinal fasciculus. The medial lemniscus is located at anterior-laterally of the PAG 
and more lateral to the medial longitudinal fasciculus. Further ventrally lies the large red 
nucleus (nucleus ruber) and close to the red nucleus is the substantia nigra (SN) (Herrera 
et al 1987).  
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3. Functional connections of the PAG 
The PAG receives input from and projects to a variety of higher and lower centers. 
The organization of the projections differs per subdivision. Most of the data presented 
here are derived from rodent and non-human primate studies. In general, the connections 
of the PAG share three different characteristics. Firstly, monosynaptic connections (e.g. 
from the vlPAG neurons to the locus coeruleus) (Bajic et al 2000). Secondly, these 
connections are implicated only in the mediation of somatic defensive behaviour such as 
flight, fight and freezing responses. The third characteristic is that the connections are 
unequally distributed between PAG subdivisions (Vianna and Brandao 2003). 
3.1 Upstream connections  
The PAG is interconnected with several upstream brain regions. The majority of 
the fibers leaving the PAG usually terminate in the parabrachial nuclei, reticular 
formation, trigeminal motor nucleus and nucleus ambiguus. The main afferents are from 
the amygdala, nucleus stria terminalis, hypothalamus, midline thalamus, periventricular 
gray, the dorsolateral and ventrolateral midbrain tegmentum (Jurgens and Pratt 1979). In 
addition, several structures in the CNS receive dopaminergic inputs from the PAG, 
including the lateral bed nucleus of the stria terminalis, central amygdaloid nucleus 
(Hasue and Shammah-Lagnado 2002), nucleus accumbens (Stratford and Wirtshafter 
1990), striatum (Descarries et al 1986), lateral habenula (Li et al 1993), hippocampus 
(Pohle et al 1984), magnocellular basal forebrain (Semba et al 1988), lateral septum and 
medial prefrontal cortex (Stratford and Wirtshafter 1990). Different subdivisions are 
connected with different brain regions. These will be discussed in more detail in the next 
paragraphs.  
3.1.1 Amygdala 
The amygdala sends broad projections to the rostral midbrain including the PAG, 
the deep layers of the superior colliculus, and the lateral mesencephalic reticular 
formation (Fendt et al 1994; Meloni and Davis 1999). It has been suggested that 
amygdala and the PAG, together with the medial hypothalamus, constitute an integrated 
circuitry in the brain that commands defensive behaviour and elaborates aversive 
emotional and motivational states (McNaughton and Corr 2004). The amygdala’s 
function is most likely to make distinction and response to the various stimulus inputs 
from the environment and then sending message to the PAG according to the degree of 
threat occurring within an organism. The PAG would be in charge of selecting, 
organizing and commanding the appropriate behaviour and neurovegetative defensive 
reactions (Fanselow 1991). Studies using electrical stimulation to evoke defensive 
behaviours in awake animals have led to the conclusion that a pathway originating in the 
amygdala, projecting to the hypothalamus and from there to the PAG is essential for the 
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expression of these responses (Clemente and Chase 1973; Fonberg 1972; Kaada 1967; 
Siegel and Edinger 1981). 
 
The central amygdaloid nucleus has an essential link in the pathway mediating the 
autonomic and behaviour symptoms of conditioned fear. It is possible to disrupt the 
conditioned fear responses by destroying areas to which the central amygdaloid nucleus 
project. Studies over the past years have provided detailed descriptions of the efferent 
targets of the central nucleus in a number of mammalian species (Cassell et al 1986; Price 
and Amaral 1981; Saper 1979; Schwaber et al 1982; van der Kooy et al 1984). It has been 
shown that lesions of the lateral hypothalamic area interfere with autonomic, but not 
behaviour conditioned responses; whereas lesions of the midbrain dorsal PAG region 
interfere with behaviour, but not autonomic conditioned responses. However, lesions of 
the amygdala in the fear-conditioning pathway disrupt both the behaviour and autonomic 
responses (Iwata et al 1986; LeDoux et al 1984). Therefore, it was suggested that the 
pathways mediating autonomic and conditioned fear responses diverge after the 
amygdala with projections to the lateral hypothalamic area and PAG.  
 
Further evidence for an amygdala-PAG interaction is derived from studies in 
which experimental lesions of the rostra1 dorsal PAG, a target of the central amygdaloid 
nucleus, disrupted the conditioned freezing response, but did not affect the arterial 
pressure conditioned response (LeDoux 1994 ). In contrast, neither the freezing nor 
arterial pressure responses were affected by ibotenic acid lesions of the rostral PAG. The 
observation that lesions of the rostral PAG disrupts behaviour and cardiovascular 
conditioned responses indicate that the projection from the forebrain mediating the 
behaviour conditioned responses passes through, but does not synapse in, the rostra1 
PAG. Nevertheless, injection of ibotenic acid into the caudal PAG region has 
significantly reduced the duration of conditioned freezing but did not affect the 
conditioned arterial pressure response. Thus, the intrinsic neurons in caudal PAG 
contribute to the conditioned freezing, but not to the conditioned arterial pressure 
response (LeDoux 1994; LeDoux et al 1988).  
 
The midbrain PAG region possesses locomotor functions and receives projections 
from various limbic forebrain areas, including the central amygdala, and projects to 
spinal motor neurons. PAG has been considered as an interface between the limbic 
forebrain and spinal cord in the expression of fear behaviour. Lesions of the PAG would 
disconnect spinal motor systems from the amygdala. Processes mediated by the amygdala 
would thus be deprived of access to final common pathways controlling emotional 
behaviour when neurons in the caudal PAG are destroyed (Swanson et al 1984). 
 
Immunohistochemistry experiments have confirmed the chemical nature of PAG 
projections to the central amygdaloid nucleus. Robust projections from the PAG and 
DRN to the lateral bed nucleus of the stria terminalis, central amygdaloid nucleus have 
been documented with retrograde (Rizvi et al 1991; Shammah-Lagnado et al 2001)  and 
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anterograde tracing techniques (Cameron et al 1995a; Cameron et al 1995b; Rizvi et al 
1991; Vertes 1991). Some of these projecting neurons were found to be cholecystokinin- 
(Seroogy and Fallon 1989), serotonin (5-HT)- (Li et al 1990), vasoactive intestinal 
polypeptide- (Kozicz et al 1998; Petit et al 1995) and TH-immunoreactive (A10dc group). 
The latter mainly contributes to the dopaminergic innervation of the central amygdaloid 
nucleus. In addition, these small TH-immunoreactive periaqueductal neurons are 
frequently co-localised with cholecystokinin (Seroogy and Fallon 1989).  
 
The amygdala and PAG receive their input mainly from the innervation of 5-HT-
containing fibers originating from the DRN. The axons that project to the amygdala 
follow the DRN -forebrain tract, while those that go to the PAG run through the DRN -
periventricular tract. Most of the nerve fibers that originate in the DRN are thin and have 
small varicosities that make preferential contact with 5-HT2A/2C receptors (Azmitia and 
Segal 1978; Mamounas et al 1991; McTavish and Heel 1992).  
 
The different parts of the midbrain are involved in mediating different measures of 
conditioned fear, namely fear-potentiated startle and freezing, both of which are 
dependent on the amygdala. The study by Zhao and co-workers showed that fear-
potentiated startle in rats is mediated by neurons in the deep layers of the superior 
colliculus/deep mesencephalic nucleus of the rostral midbrain through the glutamate non-
NMDA receptors whereas the dlPAG was responsible for freezing (Zhao and Davis 
2004).  In another study, it was shown that microinjection of glutamate in the dorsal PAG 
area produced freezing behaviour (Krieger and Graeff 1985) and microinjection of 
GABA receptor blockers or GABA inhibitors of glutamic acid decarboxylase (GAD) 
produced fear-like behaviour with a delay of action about 7 min (Brandao et al 1982; 
Brandao et al 1986; Schmitt et al 1985). Lesions of the ventral PAG disrupted the 
conditioned freezing response but did not change the dorsal PAG electrical stimulation or 
chemical stimulation-induced freezing and escape responses (Vianna et al 2001a; Vianna 
et al 2001b).  These findings suggest that freezing and escape responses induced by 
dorsal PAG stimulation do not depend on the integrity of the ventral PAG.  
3.1.2 Hypothalamus  
The hypothalamic projections to the PAG can be divided into four subregions: 
anterior hypothalamus, the paraventricular nucleus, the posterior hypothalamus and the 
lateral hypothalamus (Fig. 5a, and 5b). Bandler and colleagues showed in 1982 & 1985 
that electrical stimulation of the medial hypothalamus evoked defensive behaviour or 
“defensive rage” whereas stimulation with excitatory amino acid failed to evoke such 
behaviour (Bandler 1982; Bandler and McCulloch 1984). In the PAG, both electrical and 
chemical stimulation evokes defensive behaviour. Sun and Guyenet reported that both 
electrical and chemical stimulation of the lateral hypothalamus increased the systemic 
arterial pressure, increased lumbar sympathetic nerve discharge, and produced excitation 
in sympathetic premotor neurons in the rostral ventral lateral medulla (Sun and Guyenet 
1986). They also provided evidence that the descending pathway from the lateral 
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hypothalamus was glutamatergic. This finding was contradicted by Hilton and Redfern as 
there was no sympathetic arousal as observed in the cardiovascular defensive response 
evoked by electrical or chemical stimulation of the hypothalamus (Hilton and Redfern 
1986). Furthermore, Hilton and associates demonstrated that sympathoexcitatory 
responses characteristic of the defence reaction were readily evoked by both electrical 
and chemical PAG stimulation (Hilton and Redfern 1986; Yardley and Hilton 1986). 
Electrical stimulation in animals of the areas from which defensive behaviour is evoked 
produced a pattern of sympathetic excitation characteristically evoked by threatening 
stimuli. Thus, electrical stimulation of sites in the amygdala, hypothalamus, and PAG 
evoke cardiovascular and defensive responses (Hilton 1975; Hilton and Zbrozyna 1963; 
Thornton et al 2002; Yang and Coote 1998).   
3.1.2.1 Anterior Hypothalamus 
Neurons located in the medial area of the anterior hypothalamus project strongly to 
the vlPAG (Snowball et al 2000) as well as the dlPAG (Semenenko and Lumb 1992), the 
dorsal and superior central raphe nuclei in the pontine tegmentum, to the nucleus raphe 
magnus (NRM), nucleus raphe pallidus (NRP), to the ventral part of the upper medullary 
medial tegmental field via the medial forebrain bundle, and the dorsal longitudinal 
fasciculus (Holstege 1987). 
 
Preoptic regions are considered to be part of the anterior hypothalamus. The 
median preoptic neurons are activated by warmth exposure and project to the rostral PAG. 
These neurons influence thermoregulatory skin vasodilatation. It has been shown that 
activation of rostral PAG neurons produced skin vasodilatation, and activation of neurons 
slightly caudal to this region suppressed vasodilatation in response to local warming of 
the preoptic area (Zhang et al 1995). These findings also suggested that it is quite 
probable that the rostral PAG and caudal PAG play some role in thermoregulation during 
environmental thermal stimuli as well as during local preoptic warming.  
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Figure 5, A: Superior oblique view, from anterior to posterior direction, and B: Superior oblique 
view, from posterior to anterior direction. These 3-D reconstructions of the subdivision of the 
hypothalamus were created based on the 1998 George Paxinos and Charles Watson rat’s Atlas 4th 
Edition (from Bregma -1.30mm till -4.80mm) using the Computer Aided Design (CAD) 
Environment software (Ontario, Canada). Abbreviations: 1=, Lateral hypothalamus, 2= Posterior 
hypothalamus, 3= Dorsomedial hypothalamic nucleus, 4= Ventromedial hypothalamic nucleus, and 
5= Anterior hypothalamic nucleus. A= anterior, P= posterior, D= dorsal, and V= ventral.   
 
 
 33 
3.1.2.2 Medial Hypothalamus 
The medial hypothalamus sends axons to the dlPAG of the midbrain via the dorsal 
longitudinal fasciculus (Arnault and Roger 1987). Electrical stimulation of this area 
produces affective aggression, and lesions of the PAG can subsequently disrupt this 
behaviour (Canteras et al 2001). Immunohistochemical analysis revealed the presence of 
5-HT axons and preterminals throughout the PAG, and in particular, in its dorsolateral 
aspect which receives major inputs from the medial hypothalamus. This projection has 
been implicated in defensive rage behaviour and is mediated by 5-HT1A and 5-HT2/1C 
receptors (Shaikh et al 1997).  
3.1.2.3 Paraventricular Hypothalamic ucleus  
The paraventricular hypothalamic nucleus (PVH) projects to the caudal brainstem 
and spinal cord via the medial forebrain bundle, the mammillotegmental tract and the 
dorsal longitudinal fasciculus. The fibers continue through the lateral part of the 
mesencephalon and upper pons, along this way, some fibers project to the nucleus raphe 
magnus, rostral nucleus raphe pallidus and adjoining reticular formation and specific 
parts of the medullary lateral tegmental field (Holstege 1987). The PVH contains a large 
number of neurotransmitter substances such as oxytocin, vasopressin, somatostatin, 
dopamine, met-enkephalin, leu-enkephalin, neurotensin, cholecystokinin, dynorphin, 
substance P, glucogen, renin and corticotrophin releasing factor (Swanson and 
Sawchenko 1983). The latter provides a clear evidence of neuroactive substances 
involved in the PVH-caudal brainstem or spinal pathway (Hermes et al 1988). More 
importantly, the retrograde study of the transportation of the neuroanatomical tracer 
cholera toxin-b from both the autonomic and endocrine components of the PVH showed 
neuronal activation and projection to the visceromotor (infralimbic) cortex, median 
preoptic nucleus, ventromedial preoptic area, bed nucleus of the stria terminalis, 
parabrachial nucleus, vlPAG, ventrolateral medulla, and nucleus of the solitary tract 
(Elmquist and Saper 1996). 
3.1.2.4 Lateral Hypothalamic area 
Tracing and autoradiographic studies showed that the lateral hypothalamus sends 
fibers to the vlPAG (Behbehani et al 1988) and lPAG (Bianchi et al 1998), the cuneiform 
nucleus, parabrachial nuclei, nucleus Kolliker-Fuse, nucleus subcoeruleus, the locus 
coeruleus, the caudal pontine and medullary medial reticular formation (Holstege 1988). 
Anatomical studies using injection of anterograde tracer Phaseolus vulgaris 
leucoagglutinin
 
into the lateral hypothalamus showed an extensive projection to the 
ventromedial and the
 
vlPAG and a less dense projection to the medial and dorsal
 
parts of 
this region (Behbehani et al 1988). There was a strong correlation between the response 
of PAG cells to
 
electrical stimulation and injection of glutamic acid into the lateral 
hypothalamus and their
 
response to pressure-injected neurotensin (Behbehani 1995). 
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3.1.3 Thalamus 
The topographic organization studies by Velayos & Reinoso clearly revealed the 
brainstem afferents of the mediodorsal (MD) thalamic nucleus (Velayos and Reinoso-
Suarez 1982). After injection of the retrograde tracer horseradish peroxidase (HRP) in the 
medial part of the MD thalamic nucleus, labelled neurons were observed at the level of 
the interpeduncular nucleus, ventral tegmental area and SN.  Injections of HRP in the 
intermediate part of the mediodorsal nucleus revealed labelled cells in the 
interpeduncular nucleus, SN, dorsal and central superior raphe nuclei, dorsal tegmental 
nucleus and coeruleus complex. After injections in the lateral part of MD thalamic 
nucleus, labelled neurons were observed in the deep layers of the superior colliculus, 
lateral and vlPAG, oral paramedian pontine reticular tegmentum, interpeduncular nucleus, 
SN, locus coeruleus, dorsal tegmental nucleus, cuneiform area, and the mesencephalic 
reticular formation (Velayos and Reinoso-Suarez 1982). Krout and Loewy observed that 
PAG projections to the thalamus are predominantly from the lPAG and vlPAG, 
innervating medial and intralaminar thalamic nuclei (Krout et al 2002; Krout and Loewy 
2000). In addition, the anterograde and retrograde lectin tracing techniques showed that 
the rostral reticular thalamic nucleus received inputs not only from the cingulate, orbital 
and infralimbic cortices, but also from the vlPAG, mesencephalic reticular formation, 
laterodorsal tegmental nucleus, pedunculopontine nucleus, medial pretectum and ventral 
tegmental area (Cornwall et al 1990). 
3.1.4 Raphe nuclei and reticular formation 
The median raphe nucleus and the DRN are localized in the midbrain and contain 
cell bodies of 5-HT neurons that project to the forebrain and midbrain including the PAG 
(Azmitia and Segal 1978). The connection of raphe nuclei with the PAG has been shown 
to play a role in the pathophysiology of generalized anxiety disorder and panic disorder 
(Abrams et al 2004; Chaouloff 2000). In this respect, the activation of the DRN-
periventricular 5-HT pathway, which also innervates the dorsal PAG, inhibited the fight 
or flight reactions in response to proximal danger, behaviour reactions that have been 
related to panic (Blanchard et al 2001a; Blanchard et al 2003; Graeff 2002; McNaughton 
and Gray 2000). Furthermore, the neural connectivity of raphe nuclei and PAG has been 
investigated using the elevated T-maze, the inhibitory avoidance and one-way escape 
(Pobbe and Zangrossi 2005). This study showed that, intra-DRN injection of the 5-HT1A 
receptor antagonist WAY-100635 had consistently affected the performance of these two 
behaviours. On the other hand, the dorsal PAG local administration of WAY-100635 had 
by itself no effect, but blocked the effect of intra-DRN injection of WAY-100635 on one-
way escape in the elevated T-maze. In contrast to WAY-100635, intra-dorsal PAG 
injection of the 5-HT2A receptor antagonist ketanserin blocked all behaviour effects of 
intra-DRN injection of WAY-100635 (Pobbe and Zangrossi 2005).  
 
A retrograde labelling study from the nucleus raphe magnus and adjoining 
reticular formation showed considerable numbers of labelled neurons in the lateral PAG, 
vlPAG, dmPAG, except for the dlPAG (Mantyh 1983a; Mantyh 1983b). At the caudal 
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pontine levels, the PAG fibers gradually shift ventrally and medially to terminate in the 
ventral part of the medullary medial reticular formation and in the nucleus raphe magnus 
(Holstege 1988; Jurgens and Pratt 1979). The caudal vlPAG and the ventrally adjoining 
mesencephalic tegmentum send fibers to the nucleus raphe pallidus. The neurons in the 
dmPAG projects strongly to the medially located nucleus raphe magnus while the lateral 
PAG and the laterally adjoining mesencephalic tegmentum project mainly laterally to the 
ventral part of the caudal pontine and upper medullary medical reticular formation with 
virtually no projections to the nucleus raphe magnus (Holstege 1988).    
3.1.5 Substantia nigra and ventral tegmental area 
The connection between the SN/ventral tegmental area and the vlPAG has been 
identified as the pathway to modulate cardiovascular physiology and nociception 
(Kirouac and Pittman 2000). This functional link has been demonstrated by stimulation 
studies of the SN/ventral tegmental area which produced significant cardiovascular 
responses and pain modulation that were mediated by a pathway to the vlPAG and DRN 
(Altier and Stewart 1998; Kirouac and Pittman 2000). However, there is no evidence at 
presence that antinociception elicited by activation of neurons in the SN/ventral 
tegmental area is mediated by a projection to the vlPAG. A retrograde tracing study has 
clearly shown that the vlPAG receives substantial input from the SN/ventral tegmental 
area (Coffield et al 2004; Comoli et al 2003). This projection does not appear to use 
dopamine as neurotransmitter, but is thought to be GABAergic (Kirouac et al 2004).  
3.1.6 Cortical connections 
A number of cortical projections in the medial prefrontal areas such as the 
infralimbic, prelimbic, anterior cingulate, and precentral areas and lateral areas along the 
rhinal sulcus (the anterior and posterior insular areas, and the perirhinal areas) project 
axons that terminate focally within the rostrocaudal columns of the PAG (Bandler et al 
1985b; Illing and Graybiel 1986; Neafsey et al 1986; Shipley et al 1991). 
 
The neural projections from the prefrontal cortical region to the PAG arise 
primarily from the medial prefrontal areas 25, 32, and 10m, anterior cingulate, and 
dorsomedial areas 24b and 9, selected orbital areas 14c, 13a, Iai, 12o, and caudal 12l, and 
ventrolateral area 6v (An et al 1998). In addition, the caudal parts of the prefrontal cortex 
also project to the PAG. These projections come from the posterior cingulate cortex, the 
dorsal dysgranular, and granular parts of the temporal polar cortex, the ventral insula, and 
the dorsal bank of the superior temporal sulcus. The projections from the medial 
prefrontal areas 10m, 25, and 32 terminate predominantly in the bilateral dlPAG columns. 
Fibers from orbital areas 13a, Iai, 12o, and caudal 12l terminate primarily in the vlPAG 
column, whereas fibers from dorsomedial areas 9 and 24b terminate mainly in the lateral 
column (An et al 1998). 
 
Several studies have shown that the medial prefrontal network is subdivided into 
three main circuits (An et al 1998; Bernard and Bandler 1998; Ongur et al 1998). These 
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three subdivisions are based on the projections to the specific columns of the PAG. The 
first circuit originates from the orbital areas within the medial prefrontal network (areas 
13a, Iai, 12o and caudal 12l) and project selectively to the vlPAG and to the lateral 
hypothalamus. The second circuit runs from the medial wall areas (10m, 25, and 32) to 
the dlPAG and to the medial and lateral hypothalamus. The third circuit has its origin at 
the level of the dorsomedial areas 24b and 9 and project predominantly to the lPAG, with 
additional projections to the dlPAG, vlPAG and to the dorsal hypothalamus (An et al 
1998; Bernard and Bandler 1998; Ongur et al 1998).  
 
In summary, (1) dorsal PAG: receives information from the caudodorsal part of the 
medial wall which includes anterior cingulate dorsal, anterior cingulate ventral, and the 
caudal parts of the prelimbic area and infralimbic area; (2) vlPAG: (a) projections from 
the rostroventral part of the medial wall specifically rostral portions of prelimbic and 
infralimbic areas, (b) from the adjacent medial orbital cortex which includes medial 
orbital, ventral orbital, and the medial part of ventrolateral orbital, and (c) from the lateral 
orbital and agranular insular cortical areas including dorsolateral orbital cortex, dorsal 
agranular insular cortex, and posterior agranular insular cortex; (3) lPAG:  receives input 
from the rostral prelimbic cortex, caudal prelimbic cortex, anterior cingulate dorsal, 
dorsolateral orbital cortex, and dorsal agranular insular cortex; (4) dlPAG, vlPAG, 
dmPAG lPAG: all receive projections from the perirhinal cortex  
 
The medial prefrontal wall region is divided into the infralimbic, prelimbic, and 
medial frontal polar areas. The infralimbic area (IL) corresponds to Brodmann area 25. 
The prelimbic area (PL) corresponds to Brodmann area 32 and possesses a well-defined 
lamination. The frontal polar area (FP) occupies medial (FPm) and lateral (FPl) parts of 
the frontal pole. The dorsomedial convexity includes anterior cingulate and precentral 
areas. The anterior cingulate cortex, which corresponds to Brodmann area 24, can be 
distinguished from the prelimbic cortex by a broader and less densely packed layer V. 
The anterior cingulate cortex was further divided into dorsal (ACd) and ventral (ACv) 
divisions. The precentral area is divided into precentral medial (PrCm) and precentral 
lateral (PrCl) areas. Although the whole of the orbital region is agranular, it can be 
divided into medial orbital (MO), ventral orbital (VO), ventrolateral orbital (VLO), 
lateral orbital (LO) and dorsolateral orbital (DLO) areas. Agranular insular cortex lies 
more caudally, superficial to the claustrum. It was subdivided into dorsal (AId), ventral 
(AIv) and posterior (AIp) areas. Dysgranular (DI) and granular (GI) insular cortices were 
also distinguished (Krettek and Price 1977a; Krettek and Price 1977b; Ray and Price 
1992). 
 
In the rat, primary motor areas of forelimbs, hind limbs and trunk project 
exclusively to the lPAG and vlPAG, while primary auditory and secondary visual cortex 
innervate the dlPAG. Perirhinal, anterior cingulate and agranular lateral retrosplenial 
cortex project to the dlPAG. The vlPAG receives projection from medial, ventral, dorsal 
and ventrolateral cortex, dorsolateral orbital and posterior insular agranular cortex. The 
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prelimbic and infralimbic cortex are connected to rostroventral portion of vlPAG and 
dorsocaudal portion of dlPAG (Vianna and Brandao 2003).   
3.2 Downstream connections 
3.2.1 Pons and medulla oblongata 
The caudal PAG neurons send projections to the nucleus retroambiguus, a 
structure located in the lateral portion of the most caudal part of the medulla oblongata. 
This structure in turn projects to the motor neurons innervating the pharynx, soft palate, 
larynx, intercostals and abdominal muscles; which may account for the vocalization 
responses during lateral PAG stimulation in animals (Holstege 1987; Jurgens and Ploog 
1970). 
 
The PAG projections to the pontine lateral tegmentum or paralemniscal cell group 
is considered to mediate the antinociceptive action, which does not completely disappear 
after blocking the nucleus raphe magnus and adjacent reticular formation (Guimaraes and 
Prado 1999). This finding corresponds with dorsal PAG stimulation induced analgesia 
after physiological blockage of the nucleus raphe magnus and adjacent reticular 
formation (Gebhart et al 1983; Guimaraes and Prado 1999; Sandkuhler and Gebhart 
1984).   
 
The rostroventrolateral medulla (RVLM) receives input from neurons from the 
raphe obscurus, raphe pallidus, raphe magnus, DRN, and also from the ventrolateral, 
lateral and ventral regions of the PAG, as shown by a double-labelling study with 
Cholera toxin subunit B (Bago et al 2002). Cholera toxin B positive neurons were located 
in all PAG regions and these cells were also 5-HT-positive. The majority of the 5-HT 
containing cells are located in the vlPAG, a few in the lPAG and ventral PAG, and none 
in the dorsolateral and dorsal PAG regions (Bago et al 2002). However, the attenuation of 
the cardiovascular components of a defence response evoked from the dorsal PAG, which 
involves 5-HT in the rostroventrolateral medulla neurons, could probably be initiated via 
a direct or indirect pathway from the vlPAG (Lovick 1992). Furthermore, the sympathetic 
components of an active defence response are also mediated through the 
rostroventrolateral medulla during the activation of dorsal PAG neurons (Lovick 1991). 
The hypotensive response evoked by the sympathoexcitatory region of rostroventrolateral 
medulla neurons has been shown to receive some projections from the neurons located in 
the vlPAG (Carrive and Bandler 1991; Chen and Aston-Jones 1995).  
 
The vlPAG–rostroventrolateral medulla pathway is also involved in the mediation 
of the sympatho-inhibition during the response to severe haemorrhage. This sympatho-
inhibitory response to haemorrhage depends upon the integrity of neurons in the caudal 
midline raphe neurons, which may be activated during haemorrhage by input from the 
vlPAG (Henderson et al 1998). In addition, 5-HT projections to the rostroventrolateral 
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medulla play a modulatory role at sympatho-excitory neurons via the baroreceptor, and 
chemoreceptor (Miyawaki et al 2001). 
3.2.2 Spinal Cord 
Some neurons in the lPAG send fibers through the ipsilateral ventral funiculus of 
the cervical spinal cord to terminate in laminae VIII and the adjoining part of VII (Martin 
et al 1979). A few fibers descend ipsilaterally in the lateral funiculus to terminate in the 
T1-T2 intermediolateral cell column (Holstege 1988). The neural projection to the medial 
part of intermediate zone in the cervical cord is involved in the head movement and not in 
nociception. In addition, the descending lPAG projections to the nucleus raphe pallidus, 
caudal pontine medial reticular formation continues to the axial muscle motorneurons in 
the spinal cord (Mouton et al 2005). This projection may be responsible for the medullary 
reticulospinal activation of axial muscle electromyogram (EMG) and lateral 
vestibulospinal activation of back muscle EMG in the rat after lateral PAG stimulation 
(Cottingham et al 1987; Cottingham and Pfaff 1987).  
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4.  eurochemistry of the PAG  
4.1 Monoamines and amino acids 
4.1.1 Serotonin 
In the PAG, as in the other structures of the CNS, 5-HT plays a major role in the 
regulation of anxiety and panic disorders (Abrams et al 2004; Chaouloff 2000) (Deakin 
1991b). This is based on the distribution of 5-HT-immunoreactive fibers and DRN 
projections to the substantia nigra, striatum, amygdala and frontal cortex (Imai et al 1986; 
Steinbusch 1981; van der Kooy and Hattori 1980). 5-HT-like immunoreactive cell bodies 
have been found in the ventrolateral and ventromedial regions of the caudal PAG and 5-
HT-like immunoreactive processes throughout the PAG (Please see Fig. 6)  (Clements et 
al 2004). The dorsal PAG also contains 5-HT1A and 5-HT2A receptors (Pobbe and 
Zangrossi 2005). 
 
Moreover, the DRN has long been considered as a centre for coordination of 
behaviour activation and modulation of cardiovascular and respiratory activity. In line 
with this, stimulation of the PAG causes changes of behaviour, cardiovascular and 
respiratory function. These findings suggest that the effect of PAG stimulation on panic-
anxiety, aversion and avoidance behaviour might involve the DRN. Furthermore, the 
PAG and DRN are interconnected (Fuxe 1965; Lindvall et al 1974; Petrov et al 1992; 
Peyron et al 1996; Tanaka et al 1994).    
 
Further studies have shown that the nucleus raphe magnus receives not only 5-HT 
input but also glutamatergic, cholinergic and peptidergic (NT, Substance P, Leu- and 
Met-enkephalin) from adjacent reticular nucleus cuneiformis and PAG (Basbaum and 
Fields 1984; Behbehani and Zemlan 1986; Richter and Behbehani 1991). It is important 
to note that microinjection of the 5-HT1 receptor agonist (5-methoxy-N,N-
dimethyltryptamine; 5-MeODMT) into the dorsal PAG increased the escape threshold, 
whereas microinjection of 5-HT2A receptor antagonists (metergoline or ketanserin) 
induced aversive reaction (Schutz et al 1985). Interestingly, Nogueira and Graeff showed 
that intra-PAG administration of the 5-HT1A receptor agonists (8-hydroxy-2-di-n-
propylaminotetralin hydrobromide; 8-OH-DPAT and BAY-R-1532) decreased the escape 
threshold during PAG stimulation (Nogueira and Graeff 1995). On the other hand, Jenck 
et al. (1989), Beckett and Marsden (1997) showed the opposite effects with systemic 
injection of 5-OH-DPAT (Beckett and Marsden 1997; Jenck et al 1989) in comparison 
with other neurochemical substances. 
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Figure 6, Bright-field photomicrographs showing a coronal section (Fig. 6A) of a normal rat 
brain processed for serotonin (5-HT) immunohistochemical staining to illustrate the widespread, 
diffuse innervation pattern of serotonergic fibers throughout the entire PAG region. Boxed area in 
Fig. 6A is shown in a 100X high-magnification photomicrograph in Fig. 6B. Illustrative images of 
5-HT immunoreactivity in the dmPAG (Fig. 6C), dlPAG (Fig. 6D), lPAG (Fig. 6E), and vlPAG 
(Fig. 6F) areas are shown with 40X high-magnification. 
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4.1.2 Dopamine 
Immunohistochemical staining for tyrosine-hydroxylase (TH) revealed that TH-
positive neurons can be found throughout the lPAG and vlPAG (See Fig. 7) (Han et al 
2003). These cells are classified microscopically into two groups depending on their size 
and location, (i) large size cells: TH-positive neurons with 30–40 mm in diameter, 
located in the lateral region of the PAG, with a multipolar morphology, and giving rise to 
abundant TH-positive fibers; and (ii) small size cells: rounded neurons of 10–15 mm in 
diameter located adjacent to the aqueduct of Sylvius surface in the vlPAG. Numerous 
TH-positive fibers are scattered within the vlPAG, with regularly spaced varicosities 
(asterisks). Both types of cells are thought to be neurons because they have shown to 
express the NeuN neuronal marker (Flores et al 2004). It has been observed that the small 
TH-immunoreactive PAG neurons contain cholecystokinin (Seroogy et al 1989). Large 
dopaminergic neurons of the PAG appear to participate in the supraspinal modulation of 
opiate-induced analgesia, but spinal nociceptive pain reactions, as measured by the tail-
immersion reaction, seem not to be affected after PAG dopaminergic neuron 
manipulation. The dopaminergic network of the PAG (See Fig. 8) has been included into 
the dorsocaudal A10 group as described by Hokfelt (A10dc group, 1984), and it is 
considered as a dorsal part of the dopaminergic periventricular system (Lindvall et al 
1974; Moore et al 1978; Moore 1978; Moore and Bloom 1978).  
 
Both D1 and D2 receptors are expressed by PAG neurons (Martin-Ruiz et al 
2001) and colocalization of D1 and D2 receptors is rare in the central nervous system 
(Missale et al 1998). However, PAG neurons that are involved in the modulation of 
opiate-induced analgesia express D1 rather than D2 dopamine receptors. The neuronal 
pathways underlying these analgesic effects are largely unknown at present.  
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Figure 7, Bright-field photomicrographs showing a coronal section of the rostral (Fig. 7A) and 
caudal (Fig. 7B) PAG regions containing tyrosine hydroxylase (TH) visualized with 
immunohistochemistry to illustrate the specific localization of TH neurons in the lPAG and 
vlPAG regions. Illustrative images of the rostral and caudal regions are shown with 20X 
magnification photomicrograph in C and E; and D and F. 
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Figure 8, Bright-field photomicrographs showing a coronal section (Fig. 8A) of a normal rat brain 
processed for dopamine (DA) immunohistochemical staining to illustrate the widespread, diffuse 
innervation pattern of dopaminergic fibers throughout the entire PAG region. Boxed area in Fig. 8A is 
shown in a 100X high-magnification photomicrograph in Fig. 8B. Illustrative images of DA 
immunoreactivity in the dmPAG (Fig. 8A), dlPAG (Fig. 8B), lPAG (Fig. 8C), and vlPAG (Fig. 8D) areas 
are shown with 40X high-magnification. 
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4.1.3 oradrenaline  
Noradrenaline (NA) belongs to the category of catecholamines and plays an 
important role in the central cardiovascular regulation. The PAG is densely innervated by 
catecholamine-containing terminals (Herbert and Saper 1992) and NA is highly 
concentrated in the midbrain, including the PAG (Versteeg et al 1976a; Versteeg et al 
1976b). A study based on the injection of anterograde tracer biotinylated dextran amine 
(BDA) into the vlPAG found labelled noradrenergic neurons in the dorsolateral and 
ventrolateral pontine tegmentum. The PAG contains a dense network of adrenergic and 
noradrenergic fibres which consists of ascending fibres from the caudal and rostral 
ventrolateral medulla to the ventral and dorsal parts of the PAG (Hebert and Saper 1992). 
 
Microinjection of NA into the rostral, medial and caudal portions of the dorsal 
PAG evoked pressor responses. The pressor response is based on the basal mean arterial 
pressure and heart rate of the rats. The magnitude or degree of the pressor responses 
varied according to the location of the injection site along the dorsal PAG column. This 
response is usually accompanied by bradycardia and no gross behaviour change. The 
pressor response was significantly higher when NA was injected into the rostral portion 
of the dorsal PAG and decreased when injections were performed at the caudal parts 
(Pelosi and Correa 2005). The stimulation of the hypothalamus elicits predatory attack in 
which the mean current strength of predatory attack can be diminished by microinjection 
of noradrenaline into the dorsal PAG. This indicates that hypothalamus-induced 
aggressive responses involve beta adrenoceptive mechanisms located in the dorsal PAG 
(Saha et al 2004). 
4.1.4 Glutamate 
The distribution of glutamate-like immunoreactive neurons has been observed in 
the PAG with the majority of the stained neurons being in the ventrolateral and dorsal 
PAG subdivisions. Aspartate-like immunoreactive neurons also exhibit a similar 
distribution pattern. These neurons are usually fusiform or triangular in shape and 
predominantly localized in the dorsolateral and ventrolateral subdivisions of the PAG. 
The numbers of aspartate-like immunoreactive neurons are documented less than the 
numbers of glutamate-like immunoreactive neurons (Clements et al 1987).  
 
Immunohistochemical staining methods have shown the presence and distribution 
of glutamate receptors in cell bodies located in the dorsal parts of the PAG. The 
glutamatergic system in the PAG has been associated with the expression of defensive 
rage responses (Beitz 1989; Carobrez 2003; Lima et al 2007). Injections of the NMDA 
receptor antagonist AP7 into the dorsal PAG induced anti-aversive effects in animal 
models of anxiety, such as in the elevated plus maze (Guimaraes et al 1991) or the Vogel 
punished licking test (Molchanov and Guimaraes 1999). In other studies, microinjection 
of NMDA into the PAG induced seizures followed by generalized clonic convulsions 
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(N'Gouemo and Faingold 1999; Peterson et al 2000; Raisinghani and Faingold 2003). 
The apparent convulsive behaviour was confirmed as seizure activity from EEG 
recordings (Peterson et al 2000). 
 
One of the glutamate-receptors that plays an important role in defensive responses 
is the kainate receptor. These receptors participate in excitatory neurotransmission by 
activating post-synaptic receptors and also bind to kainate and acts as a cation channel. 
They also modulate the release of inhibitory neurotransmitter GABA through a 
presynaptic mechanism. There are five types of kainate receptor subunits, GluR5, GluR6, 
GluR7, KA1 and KA2, which are similar to AMPA and NMDA receptor subunits. 
Kainate receptors play a role in both pre- and postsynaptic neurons (Huettner 2003). They 
have a limited distribution in the brain when compared to AMPA and NMDA receptors. 
In the PAG, prominent mRNA has been found of GluR-A, -B, and NR1. In adult rats, 
kainate triggers a full range of behaviour and autonomic defensive responses (Bandler 
and Depaulis 1988). Administration of kainate receptor antagonist into the PAG induces 
anxiolytic-like effects in the elevated plus maze (Matheus and Guimaraes 1997). The 
pretreatment with AMPA/kainate or NMDA glutamate receptor antagonists also 
attenuated the defensive reactions (flight reactions characterized by running and jumping) 
induced by an NO donor in the dlPAG (Moreira et al 2004). 
 
Injection of kainic acid into the DRN significantly increased the 5-HT release in the 
amygdala and the dorsal PAG (Adell et al 1991). In line with this, Viana and co-workers 
(Viana et al 1997) found that the 5-HT release in both structures enhanced inhibitory 
avoidance and impaired one-way escape in the elevated T-maze which is in accordance 
with Deakin & Graeff’s suggestion that release of 5-HT in the amygdala enhances 
conditioned fear (inhibitory avoidance) while the release of 5-HT in the dorsal PAG 
decreases unconditioned fear (escape) (Deakin 1991a; Viana et al 1997). 
 
Local infusion of the non-NMDA, AMPA/kainate glutamate receptor antagonist 
2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)-quinoxaline (NBQX) into the dorsal/lateral 
PAG, the lateral mesencephalic reticular formation, or the superficial superior colliculus 
did not affect the fear-potentiated startle. But the NBQX tended to reduce contextual 
freezing when infused into the dorsal/lateral PAG. However, the same dose of NBQX 
infused into the deep layers of the superior colliculus/deep mesencephalic nucleus (deep 
SC/DpMe) blocked fear potentiated startle. This suggests that the deep SC/DpMe, but not 
the ventral PAG, is critical for fear-potentiated startle but not freezing; whereas the PAG, 
but not the deep SC/DpMe, is critical for freezing (Zhao and Davis 2004). 
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4.1.5 GABA 
Gamma-amino butyric acid (GABA) is the most ubiquitous inhibitory transmitter 
with two major subtype receptors, GABA-A and GABA-B receptors. The GABA-A 
receptor is an ionotropic receptor that gates a chloride channel and GABA-B receptor is 
metabotropic, activating a second messenger cascade that activates a potassium channel. 
Immunohistochemical studies have shown that GABAergic neurons are widely 
distributed throughout the whole brain and are the major source of synaptic inhibition in 
the central nervous system. The precursor for GABA is glutamate and the key 
synthesizing enzyme is glutamic acid decarboxylase (GAD) which is a relatively good 
marker for GABAergic neurons  (Bear et al 2001; Brodal 2004; Kandel et al 1995).  
  
The GABA immunoreactive neurons are sparsely scattered throughout the PAG, 
but high numbers are present particularly in the dorsal and ventrolateral subdivisions 
(Borelli et al 2005a; Vianna et al 2003a). The post-embedding double-immunogold 
electron microscopic method of labeling provides better visualization of the subcellular 
morphological structures and permits quantification of the GABA and enkephalin 
neurotransmitters. This method has shown that there are 247 vesicle-containing axon 
terminals and 165 dendrites which are classified as GABA in the vlPAG (Renno et al 
1999). The enkephalin- and/or GABA-labelled terminals in this PAG area contain 
densely packed round or pleomorphic, small, agranular vesicles and form mainly 
symmetrical pre- and postsynaptic density contacts with enkephalin-labelled dendrites 
(Renno et al 1999). An autoradiography study has shown that both GABA-A and GABA-
B receptors exist in the PAG which indicates that many of the GABA-responsive PAG 
neurons have both subtypes of GABA receptors (Bowery et al 1987). With regard to this, 
the next finding by Reichling and associates in 1990, the short intrinsic circuit in the PAG, 
identified the GABAergic presypnaptic fibers in the dlPAG  (Reichling and Basbaum 
1990; Tredici et al 1983). 
 
Injection of GABA into the midbrain PAG activates medullary neurons that are 
involved in pain inhibition and potentate morphine-induced analgesia (Levy and Proudfit 
1979; Moreau and Fields 1986; Morgan et al 2003). GABAergic mechanisms in the PAG 
modulate the descending pain inhibitory system (Behbehani et al 1990). 
Electrophysiological studies have suggested that activation of µ-opioid receptors inhibits 
GABA neurons, thereby allowing the off-cells of the PAG to activate neurons in the 
nucleus raphe magnus, ultimately producing analgesia (Fields et al 1991). This suggests 
that GABAergic neurons are involved in the modulation of antinociception effects of 
opiates at the level of PAG. 
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4.2 europeptides  
4.2.1 Substance P  
Substance P is a short-chain neuropeptide that functions as a neurotransmitter. It 
belongs to the tachykinin neuropeptide family. In the central nervous system, substance P 
has been associated in the regulation of mood disorders, anxiety, stress, reinforcement, 
neurogenesis, respiratory rhythm, neurotoxicity, nausea/emesis and pain (Harrison and 
Geppetti 2001). Substance P is particularly concentrated in the amygdala and other 
regions that regulate affective behaviour and neurochemical responses to stress. The PAG 
also contains substance P-positive, medium-sized fibers with multiple varicosities 
(Kramer et al 1998; Maubach et al 1999; Renoldi and Invernizzi 2006).  
4.2.2 Cholecystokinin  
Cholecystokinin (CCK)-immunoreactive fibers are ranged from small to medium 
size with regular varicosities and its receptors are widely distributed within the gut and 
the brain (Moran et al 1986; Zarbin et al 1983). The immunohistochemical studies have 
shown that the CCK-like immunoreactive fibers and terminals are present throughout the 
rostrocaudal levels of the PAG and are more heavily distributed in the caudal two-thirds 
area. It was also demonstrated that a higher concentration of CCK immunoreactivity 
fibers and terminals was found in the dlPAG as compared with the dmPAG (Liu et al 
1994).  
 
Recently, systemic administration of CCK2 receptor agonist has been shown to 
trigger panic attacks in human (Bourin et al 1991; Bradwejn and Koszycki 2001). This 
effect seems to involve the dPAG since systemic administration of the latter drug induced 
Fos immunoreactivity in this area (Singewald and Sharp 2000). Further evidence for the 
involvement of CCK in panic is that intra-dPAG or systemic injection of CCK-8s 
induced escape or panic-like reaction in rats (Zanoveli et al 2004). This finding was also 
in consistent with previous reports that intra-dlPAG injection with CCK2 receptor agonist 
CCK-4 facilitated escape behaviour when the animals were tested in the elevated T-maze 
(Bertoglio et al 2006; Bertoglio and Zangrossi 2005) and in the bowl-shape cage 
(Bertoglio et al 2007). On the other hand, the treatment with CCK2 receptor antagonist 
LY225910 had significantly inhibited the escape reaction in the elevated T-maze, 
indicative of panicolytic-like action (Bertoglio and Zangrossi 2005). In view of these 
behavioural and immunohistochemical studies, among other factors, they support 
strongly that the regulatory site for panic-related behaviour is probably located in the 
dlPAG.  
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4.2.3. Enkephalin 
In1979, Gramsch and co-workers detected β-endophin and met-enkephalin in the 
PAG (Gramsch et al 1979). Several investigations showed that enkephalin neurons 
especially in the vlPAG play a role in pain modulation (Budai and Fields 1998; Williams 
et al 1995). Enkephalinergic terminals synapse on GABA containing dendrites in the 
PAG.  
 
The enkephalinergic system in the PAG is also involved in the modulation of 
hypothalamus-induced predatory attack behaviour (Siegel et al 1997). The predatory 
attack was elicited by electrical stimulation of lateral hypothalamus in the rat and it was 
completely suppressed by injections of delta-alanine methionine enkephaline in the dorsal 
PAG (Bhatia et al 1997). The injection of delta-alanine methionine enkephaline into the 
dPAG also completely suppressed the somatomotor components of predatory attack 
behaviour (Manchanda et al 1995). The administration of naloxone facilitated the 
hypothalamus-induced attack behaviour and cancelled the inhibitory effect of delta-
alanine methionine enkephaline (Bhatia et al 1997; Brutus and Siegel 1989; Manchanda 
et al 1995; Weiner et al 1991).  
4.2.4 Opioid receptors 
Opioid peptides are derived from proenkephalin A, and are found in very high 
levels in the PAG (Pittius et al 1984). Opioid peptides act on their receptors. These are 
the µ-, δ-, and κ-opiate receptors. Binding sites of these receptors have been localized in 
the PAG and possess excitatory effects and play a critical role in the activation of 
descending pain systems (Pfeiffer et al 1982a; Pfeiffer and Herz 1982; Pfeiffer et al 
1982b). Opiates typically exert inhibitory effects on neurons in the central nervous 
system except for PAG neurons (Gent and Wolstencroft 1976). Opioid effects in the PAG 
are mimicked by glutamate receptor agonists including NMDA and electrical stimulation 
(Jacquet and Squires 1988; Jensen and Yaksh 1989) and all drive PAG output. Numbers 
of neurons expressing c-Fos immunoreactivity after opioid withdrawal in both awake and 
anesthetized rats were elevated in the lateral and ventrolateral subdivisions of the PAG, 
predominantly in the caudal areas of the vlPAG (Chieng et al 1995).  
 
Stimulation of opioid receptors within the PAG activates the descending inhibitory 
pathways and suppresses nociception (Bellgowan and Helmstetter 1998; Rossi et al 1994). 
In addition, vlPAG stimulation in opioid-naive animals with excitatory amino acids 
produces quiescence, hyporeactivity, hypotension, bradycardia, and opioid-mediated 
analgesia (Keay et al 1997). Many vlPAG neurons that descend to the rostral 
ventromedial medulla, the excitation of which is thought to be crucial for analgesia, have 
immunolabelling for µ-opioid receptors (Commons et al 2000). The PAG also mediates 
several behaviour reactions such as freezing and defensive immobility, which are partly 
under opioid control (Fanselow et al 1991).  
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The µ-opioid receptor immunoreactivity is present in both subpopulations of 
GABAergic vlPAG neurons and vlPAG neurons that project to the rostral ventromedial 
medulla (Commons et al 2000).  
 
The κ-opioid receptor was previously known for its ability to cause strange 
psychoactive effects which have been called 'hallucinogenic'. Pharmaceutical companies 
looking for novel analgesics investigated kappa-opioid agonists and discovered that they 
caused unwanted side effects in humans which made them non-applicable as pain 
medications. The kappa opioid agonist, enadoline significantly increased measures of 
sedation, confusion and dizziness, produced visual distortions and feelings of 
depersonalization, and increased urinary output. The highest dose (160 µg/70 kg) was not 
tolerated and led to psychotomimetic effects (Walsh et al 2001). When rats are given the 
kappa opioid receptor agonist U50,488 during the first 3 post-natal weeks, they exhibited 
an increase in ultrasonic vocalization production and in contrast with adult rats showed 
no behaviour activation (Carden et al 1994; Kehoe and Boylan 1994). Kappa opioid 
receptors are also expressed in the PAG as early as the first postnatal week (Kitchen et al 
1990).  
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5. Discussion  
5.1 The defence circuit of the PAG 
According to the two-dimensional neuropsychology of defence proposed by 
McNaughton & Corr and in agreement with previous evidence, PAG and its connections 
control the alterations of circulation, respiration, pain perception, behaviour and 
automatic movements in response to threatening or novel stimuli (McNaughton and Corr 
2004). As for the PAG efferents, the majority of the fibers leaving the PAG usually 
terminate in the parabrachial nuclei, reticular formation, trigeminal motor nucleus and 
nucleus ambiguus. The PAG also receives afferents from the following structures such as 
the amygdala, nucleus stria terminalis, hypothalamus, thalamus, periventricular gray, the 
dorsolateral and ventrolateral midbrain tegmentum (Jurgens and Pratt 1979). Besides, 
several structures in the CNS receive dopaminergic (TH-ir) inputs from the DR/PAG, 
including the lateral bed nucleus of the stria terminalis, central amygdaloid nucleus 
(Hasue and Shammah-Lagnado 2002), accumbens (Stratford and Wirtshafter 1990), 
caudate-putamen (Descarries et al 1986), lateral habenula (Li et al 1993), hippocampus 
(Pohle et al 1984), magnocellular basal forebrain (Semba et al 1988), lateral septum and 
medial prefrontal cortex (Stratford and Wirtshafter 1990; Yoshida et al 1989). 
 
The medial hypothalamic area, including the anterior hypothalamus, dorsomedial 
part of the ventromedial hypothalamus (VMHdm), and dorsal premammillary nucleus 
(PMd), which together form a defensive system (Canteras 2002; Canteras et al 2001), 
shows a strong activation to conditioned fear (e.g. cat odor, as well as a live cat) 
(Canteras et al 1997; Dielenberg et al 2001a; Dielenberg et al 2001b; Dielenberg and 
McGregor 2001). The bed nucleus of the stria terminalis, ventral part of the lateral 
septum, and PAG are also activated during cat odor exposure. Keay & Bandler illustrated 
the axons of medial prefrontal cortex densely targeted the ventromedial hypothalamic 
nucleus and anterior hypothalamic area and terminated within the dlPAG (Canteras 2002; 
Vianna and Brandao 2003). On the other hand, the orbital and anterior insular prefrontal 
cortex areas selectively targeted the lateral hypothalamus and projected only to the 
vlPAG. As for the lPAG, the dorsomedial prefrontal cortex convexity and anterior 
cingulate cortex (area 24) firstly project its fiber to the dorsal hypothalamic areas and 
finally terminated in the lPAG column.  
 
It is interesting to note that the functional significance of the parallel projection 
from the prefrontal cortex to the different parts of hypothalamus finally terminate in 
specific columns of the PAG. Recent data have shown that the amygdala and the PAG, 
together with the medial hypothalamus, constitute an integrated circuitry in the brain that 
commands defensive behaviour and elaborates aversive emotional and motivational states. 
The function of the amygdala would be to synthesize the various stimulus inputs from the 
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environment and then signal to the PAG according to the degree of threat represented to 
the organism (LeDoux 1994 ; LeDoux et al 1988; McNaughton and Corr 2004).   
 
A series of retrograde studies revealed that the projections to the PAG arise 
predominantly from the medial prefrontal cortex wall and a few selected orbital/anterior 
insular prefrontal cortex regions (Floyd et al 2000; Reep and Winans 1982). In addition, 
injections of anterograde tracers into each PAG-projecting prefrontal region revealed 
distinct columnar patterns in the PAG. The medial prefrontal cortex projects densely to 
the dlPAG; whereas vlPAG received an exclusive robust input from the orbital and 
anterior insular areas (12o, 12l, 13a, 14c, Iai) and weaker input from the medial and 
dorsomedial prefrontal areas (Floyd et al 2000; Floyd et al 2001; Jasmin et al 2004). In 
addition, the dorsomedial prefrontal cortex (areas 9 & 24) was found to project robustly 
to the lPAG column, which indicates that different types of defensive behaviour are 
resulting from different columnar organization of the PAG (Gabbott 2003; Gabbott et al 
2003; Jasmin et al 2004; Yasui et al 1991).  
 
In line with McNaughton and Corr’s defensive system, Keay and Bandler (2001) 
divided emotional coping strategies of different types of stress into active and passive 
strategies. The active coping is regarded as the activation of either the dorsolateral or 
lateral PAG columns; whereas passive emotional coping strategy is triggered by 
activation of the ventromedial PAG column. This behaviour was observed during the 
microinjection of excitatory amino acid into the rostral dlPAG or lPAG which evoked a 
confrontational defensive reaction, while microinjection at the caudal dlPAG or lPAG 
evoked a response of escape or flight reaction (Keay and Bandler 2001). In addition, 
hypertension and tachycardia were noticed during the rostral dlPAG or lPAG 
(confrontational defence system) stimulation with decreased blood flow to skeletal 
muscle and viscera, but increased extracranial flow. Meanwhile, stimulation of the caudal 
dlPAG and lPAG evoked only the hypertension which was accompanied by increased 
blood flow to the skeletal muscle but decreased blood circulation in the visceral and oral 
facial region. In contrast to the stimulation of dlPAG or lPAG, microinjection of 
excitatory amino acid into the vlPAG produced a passive reaction of 
quiescence/immobility, decreased vigilance and hyporeactivity with hypotension and 
bradycardia, not responding to any external environmental stimuli. The similar effect of 
hypotensive responses without significant heart rate changes was also observed during 
the stimulation in the dmPAG (See Table 2) (Pajolla and de Aguiar Correa 2004; Pajolla 
et al 2005). 
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Table 1, Definition of different types of defensive behaviour associated with 
periaqueductal gray stimulation either by electrical or chemical compounds. 
TERMS DEFI ITIO  
Affective defense 
behaviour  
It is characterized by an aggressive response based on the presence of 
elements of either fear and/or threat, which may be real or perceived to be a 
threat stimulus as defined in both human and animal studies. In rodents, the 
behavioural response includes a flattening of the ears, a shrinking or 
lowering of the body, drawing in of the head, piloerection, hissing, and 
pupillary dilatation. 
Conditioned fear 
Behavioural inhibition with neurovegetative changes such as raised fur, 
defecation, urination, and teeth clattering which is associated with previous 
experience of aversive stimulus.  
Defecation 
Discharge of feces during emotional distress or normal physiological 
function. 
Defensive behaviour 
Behavioural and neuropsychological reaction in response to fear or anxiety 
condition with respect to avoidable and unavoidable threat stimuli. It is 
commonly categorized into flight, fight, and freezing response in the 
laboratory animal studies. 
Defensive rage 
It is a form of aggressive behaviour that characterized by remarkable 
sympathetic activation with behavioural signs such as arching of the back, 
pupillary dilatation, piloerection, retraction of the ears, growling, hissing, 
and paw striking at a moving object.  
Exophthalmus 
Eyeball protrusion and wide opened eyelids (contraction of orbital and tarsal 
sympathetic muscles, respectively). The eyes take on a spherical shape and 
brilliant appearance suggestive of an increased entrance of light.  
Flight 
It is a general model of predation defense behaviour to avoid or flee the 
animals from the attack of predator. In rats, the behaviour comprises the 
running (trotting or galloping) and/or jumping responses.  
Fight 
It is a form of aggressive behaviour to defend the animals against any attack 
from predators that the prey may fight back ferociously. Sometimes, it can be 
defending for a territory, food, shelter and mates.  
Freezing 
Most prey animals will avoid fights with predators, in general they will 
display a posture of tense immobility accompanied by exophthalmus, 
mystacioplegia and, quite often, defecation and micturition, accompanied by 
hypertension, hypervigilance and increased autonomic function. 
Galloping 
Fast running alternating stance and swing movements of anterior and 
posterior limb pairs.  
Grooming 
Self-directed behaviours consisting of the repetitive manipulation of the fur 
of the head and trunk as well as the manipulation and/or licking of the 
genitals. The rat displays a ‘sitting’ posture (upright posture on flexed hind 
limbs). 
Immobile behaviour The animals remain on a location usually with four paws on the ground.   
Jumping Upward leaps directed to the border of the open arena. 
Micturition 
Discharge of urine during aversive response or normal physiological 
function. 
Mystacioplegia Paralysis of ongoing vibrissae movements. 
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TERMS DEFI ITIO  
Panic-like 
symptoms 
Palpitation, blushing of face and neck and respiratory arrest or 
hyperventilation, feelings of terror or impending death, and desire to flee. 
The behaviour mimics defensive and escape behaviour.  
Predatory attack  
Aggressive behaviour specifically triggered by the presence of a prey object 
within the visual field of the predator that consists of a purposeful and goal-
directed attack with absence of sympathetic arousal. 
Rearing 
Upright posture with extended hind limbs and forelegs lean against the wall 
or an object. 
Resting 
Quiescent horizontal posture with open or half-open eyes, reduced sniffing 
activity and muscle relaxation as suggested by the flexion of the limbs and 
lowering of trunk and tail. The head may be raised and the rat displays a 
‘sphinx’ like posture.  
Running 
Increased locomotor activity with rapid movement of fore- & hind-limb 
toward or away from aversive stimuli. 
Sleeping 
Quiescent horizontal posture with closed eyes, no sniffing activity and 
overall muscle relaxation as suggested by the flexion of the limbs and 
lowering of the trunk, head, neck & tail.  
Tense immobility 
Overall behavioural arrest accompanied by an increased muscle tonus as 
suggested by the extension of the neck and:or limbs and raising of head, 
trunk and/or tail. Except for the visible tachypnoea, the rat looks like a 
‘statue’ for periods lasting from 10 s to the end of the stimulus (60 s).  
Trotting Running keeping the same pattern of walking 
Walking 
Typical rat locomotion showing out phase stance and swing movements of 
the contralateral limbs. 
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5.2  Summary  
In this review, we have outlined the general neuroanatomy and neurochemical 
properties of the PAG. The PAG has been considered a key structure to coordinate 
behaviour in response to threatening stimuli and pain regulation. It has been 
demonstrated that stimulation of this area in rats initiate different defensive behaviours 
such as fight, flight and freeze in response to aversive external and internal stimuli. 
Besides, it also eliminates the perception of pain by stimulation which is called 
stimulation produced analgesia. Several physiological changes have been observed in the 
alteration of blood circulation, respiration, pain perception, autonomic movement and 
postural adjustment with complex behaviour during and after the stimulation or lesions of 
the PAG. In addition, the PAG also modulates several biological functions such as 
reproductive or sexual behaviour, maternal behaviour, vocalization, anxiety, 
cardiovascular, and respiratory activities.  
 
The finding that the PAG is composed of different anatomical columns has 
contributed to the understanding of its functional differentiation. It consists of several 
columnar groups of neurons, each differing with regard to their connections. More 
specifically, it has become clear that the dorsal and lateral PAG are involved in the active 
emotional coping (fight and flight reaction), whereas the ventrolateral PAG is responsible 
for the passive emotional coping (quiescence/freezing). Several behaviours are 
coordinated through these columns by means of efferent connections to the reticular 
formation, raphe nuclei, cuneiform nucleus, and thalamus. The main afferent connections 
consist predominantly of projections from the sensory cortex, prefrontal cortex, cingulate 
cortex, motor cortex, insular cortex via the hypothalamus, amygdala, dorsal and median 
raphe nuclei. Such connectivity of different neuroanatomical structures presents a picture 
of neural systems in controlling the fundamental basis for defensive reactions. In view of 
these, the neuropsychology of defence also requires different interaction of 
neurochemical properties in concert with their morphological structures to achieve the 
optimal condition for defensive functions.     
5.3 Perspectives 
The history of PAG investigation dated almost a century old (See Table 2) and the 
future research should focus on the neurobiology aspect of its pathogenesis using the 
state-of-art technology of electrophysiological investigation. The precise relationship 
between the experimentally induced panic and naturally occurring panic attack share 
many similar clinical features in humans. However, the exact relationship of the 
underlying pathogenesis between these two remains largely unknown. Many studies in 
which the effects of the PAG stimulation have been investigated in combination with 
psychopharmacological challenge showed that the PAG is involved in panic or anxiety-
like behaviour. Thus, electrical stimulation of the PAG in animals would be a promising 
future direction in the aspect of neuropsychiatric disorders for developing potential 
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panicolytic and anxiolytic drugs. Besides, the anatomical structure and functional roles of 
the PAG in the animal brain have been studied extensively, whereas the human PAG is 
still poorly understood. It will be essential to conduct some fundamental investigations on 
the translational studies from the experimental rodent findings into human subjects. 
Further, electrical stimulation of the PAG has been shown to produce analgesic effect and 
lowering the blood pressure. These findings suggest a possible mechanism in the 
therapeutic approach to modify the pathological states of neuronal condition as well as 
their firing patterns. Such potential approach in normalizing the mechanism of 
dysfunctional neurons and its connectivity may possibly contribute to future 
neuropsychiatry surgery in terms of normalizing its neuronal firing patterns. Though, 
many hypotheses have been proposed to explain on how deep brain stimulation exerts its 
therapeutic effects, but still there is no well-established theories underlying its working 
mechanism (Lozano and Eltahawy 2004; Montgomery and Gale 2007). More importantly, 
addressing the application of these electrophysiological modulation techniques and a 
careful assessment during the intervention is required to explore these possible future 
therapies.  
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Table 2, The table presents the major milestones in the history of PAG research. The 
following dates and events were gathered chronologically from several sources based on 
the scientific published data dated since 1915. 
 
Years Chronological Events 
1915 
Brown made the first observation of the central gray in phonation. He stimulated 
the cut surface of the transected brain stem of rostral PAG and obtained a sound 
‘resembling laughter’. 
1935 
Kabat et al. demonstrated that central gray stimulation increases the respiratory 
rate and blood pressure. 
1937 
Magoun et al. demonstrated that stimulation of rostral PAG yielded species-
specific calls. 
1944 
Bailey and Davis described the central gray has been implicated in rage and fear 
reactions. 
1954 
Olszewski and Baxter subdivided the human PAG into a region adjacent to the 
mesencephalic aqueduct termed the subnucleus medialis, lateralis and dorsalis. 
1954 
Delgado et al. stimulated the dorsal PAG with observation of laboratory animals 
easily learned to switch off the experimental electrical stimulation. 
1956 
Hunsperger conducted electrical stimulation of the dorsal PAG in laboratory 
animals which induced defensive reactions, such as vigorous flight or defensive 
aggression. 
1958 
 auta’s limbic system-midbrain circuit proposed that limbic system has robust 
connenctions with mesencephalic structures such as PAG & tegmentum. 
1963 
Skultety demonstrated that many autonomic reactions can be elicited by 
stimulation or lesions of the central gray. 
1969 
Reynolds discovered that electrical stimulation of the periaqueductal gray 
induce profound analgesia. 
1969 
 ashold et al. demonstrated that during stimulation of human central gray 
produces feeling of intense fear. 
1972 
Wise et al. elaborated the theoretical model on serotomin with anxiety and 
expected the facilitation of serotonin in the escape behaviour. 
1972  
Kiser et al. (1972, 1975, 1978, 1980) showed the different ways of increasing 5-
HT activity in the dorsal PAG had an anti-aversive effect, whereas 5-HT 
depletion resulted in the facilitation of escape from dorsal PAG electrical 
stimulation. 
1973  
 obin and Bjorklund were the first to describe scattered neurons displaying 
catecholamine fluorescence lying ventrolateral to the aqueduct in the human 
fetal midbrain. Serotonin-containing cells were first identified in the human 
ventrolateral and ventral central gray using the Falck-Hillarp histochemical 
technique. 
1973 Hamilton conducted a study on the cytoarchitechture of the PAG subdivisions. 
1975  
Kiser and Lebovitz demonstrated that the stimulation of the dorsal central gray 
induces aversive behaviour in animals which might serve as animal model for 
anxiety. 
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1977  
Jurgens and Muller-Preuss emphasized the importance of direct descending 
limbic system input to the primate central gray. 
1977 
Hosobuchi et al., Richardson and Akil showed preliminary results on 
stimulation of the PAG was effective in reducing intractable pain. 
1978 
Schenberg & Graeff demonstarted that Benzodiazepines diminishes the 
aversive behaviour induced by central gray stimulation. 
1979 
Laemle described the vertical and horizontal cell in central gray, stellate cells 
with 4 randomly oriented primary dendrites and reported the neuronal axons 
arise from soma ascend and descend in the central gray. 
1979 
Holstege  mapped the central gray cells projecting to the spinal cord, raphe 
magnus/ pallidus and adjacent reticular formation of the cat. 
1979 
Gramsch et al. detected moderate amount of both β-endorphin & met-
enkephalin in human central gray. 
1979 
Sakuma and Pfaff described the central gray has been implicated in sexual 
behaviour. 
1979 
Rose demonstrated electrophysiologically the presence of neurons in the primate 
central gray which respond to genital, rectal, innoculous somatosensory and 
various forms of noxious stimulation. 
1980 
Kesner and Calder described the central gray has been implicated in the 
memory storage. 
1981 
 
Hardy and Leichnetz demonstrated that the prefrontal cortex of the monkey 
projects predominantly to the lateral dorsal subdivision of the central gray. 
1981 
Morato de Carvalho et al. carried out an experiment using electrical 
stimulation of the dorsal PAG as a punishing stimulus and showed that the 
neural substrate of dorsal PAG delivered punishment seems to be different from 
that of peripherally applied punishment as compared with Graeff 1974 electrical 
foot shock punishment. 
1982 
Pfeiffer et al. identified the localization of µ-, δ-, and κ-opiate receptor binding 
sites it the human PAG and possess the excitatory effects in the periaqueductal 
gray which play a critical role in the opiate activation of the descending pain 
modulatory systems as opioid-induced analgesia 
1982 
Mantyh investigated the hypothalamus with greatest descending input to the 
primate central gray, described the fusiform neuron in the monkey central gray, 
multipolar neurons and stellate cells. 
1982 
Brandao et al. concluded that the GABAergic terminals tonically inhibit the 
neurons of the dorsal PAG that control defensive behaviour and serotonergic 
fibers seem to exert a phasic inhibition of aversion. 
1983 
Palacios et al. concluded that serotonin receptors are present in the human 
central gray. 
1983 
Pearson et al. described tyrosine hydroxylase immunoreactive fibers in the 
ventral and ventrolateral PAG. 
1984 
Cortes et al. identified the human central gray contains a high density of 
muscarinic receptors especially in the dorsolateral subdivision. 
1985 
Kirzinger and Jurgens suggested that stimulation of caudolateral involved in 
vocal motor control. 
1986 Takahashi et al. confirmed the distribution of serotonergic neurons. 
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1987 
Pazos et al. identified the serotonin-1 & serotonin-2 receptors are present in 
human central gray. 
1987 
Clements et al. identified the distribution of glutamate-like immunoreactive 
neurons in ventrolateral and dorsal subdivisions of central gray. 
1988 
Beitz et al. provided the first detailed analysis of the interaction of central gray 
descending projections with bulbospinal neurons in the rat. 
1989 
Jenck et al. reported that 5-HT1A-receptor agonist enhanced escape from 
DPAG electrical stimulation. 
1990 
Graeff et al. concluded that the amygdala, the medial hypothalamus and the 
PAG constitute a set of interrelated structures, brain aversive system (BAS) that 
includes the dorsal PAG (Graeff 1981) act together to produce response 
suppression, emotional and motivational states. 
1994 
Bandler & Shipley described the columnar organization in the midbrain 
periaqueductal gray with 4 subdivisions as the dorsomedial, dorsolateral, lateral 
and ventrolateral PAG. 
1995 
 ogueira and Graeff explored the roles of serotonin receptors subtypes 5-
HT1A and 5-HT2A/2C in the regulation of aversion in the dorsal PAG. 
1996 
Reddy et al. identified the neurotransmitter receptors: nicotinic, muscarinic, 
serotoninergic, opiod, and kainate receptors in the middle gestational period of 
fetal development in the human PAG. 
1999 
Renno et al. confirmed the colocalization of GABA and enkephalin in the 
ventrocaudal periaqueductal gray. 
1999 
Brandao et al. regarded the dPAG contained fear neural substrates, with 
previous experimental evidence (see Brandao et al., 1982). 
2000 
Kirouac & Pittman showed a projection from the ventral tegmental area to the 
periaqueductal gray involved in cardiovascular regulation. 
2004 
Mc aughton and Corr  present a two-dimensional neuropsychology of 
defense: fear/anxiety and defensive distance  
2004 
Zhao & Davis confirmed that fear-potentiated startle is mediated by neurons in 
the deep layers of the superior colliculus/deep mesencephalic nucleus whereas 
the dorsal/lateral PAG responsible for freezing. 
2005 
Yoshida et al. concluded that the rostral PAG receives warm signals from the 
median preoptic nucleus and the caudal PAG receives cold signals from the 
dorsomedial hypothalamus/dorsal hypothalamic area. 
2006 
Maekawa et al. confirmed that the ventromedial hypothalamus are connected to 
the PAG. 
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CHAPTER 3 
 
Fos immunoreactivity in the rat forebrain  
induced by electrical stimulation of the  
dorsolateral periaqueductal gray matter  
 
Lee Wei Lim, Yasin Temel, Veerle Visser-Vandewall,  
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Abstract 
Electrical stimulation of the dorsolateral periaqueductal gray (dlPAG) matter 
induces panic- or fear-like responses with intense emotional distress and severe anxiety. 
In this study, we evoked this panic-like behaviour by dlPAG stimulation and evaluated 
the effects on neuronal activation in different brain regions. The number of c-Fos 
immunoreactive (c-Fos-ir) cells was measured semi-quantitatively through series of 
stained rat brain sections. Our results demonstrate strong neural activation in the medial 
prefrontal cortex, orbital cortex, anterior olfactory nuclei, secondary motor cortex, and 
the somatosensory cortex. A significant moderate increase in the number of c-Fos-ir cells 
was also detected in various regions, including the hypothalamus, amygdala, striatum, 
and frontal cortex. Additionally, there was mild expression of positive c-Fos-ir cells in 
the hippocampus, thalamus, and habenular regions. In conclusion, we have shown that 
electrical stimulation of the dlPAG produced a distinctive pattern of neuronal activation 
across forebrain regions as compared to the sham and control animals. Interestingly, the 
pattern of activation matched the defence system as described by McNaughton and Corr. 
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Introduction 
Electrical stimulation of the dorsolateral periaqueductal gray (dlPAG) evokes a 
typical reaction which is generally seen as escape or defensive behaviour (Bandler and 
Shipley 1994; De Oca et al 1998). This behaviour consists of a spontaneous flight 
reaction characterized by wild running, galloping, and jumping accompanied by 
hypertension, tachycardia, tachypnoea, freezing, and fear-like responses (Bittencourt et al 
2005; Hogg et al 2006; Lim et al 2008a). It is now widely accepted that this escape 
behaviour has similarities with panic-like symptoms in humans (Deakin and Graeff 1991; 
Nashold et al 1969; Schenberg et al 1998). In clinical practice, panic attack occurs 
spontaneously and produces intense emotional distress with significant changes in 
autonomic and neurological functions including palpitation, chest strains, sweating, 
dyspnoe, feeling of choking, trembling, nausea, dizziness, paresthesia, chills or hot 
flushes, depersonalization or derealization, and fear of dying or losing control (American-
Psychiatric-Association 1994; Cassano and Savino 1993). Importantly, the clinical and 
pre-clinical neuropsychological data have demonstrated a similar pattern of emotional 
changes of fear or panic-like behaviour during stimulation of the dorsal parts of the PAG 
(Hogg et al 2006; Hunsperger 1956; Nashold et al 1969).         
 
Numerous studies have been conducted to understand the pathophysiology of fear 
and panic processes within the PAG, and still not much is known about the mechanisms 
involved, most probably due to complicated neuroanatomy and neurochemistry (Borelli 
et al 2005b; de Bortoli et al 2006; Lim et al 2008a). This type of fear-like behaviour is 
rather complex and requires some higher cortical connections to process the acquired 
defensive information of external threats. In considering the neuronal structures for fear 
and panic-like reaction, there is evidence confirming that the PAG is involved in the 
coordination of defensive behaviour (Maren and Quirk 2004; Mobbs et al 2007). Recent 
preclinical studies have demonstrated that electrical stimulation of the dlPAG at the 
escape threshold led to a significant increase in the number of c-Fos immunoreactive (c-
Fos-ir) cells in specific neuroanatomical structures (Borelli et al 2005b; Lim et al 2008a). 
This neural activation is thought to reflect an extended neuroanatomical network 
controlling defensive behaviour (Coimbra et al 2006; McNaughton and Corr 2004; 
Vianna and Brăndao 2003). For instance, electrical or chemical stimulation of the dlPAG 
induced significant c-Fos expression in the ventromedial hypothalamus, dorsal 
premammillary nucleus, local coeruleus, amygdala and prefrontal cortex (Coimbra et al 
2006; McNaughton and Corr 2004; Vianna et al 2003b). Nevertheless, a systematic 
analysis of the effects of dlPAG stimulation on c-Fos expression is lacking. Such 
information would unravel which brain regions are directly or indirectly involved in 
defensive behaviour. In this experiment, we systematically analyzed the neuronal 
activation in different forebrain regions associated with electrical stimulation of the 
dlPAG. The number of c-Fos immunoreactive (c-Fos-ir) cells was measured semi-
quantitatively through consecutive series of immunohistochemically stained rat brain 
sections. 
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Material and Methods 
Subjects 
Subjects were male albino Wistar rats ( = 16, 12 weeks old, bred and housed at 
the Central Animal Facility of Maastricht University, Maastricht, the Netherlands). Rats 
had an average body weight of 300-350 g at the time of surgery. They were housed 
individually in standard cages on sawdust bedding in an air-conditioned room (about 20 
ºC) under a 12/12-h reversed light/dark cycle. Food, standard laboratory chow 
(Hopefarms, Woerden, the Netherlands) and water were available ad libitum. All 
experimental procedures were approved by the Animal Experiments and Ethics 
Committee of Maastricht University, the Netherlands.  
Surgical procedure 
A detailed description of the surgical procedure and the electrodes has been 
provided previously (Lim et al 2008a; Temel et al 2007). In brief, the rats were 
anesthetized throughout the entire surgical procedure using a combination of ketamine 
(90 mg/kg s.c.) and xylazine (10 mg/kg s.c.). Rats were placed in a stereotactic apparatus 
(Stoelting, Wood Dale, USA; model 51653). After making burr holes in the skull, rats of 
group A and B received implantation of the electrodes at the level of the dlPAG 
(coordinates from Bregma: AP, −7.6; ML, 0.7; and V, −4.8; approached with a coronal 
angle of 10°). A construction of one gold-plated needle-like electrodes with an inner wire 
of a platinum–iridium combination (Technomed, Beek, The Netherlands), with a tip 
diameter of 50 µm and a shaft diameter of 250 µm, was employed in this experiment. The 
electrode was fixed in position using dental cement (Heraeus Kulzer, Hanau, Germany). 
After the operation, rats were injected with Temgesic (0.1 mg/kg, s.c.) and received two-
week recovery and animal handling periods. Rats of group C (control) received no 
surgery.    
Deep brain stimulation 
The stimulation procedures were performed by two researchers. All animals had a 
preliminary stimulation session to determine the escape threshold. The stimulation 
amplitudes were gradually increased until the escape behaviour was observed. At each 
step, stimulation duration was 15 sec followed by stimulation off period of 45 s. The 
stimulation frequency was set at 50 Hz, and pulse width at 0.1 ms based on previous 
experiments that variation in pulse width did not influence the behavioural performance 
(Desbonnet et al 2004). A World Precision Instruments digital stimulator (DS8000, WPI, 
Berlin, Germany) and a stimulus isolator (DLS100, WPI, Berlin, Germany) were used to 
deliver the stimuli. Real time verification of the parameters applied during stimulation 
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was obtained using a digital oscilloscope (Agilent 54622D oscilloscope, Agilent 
Technologies, Amstelveen, the Netherlands). After confirming the current amplitudes 
necessary to evoke escape behaviour, all rats had a two-week stimulation off period 
before the final stimulation session was performed at the lowest threshold of escape 
reaction.     
Behavioural evaluation  
Rats were placed in the open-field (OF) arena (square: 100cm x 100cm, and height: 
40cm), clear Plexiglas box with an open top and a dark floor (Lim et al 2008e). The 
apparatus was located in a dimly red lit condition (15-20 lux) based on the 
recommendation of the guide for light intensity in animal rooms (UFAW 1999; Van 
Zutphen et al 2006). All testing was conducted in the same room and the apparatus was 
cleaned after each experimental procedure with ethanol. Rats were connected with an 
external stimulator through externalized leads. The stimulation started approximately 1 
min after the rat was placed in the OF arena. We observed three different types of 
behaviour during the experimental procedure, consisting of ‘no effect’, ‘freezing’ 
behaviour characterized by piloerection, micturition/defaecation, and immobility, and 
‘escape behaviour’ characterized by rigorous and aimlessly running. Behavioural changes 
during this procedure were observed by two researchers. Freezing behaviour was 
consistently characterized by immobility (without body movement) accompanied by two 
distinctive symptoms of increased alertness (head scanning) and piloerection. After 
cessation of stimulation, freezing disappeared and animals began to move again. Animals 
with escape thresholds above 100 µA were discarded from analysis. All the testing 
condition and experimental paradigm were ensured to be similar in all animals in order to 
avoid differences in activation due to factors other than the stimulation.  
Experimental groups 
These procedures resulted in three experimental groups: A. dlPAG stimulation 
(n=7,) B. dlPAG sham (n=2), and C. control (n=5). The sham (operated) and control 
animals (non-operated) were tested similarly with those of electrical stimulation group. 
The sham group consisted of two rats who were originally in group A, but showed 
malfunction of the electrode and have therefore been treated as a separate, sham 
stimulated group.  
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Histological processing 
Two hours after the final electrical stimulation procedure, rats were placed under 
generalized anesthesia with Nembutal (75 mg/kg) and perfused transcardially with 
Tyrode (0.1 M) and fixative containing 4% paraformaldehyde, 15% picric acid and 
0.05% glutaraldehyde in 0.1 M phosphate buffer (pH 7.6). The rat brains have been post-
fixed for 2 hours in the same fixative used for perfusion. Hereafter, the brains have been 
cryprotected by overnight sucrose treatment at 4 °C. Brain tissue was then quickly frozen 
with CO2 and stored at − 80 °C. Subsequently, the forebrain regions were cut serially (10 
series) on a cryostat (MICROM, Germany) into 30 µm frontal sections and again stored 
at − 80 °C. One from the ten series was taken for c-Fos immunohistochemistry which 
was carried out by using an anti-c-Fos rabbit polyclonal antibody (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA) (diluted 1:20,000 in 0.1% Bovine Serum Albumin 
(BSA) and Tris Buffered Solution (TBS)-Triton (TBS-T) solution) which was used as the 
primary antibody. After overnight incubation at room temperature on a constant shaker 
with this primary anitibody, sections were rinsed with TBS-T, then TBS, and then TBS-T 
again. They were then incubated with the secondary antibody (diluted 1: 400 in 
biotinylated donkey anti-rabbit biotine; Jackson Immunoresearch Laboratories Inc., 
Westgrove, USA) for 90 min. Subsequently, the sections were incubated with an avidin-
biotin-peroxidase complex (diluted 1:800 in Elite ABC-kit, Vectastatin; Burlingame, 
USA) for 2 h. In between steps, sections were washed with TBS and TBS-T. To visualize 
the immune complex of Horseradish Peroxide (HRP) reaction product, sections were 
incubated with 3,3’-diaminobenzidine tetrahydrochloride (DAB)/ Nickel Chloride 
(NiCL2) solution (5ml DAB solution, 5ml Tris/HCl, 50µl NiCL2, and 3.35 µl hydrogen 
peroxide). This reaction was stopped after 10 min by rinsing thoroughly all the sections 
with TBS. All sections were then mounted on gelatin-coated glasses. After dehydrating, 
all sections were cover-slipped with Pertex (HistolabProducts ab, Goteborg, Sweden). 
Additionally, another sequence of sections per animal was stained with standard 
hematoxylin–eosin (Merck, Darmstadt, Germany) to examine the localization of the 
electrode tips. 
Semi-quantitative evaluation of c-Fos immunoreactive cells 
Photographs of the areas of interest were taken at 4X magnification using an 
Olympus DP70 camera connected to an Olympus AX70 bright-field microscope 
(analySIS; Imaging System, Münster, Germany). The semi-quantitative assessment was 
similar to a previously reported method, with minor modifications (Nguyen et al 2006). 
The nomenclature and selected boundaries for semi-quantitative evaluation of the areas 
of interest were analyzed according to the rat brain atlas of Paxinos and Watson (Paxinos 
and Watson 1998) and based on the following coordinates according to bregma (mm, 
anteroposterior levels): 3.70, 3.20, 2.70, 2.20, 1.70, 1.20, 0.70, 0.48, 0.20, -1.80, -1.88, -
2.12, -2.80, -3.14, -3.30, -3.80, -4.16, and -4.30. Sections after bregma levels -4.52 mm 
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were not taken into evaluation because they were stained with standard hematoxylin–
eosin (Merck, Darmstadt, Germany) for evaluation of electrode tip localization. The areas 
of evaluation were based on histological criteria. The number of positive c-Fos-ir cells 
was semi-quantitatively graded with the following scores as: negative (–), weak (+/–) 
mild (+), moderate (++), and strong (+++), a method used previously (Nguyen et al 2006). 
The determination of scores was based on the number of positive c-Fos-ir cells with 
consideration of the areas’ size of interest in comparison with the control (n=5) and sham 
(n=2) groups. The procedures of grading were performed twice for each animal and the 
average of the scores was used as the final grade. The same light intensity and threshold 
conditions were employed for all sections. In addition, artifacts (dust debris) and nature 
of the c-Fos cells in the sections were taken into consideration to ensure the accuracy of 
measurements. An inter-rater reliability assessment was used to assess the consistency of 
a measure involving a comparison of the dlPAG DBS group with the control and sham 
groups.  
Statistical analysis 
Behavioural data are presented as mean ± S.E.M using one-sample T-test. The c-
Fos-ir cells were assessed semi-quantitatively, as explained earlier.  The inter-rater 
reliability was approximately 90% for c-Fos ratings.  
Results 
Histological evaluation of the electrode localization 
In two rats electrode tips were not located in the dlPAG and in these rats the 
escape threshold was > 100 µA. These rats were discarded from analysis. The 
localizations of the electrode tips in the dlPAG are illustrated in Fig. 1. Based on the 
histological staining with hematoxylin and eosin, no gross neuronal damage was 
observed except for the electrode trajectory. 
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Figure 1. Representative low-power photomicrographs of a 30 µm-thick coronal section 
from the brain of a rat subjected to stereotactic implantation of concentric bipolar electrode 
to stimulate the dlPAG (Fig. A, scale bar = 250µm) are shown. Fig. B, Schematic 
representation of the electrode sites in the dlPAG according to the Paxinos and Watson atlas, 
respectively. The symbol (▲) indicates the electrode localization in the dlPAG. 
Abbreviation: Aq = aquaduct of Sylvius, dlPAG = dorsolateral periaqueductal gray. 
Behavioural effects on stimulation  
The current intensity applied to the dlPAG was based on the lowest threshold to 
induce escape behaviour. The mean current amplitude necessary for inducing ‘freezing 
behaviour’ was 78.57 ± 4.04 µA, and 85.71 ± 5.05 µA for ‘escape behaviour’ (Fig. 2).  
 
 
Figure 2. This figure shows the current amplitudes (µA) necessary to induce escape 
reaction. Data represent means ± S.E.M. of dlPAG group. 
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Distribution of c-Fos immunoreactive cells  
High numbers of c-Fos-ir cells were observed in the medial prefrontal cortex, 
orbital cortex, anterior olfactory nuclei, secondary motor cortex, and the somatosensory 
cortex in rats with dlPAG stimulation as compared to rats without dlPAG stimulation. In 
addition, moderate numbers of c-Fos-ir cells were detected in various regions, including 
the hypothalamus, amygdala, striatum, and frontal cortex. Furthermore, there was mild 
expression of c-Fos-ir cells in the hippocampus, thalamus, and habenular regions. Tables 
1, 2, and 3 provide more detailed information concerning the pattern of c-Fos-ir cells in 
different areas of the brain resulting from dlPAG stimulation.  
Cortical Regions 
Electrical stimulation of the dlPAG increased the number of c-Fos-ir cells in the 
frontal cortical areas  such as the cingulate gyrus (Cg1 & Cg2), prelimbic (PrL), 
infralimbic (IL), and motor cortex 2 (M2), but not in the motor cortex 1 (M1) (Figs. 3 A-
F). Other cortical regions, for instance the piriform cortex (Pir), dorsal and ventral parts 
of agranular insular cortex (AID and AIV), claustrum (Cl), ventral and lateral part of 
orbital cortex (VO and LO) (Figs. 4 A-F), retrosplenial agranular (RSA), retrospenial 
agranular a and b cortex (RSGa and RSGb), primary somatosensory cortex (S1), and 
secondary somatosensory cortex (S2) (Figs. 5 A-F), showed a strong increase in the 
number of c-Fos-ir cells. Interestingly, we noted that dlPAG stimulation induced c-Fos 
expression in the 5
th
 and 6
th
 cortical layers of the granular insular cortex (GI), dysgranular 
insular cortex (DI), and the posterior part of agranular insular cortex (AIP), but not in the 
1
st 
- 4
th
 cortical layers (Figs. 6A, B, C, and D).    
Thalamus, hypothalamus, and habenula 
Moderate numbers of c-Fos-ir cells were observed in the dorsomedial part of 
laterodorsal thalamic nucleus (LDDM), and the paraventricular thalamic nuclei (PV); 
while the central thalamic nucleus (CM) only showed mild significant difference, in 
dlPAG-stimulated animals. No remarkable changes were detected in other parts of the 
thalamic nuclei (Figs. 7A, B, C, and D). Similarly, the habenular nuclei were also less 
affected except for the medial part of the lateral habenular nucleus (LH) which showed a 
mild increase in c-Fos-ir cells (Figs. 7A and B). However, dlPAG DBS caused a 
pronounced increase in the number of c-Fos-ir cells in different parts of the hypothalamus, 
particularly in the lateral hypothalamic area (LH), posterior part of anterior hypothalamic 
area (AHP), ventromedial hypothalamus (VMH), and periventricular hypothalamic 
nucleus (Pe) (Figs. 7E and F).  
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Figure 3. Representative photomicrographs of a 30 µm-thick coronal section from brain regions of the frontal 
cortical areas at the bregma level of 2.20 mm. Figures. A, C, and E show the c-Fos-ir cells in animals with the 
dlPAG DBS as compared to the control animals (Figs. B, D, and F). The small dark dots represent c-Fos-ir cells 
at 4X magnification power. The inset in A shows a representative high-power photomicrograph of a c-Fos-ir 
cell. Abbreviations: Cg1 (cingulate gyrus 1), M1 (motor cortex 1), M2 (motor cortex 2), PrL (prelimbic cortex), 
IL (infralimbic cortex), fmi (forceps minor of the corpus callosum), Cl (claustrum), VO (ventral orbital cortex), 
Acb (nucleus accumbens), aca (anterior commissure, anterior part), TuPO (olfactory tubercle plexiform), and 
TuDC (olfactory tubercle densocellular layer).  
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Figure 4. Representative photomicrographs of a 30 µm-thick coronal section from brain regions of the frontal 
cortical areas at the bregma level of 2.20 mm. Figs. A, C, and E show the c-Fos-ir cells in animals with the 
dlPAG DBS as compared to the control animals (Figs. B, D, and F). The small dark dots represent c-Fos-ir cells 
at 4X magnification power. Abbreviations: M1 (motor cortex 1), fmi (forceps minor of the corpus callosum), Cl 
(claustrum), VO (ventral orbital cortex), LO (lateral orbital cortex), AIV (agranular insular cortex, ventral part), 
AID (agranular insular cortex, dorsal part), aca (anterior commissure, anterior part), and Pir (piriform cortex).  
 
 82
 
 
Figure 5. Representative photomicrographs of a 30 µm-thick coronal section from brain regions of the cortical 
areas at the bregma level of -2.3 mm. Figs. A, C, and E show the c-Fos-ir cells in animals with the dlPAG DBS 
as compared to the control animals (Figs. B, D, and F). Abbreviations: RSGb (retrosplenial granular b cortex), 
RSA (retrosplenial agranular cortex), M1 (motor cortex 1), M2 (motor cortex 2), S1Tr (primary somatosensory 
cortex, trunk region), S1Dz (primary somatosensory cortex, dysgranular region), S1BF (primary somatosensory 
cortex, barrel field), and cc (corpus callosum). 
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Figure 6. Representative photomicrographs of a 30 µm-thick coronal section from brain regions of the cortical 
areas at the bregma level of -2.3 mm. Figs. A, C, and E show the c-Fos-ir cells in animals with the dlPAG DBS 
as compared to the control animals (Figs. B, D, and F). Abbreviations: S2 (secondary somatosensory cortex), GI 
(granular insular cortex), DI (dysgranular insular cortex), AIP (agranular insular cortex, posterior part), CPu 
(caudate-putamen), Pir (piriform cortex), BLA (basolateral amygdaloid nucleus, anterior part). 
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Figure 7. Representative photomicrographs of a 30 µm-thick coronal section from brain regions of the 
epithalamic nuclei and thalamic nuclei (Figs. A, B, C & D), and hypothalamic nuclei (Figs. E & F) at the 
bregma level of -3.14 mm. Figs. A, C, and E show the c-Fos-ir cells in animals with the dlPAG DBS as 
compared to the control animals (Figs. B, D, and F). Abbreviations: LDDM (laterodorsal thalamic nucleus, 
dorsomedial part), sm (stria medullaris of the thalamus), LHbL (lateral habenular nucleus, lateral part), LHbM 
(lateral habenular nucleus, medial part), MHb (medial habenular nucleus), MD (mediodorsal thalamic nucleus), 
VL (ventrolateral thalamic nucleus), PV (paraventricular thalamic nucleus), IMD (intermediadorsal thalamic 
nucleus), CM (central medial thalamic nucleus), D3V (dorsal 3rd ventricle), ic (interna capsule), Rt (reticular 
thalamic nucleus), VPL (ventral posterolateral thalamic nucleus), VPM (ventral posteromedial thalamic 
nucleus), Po (posterior thalamic nuclear group), LH (lateral hypothalamic area), TC (tuber cinereum area), AHP 
(anterior hypothalamic area, posterior part), VMH (ventromedial hypothalamic nucleus), Pe (periventricular 
hupothalamic nucleus), Arc (arcuate hypothalamic nucleus), and 3V (3rd ventricle).  
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Table 1. Overview of the effects of electrical stimulation of the dlPAG on c-Fos-ir cells expression in brain 
regions of medial prefrontal cortex, orbital cortex, agranular insular cortex, somatosensory cortex, olfactory 
areas, and other areas (bregma coordinates from 3.70 mm till 0.20 mm). Semi-quantitative scores of positive c-
Fos-ir cells: - , negative; +/-, weak, but definite; +, mild; ++, moderate; +++, strong; N/A, brain structure not 
available in the mentioned bregma coordinates. 
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Table 2. Overview of the effects of electrical stimulation of the dlPAG on c-Fos-ir cells expression in brain 
regions of cortical areas, amygdala, basal ganglia, and hippocampus (bregma coordinates from – 1.80 mm till – 
4.30 mm). Semi-quantitative scores of positive c-Fos-ir cells: - , negative; +/-, weak, but definite; +, mild; ++, 
moderate; +++, strong; N/A, brain structure not available in the mentioned bregma coordinates. 
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Table 3. Overview of the effects of electrical stimulation of the dlPAG on c-Fos-ir cells expression in brain 
regions of habenular, thalamus, and hypothalamus (bregma coordinates from – 1.80 mm till – 4.30 mm). Semi-
quantitative scores of positive c-Fos-ir cells: - , negative; +/-, weak, but definite; +, mild; ++, moderate; +++, 
strong; N/A, brain structure not available in the mentioned bregma coordinates. 
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Basal Ganglia 
As shown in figures 8 (C) and (D), dlPAG DBS did not cause clear c-Fos 
expression in the global pallidus, but in the CPu moderate number c-Fos-ir cells 
expression was found as compared to rats of the control group.  
Other Brain Areas 
Moderate expression of c-Fos-ir cells was observed in the medial (MeA), 
basomedial (BMA), and anterior cortical (ACo) amygdaloid nuclei; while the basolateral 
(BLA) and central (CeA) nuclei of the amygdala only showed mild increase in the 
number of positive c-Fos-ir cells, in dlPAG-stimulated animals (Figs. 8E and F) . As 
shown in figures 8 (A) and (B), mild neural activation was detected in the hippocampal 
regions of CA1 and dentate gyrus (DG) but not in the hilus and CA3 regions.       
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Figure 8. Representative photomicrographs of a 30 µm-thick coronal section from brain regions of the 
hippocampus areas (Figs. A & B), basal ganglia structures (Figs. C & D), and amygdaloid nuclei (Figs. E & 
F) at the bregma level of -3.14 mm. Figs. A, C, and E show the c-Fos-ir cells in animals with the dlPAG 
DBS as compared to the control animals (Figs. B, D, and F). Abbreviations: CA1, CA3 (CA1, CA3 fields 
of hippocampus), Hilus (CA4 field of hippocampus), DG (dentate gyrus), CPu (caudate-putamen), cc 
(corpus callosum), LGP (lateral globus pallidus), MGP (medial globus pallidus), ic (interna capsule), Rt 
(reticular thalamic nucleus), VPL (ventral posterolateral thalamic nucleus), BLA (basolateral amygdaloid 
nucleus, anterior part), CeA (central amygdaloid nucleus), MeA (medial amygdaloid nucleus), BMA 
(basomedial amygdaloid nucleus), and ACo (anterior cortical amygdaloid nucleus).  
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Discussion 
In the present study, we have evaluated the pattern of neuronal activation in 
different forebrain regions induced by electrical stimulation of the dlPAG. This 
stimulation appears to activate regions located in the hypothalamus, amygdala, prefrontal 
cortex, and some related cortical areas. In addition, our results have revealed changes in 
neuronal activities in some specific parts of the thalamus and basal ganglia resulting from 
dlPAG DBS. This pattern of neuronal activation is in agreement with the two-
dimensional defence circuit as proposed by McNaughton & Corr in controlling behaviour 
in response to threatening or novel stimuli (McNaughton and Corr 2004). In this two-
dimensional defence system, the circuitry for panic includes the PAG, hypothalamus, 
amygdala, anterior cingulate and prefrontal cortex (Fig. 9).  
 
 
Figure 9. Schematic illustration of the forebrain upstream connections of the 
periaqueductal gray matter in defensive behaviour for escape or panic-like behaviour. 
Abbreviations: PAG: periaqueductal gray; Hypo: hypothalamus; Amyg: amygdala; Ant. 
Cg: anterior cingulate gyrus; and PFC: prefrontal cortex. 
Frontal Cortex  
In consistent with the current results, a series of retrograde studies have revealed 
that the projections to the PAG arise predominantly from the medial prefrontal cortex 
wall and a few selected orbital/anterior insular prefrontal cortex regions (Floyd et al 2000; 
Reep and Winans 1982). In addition, the injections of anterograde tracers into each PAG-
projecting prefrontal region have also revealed distinct columnar patterns in the PAG. 
The medial prefrontal cortex projects densely to the dlPAG, whereas ventrolateral PAG 
received an exclusive robust input from the orbital and anterior insular areas and weaker 
input from the medial and dorsomedial prefrontal areas (Floyd et al 2000; Floyd et al 
2001; Jasmin et al 2004). Besides, the dorsomedial prefrontal cortex was found to project 
robustly to the lateral PAG column which indicates that different types of defensive 
behaviour are controlled by different PAG columns (Gabbott 2003; Gabbott et al 2003; 
Jasmin et al 2004; Yasui et al 1991).  
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There were some novel findings in the current study. For instance we have found 
c-Fos-ir cells mainly in the 5
th
 and 6
th
 cortical layers of the granular insular cortex (GI), 
dysgranular insular cortex (DI), and the posterior part of agranular insular cortex (AIP), 
but not the 1
st 
- 4
th
 cortical layers. This is actually in line with the observation that cortical 
projecting neurons to subcortical areas are located in the deep layers 5 and 6 of the cortex 
(DeFelipe and Farinas 1992). The insular cortex is considered as the viscerosensory 
region processing afferent cardiovascular, cardiopulmonary, gastrointestinal, odour, 
gustatory, and other related sensory and pain information (Jasmin et al 2004; Ruggiero et 
al 1987; Saper 1982). This information is subsequently relayed to a variety of subcortical 
autonomic regions (ventral striatum-nucleus accumbens, basolateral amygdala, 
mediodorsal thalamus, lateral hypothalamus, parabrachial nucleus, dlPAG, ventral 
tegmental area, dorsal raphe, and medullary regions) and to orbital and medial prefrontal 
cortex regions (Gabbott et al 2003; Jasmin et al 2004). 
 
In view of these results, the connection of the frontal cortex with subcortical 
regions and the PAG seems to be particularly important in the integration of cognitive-
affective information during the escape- or panic-like behaviour. The prelimbic and 
infralimbic cortices have a significant role in the expression of fear and cognitive 
functions (Corcoran and Quirk 2007; Radley et al 2006), and in learning and coping with 
threatening stimuli or environments (Rich and Shapiro 2007). Furthermore, the cingulate 
gyrus and insular cortex are connected with the hypothalamus and amygdala which 
appear to be involved in the autonomic functions such as regulating the blood pressure 
and heart rate during defensive behaviour (Allman et al 2001; Jasmin et al 2004). 
Hypothalamus  
The medial hypothalamic area, including the anterior hypothalamus, dorsomedial 
part of the ventromedial hypothalamus (VMHdm), and dorsal premammillary nucleus 
(PMd), which together  form a defensive system (Canteras 2002; Canteras et al 2001), 
shows a strong activation to conditioned fear (e.g. cat odor, as well as a live cat) 
(Canteras et al 1997; Dielenberg et al 2001a; Dielenberg et al 2001b; Dielenberg and 
McGregor 2001). The bed nucleus of the stria terminalis, ventral part of the lateral 
septum, and PAG are also activated during cat odor exposure. Keay & Bandler showed 
that the axons of the medial prefrontal cortex wall densely target the ventromedial 
hypothalamic nucleus and anterior hypothalamic area and terminate within the dlPAG 
(Canteras 2002; Keay and Bandler 2001; Vianna and Brăndao 2003). On the other hand, 
the orbital and anterior insular prefrontal cortex areas selectively target the lateral 
hypothalamus and project only to the vlPAG. As for the lPAG, the dorsomedial 
prefrontal cortex convexity and anterior cingulate cortex (area 24) firstly project to the 
dorsal hypothalamic areas and then send collaterals that terminate in the lPAG column.  
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Amygdala 
Recent data have shown that the amygdala and the PAG, together with the medial 
hypothalamus, constitute an integrated circuitry in the brain that commands defensive 
behaviour and elaborates aversive emotional and motivational states. The function of the 
amygdala would be to synthesize the various inputs from the environment and then signal 
the PAG according to the degree of threat presented to the organism (LeDoux 1994 ; 
LeDoux et al 1988; McNaughton and Corr 2004). Retrograde tracer experiments have 
demonstrated the subcortical structures such as the central nucleus and ventrolateral part 
of the basal nucleus of the amygdala having projections to the PAG and other midbrain 
structures (Gabbott et al 2003; Gabbott et al 2005; Gray and Magnuson 1992). Different 
parts of the midbrain are involved in mediating different measures of conditioned fear, 
such as the fear-potentiated startle and freezing, both of which are dependent of the 
amygdala. A study by Zhao & Davis has shown that fear-potentiated startle in the rats is 
mediated by neurons in the deep layers of the superior colliculus/ deep mesencephalic 
nucleus of the rostral midbrain through the glutamate non-NMDA receptors whereas the 
dorsal or lateral PAG were responsible for freezing (Zhao and Davis 2004). Previous 
studies also suggested that unconditioned fear (cat odour) activated downstream 
pheromone-related structures, including the posteroventral part of the medial amygdala 
(Dielenberg and McGregor 2001; McGregor et al 2004). It is notable that the effects of 
medial amygdala lesions in rats reduced freezing/immobility in the cat odour exposure 
(Blanchard et al 2005; Li et al 2004). In addition, the VMH receives major input from 
areas involved in sensory processing, such as the bed nucleus of the stria terminalis and 
medial amygdala (Canteras et al 2001; Petrovich et al 2001). Involvement of these 
structures in defensive behaviour appears to mediate the responsivity to predatory threats 
which provides a fundamental understanding of the functional mapping with other brain 
structures. 
Conclusion 
Our results have shown that electrical stimulation of the dlPAG produced different 
patterns of neuronal activation in specific parts of the forebrain which are involved in 
panic- or fear-like behaviour. Interestingly, this pattern of activation matched the concept 
of the defence system by McNaughton and Corr related to rage, panic and fear. The 
present study provides evidence that other forebrain structures are also involved in these 
behaviours. 
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CHAPTER 4 
 
Effect of Buspirone on the behavioural regulation of 
Wistar rats in low versus high anxiety conditions 
 
Lee Wei Lim, Yasin Temel, Veerle Visser-Vandewalle, Harry Steinbusch, 
Koen Schruers, Rob Hameleers, Gabriel Esquivel, Eric Griez, and Arjan Blokland 
 
 
Abstract 
Buspirone is reported to have anxiolytic effects in humans and is mostly described 
for mild anxiety. To further explore the effects of buspirone on different levels of anxiety, 
the effect of buspirone was evaluated in two different conditions of the open-field which 
were distinguished as low and high anxiety (enclosed and exposed open-field, 
respectively). Twenty-eight albino Wistar rats (350-400g) were tested in two different 
arena settings, an enclosed and an exposed open-field. Fourteen animals were initially 
injected with 1 ml saline while the others n=14 received buspirone 3 mg/kg. Our data 
showed clear differences in the two open field settings suggesting a higher anxiety level 
in the exposed open field. In addition, correlation analysis showed that both anxiety test 
measure different aspects of anxiety. Buspirone treatment reduced the behavioural 
activity in both the enclosed and exposed open-field which is generally interpreted as an 
anxiogenic effect. However, buspirone increased the time in the center areas and 
decreased the frequencies in the outer regions. These behavioural changes are generally 
seen as an anxiolytic effect. Correlation analysis showed that buspirone treatment 
disrupted the relation between indices of anxiety. These results showed that in an open 
field setting buspirone appears to have a dual effect. The reduced activity and increase in 
time spent in the center areas are indicative of both an anxiogenic and an anxiolytic effect, 
respectively. This was found in both open field settings, suggesting that the effects of 
buspirone are independent of the anxiety level.  
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Introduction 
Buspirone (CAS number: 33386-08-2), a classic 5-HT-1A receptor partial agonist 
has been reported to have therapeutic role in clinical anxiety and possibly in mood 
disorders. Its mechanism of action is complex involving both the pre- and postsynaptic 
receptor sites. De Vry and Schreiber hypothesized that the anxiolytic effects of 5-HT1A 
partial agonists result predominantly from an interaction with presynaptic 5-HT1A 
receptors, resulting in a decrease of hyperactive serotonergic neurotransmission (De Vry 
et al 2004).  
 
In human studies, buspirone has been well established in the clinical practice, 
typically for generalized anxiety disorder while it is considered relatively ineffective for 
other anxiety conditions (Ninan 2004a). However, there are findings where this agent 
appeared to be less effective than benzodiazepines (Goldberg and Finnerty 1982; Lader 
and Scotto 1998). As the first alternative to the benzodiazepines, its efficacy level was 
reported to be effective only in mild anxiety with a slow onset of action (Sramek et al 
2002). Several authors consider buspirone to be inferior and not as acceptable as 
benzodiazepines (Chessick et al 2006). It was also pointed out by some authors that 
patients who were treated with benzodiazepines were not satisfied when switching to 
buspirone (Goa and Ward 1986). Furthermore, several studies have shown conflicting 
results and whether buspirone is useful as first line treatment in general anxiety disorders 
still needs to be answered. In consideration of these clinical data, indicating that there is a 
degree of uncertainty regarding the efficacy of buspirone; one could conclude that 
buspirone is only effective in mild anxiety but not in more severe cases of anxiety. 
 
Over the past decades, several animal models have been developed to investigate 
the neurobiological mechanisms underlying anxiety. The most widely used behavioural 
models for experimental anxiety include the open field tests (Blokland et al 2002; 
Klebaur and Bardo 1999), the elevated plus maze (Cruz et al 1994; Hogg 1996) and the 
zero maze test (Hranilovic et al 2005). Recently many other modifications of these 
models have been designed and proven to be bidirectional sensitive to stressful 
manipulation based on the animal emotional reactivity (Jacobson et al 2007; Kalueff and 
Tuohimaa 2004; Ring et al 2006). 
 
In the open field procedure, the animal is usually placed in the center or the 
periphery of the apparatus. In such situation, rodents spontaneously prefer the periphery 
of the apparatus to the central parts of the open field. When the mice and rats explore or 
walk close to the walls, the behavioural is called thigmotaxis. The increased exploratory 
activity and/or increased exploration of the center of the open field versus the periphery 
are considered strong indices of decreased anxiety levels (Prut and Belzung 2003; Romeo 
et al 2003; Song et al 2003). The anxiogenic behaviour in the open field is triggered by 
two factors: individual testing (the animal is separated from its social group) and 
anxiogenic environment (as the arena is very large relative to the animal’s breeding or 
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natural environment). The influence of the latter two factors on the animals’ behaviour is 
especially important in those species that show fear of open spaces or new environment. 
This is particularly for the case of rodents as they usually live in social groups and in 
small tunnels  (Kessler et al 1998).  
 
The exploratory behavioural of rats when they are placed in the open field arena 
has been generally considered as the classical paradigm to assess emotionality, timidity 
and also to measure the anxiety state of rats (Dember 1956; Hall 1934). This concept is 
widely accepted based on the rats’ unfamiliarity with the new environment in which they 
displayed hyperactivity and typical thigmotaxic behavioural in the open field by moving 
more along the walls or corners of the arena (Schwarting et al 1993). The measurement of 
the animal’s movement in different areas of an open field is essential to determine the 
exploratory behavioural especially during anxiolytic pharmacological challenge in this 
animal model (Arakawa 2006; Koob et al 2006).  
 
However, studies showed that high and low levels of locomotor activity in the rat 
were well correlated with high and low responsivity, respectively, to the behavioural 
effect of psychotherapeutic drugs (Prut and Belzung 2003). Extensive pharmacological 
validation has revealed that open field behavioural is sensitive to the classical anxiolytic-
like activity of benzodiazepines. Similarly, 5-HT1A receptor agonists such as buspirone 
are active in the open field test (Hooks et al 1994).  
 
Graeff suggested that the existing animal models do not satisfactorily discriminate 
between specific types of anxiety disorders according to current classification systems 
such as the DSM-IV e.g. generalized anxiety disorder, panic disorder, phobia and etc. 
(Graeff et al 1998). However, recent studies showed that different variants of existing 
laboratory models may mimic different degrees of anxiety, for instance low and high 
anxiety (Ennaceur et al 2006; Mallo et al 2007).  
 
The purpose of our present investigation is to study the effect of buspirone versus 
saline injection on the animals’ behaviour in two different conditions of the open field 
test. The two anxiogenic conditions used in this study are: (i) An enclosed open-field 
with dim light condition, assumed to represent a low anxiety (LA) paradigm (Blanchard 
et al 2001b; Treit and Fundytus 1988) and (ii) An exposed open-field with elevated 
platform which has no wall surrounding the arena ‘without visible boundaries’ (Ennaceur 
et al 2006) and being illuminated by fluorescent light, assumed to represent a high or 
severe anxiety (HA) condition. We hypothesized that buspirone would display anxiolytic 
activity in both the LA and HA conditions, in terms of a general increase in locomotor 
activity (total distance moved) and an increase in the duration spent in the unsafe areas of 
the open field settings.  
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Material and Methods 
Subjects 
This study was approved by the Experimental Animal Commission of Maastricht 
University, the Netherlands. Twenty-eight male albino Wistar rats (Harlan, Horst, The 
Netherlands) with the weight 350-400 g were used in this study. The animals were 
housed individually in standard transparent polypropylene cages under controlled 12-h 
dark-light cycle with room temperature 20-22 °C and humidity 60-70%. During the stay 
in their respective housing condition, food and water was given in free access and they 
were transferred to new cages once a week for cleaning purposes and renewing their food 
and water supply. All the animals were handled daily in order to habituate them to being 
picked up in order to reduce handling stress during behavioural testing.  
Apparatus 
The apparatus consisted of an enclosed open field, clear Plexiglas box with an 
open top and a dark floor (Fig. 1a). The apparatus was placed in a dimly lit room. The 
exposed open-field arena was covered by a wooden platform, which was placed on the 
top part of the enclosed open-field arena with an altitude 40 cm above the ground without 
any surrounding walls (Fig. 1b). The apparatus was placed in a brightly lit room. All 
testing (enclosed and exposed open field) was conducted in the same room and the 
apparatus was cleaned after each experimental procedure. The movements of each rat 
were recorded automatically using a camera and Ethovision tracking software 
(Ethovision®, Noldus Information Technology in Wageningen, the Netherlands).  
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Figure 1: Schematic drawings (and dimensions in cm) of the open field settings. A) 
Enclosed open-field and B) Exposed open field. The enclosed open field was located in a 
dimly lit room whereas the exposed open-field was located in a brightly lit room. 
Procedures 
An overview of the experiment is shown in Table 1. The animals were divided into 
four groups (each n=7). Two groups were treated with saline and the other two groups 
were treated with buspirone. Each group of animals (both the saline and buspirone group) 
was divided again into 2 sub-groups (n=7, enclosed open field and n=7, exposed-elevated 
open field). 
 
 
 Table 1: Design of the experiment. 
(B) 
(A) 
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Behavioural testing started after the rats were placed in the middle of the arena. A 
trial was stopped after 5 min and the rat was removed from the arena and put back in its 
home cage. This procedure was repeated and performed randomly on two successive 
days and two researchers were blind with respect to the conditions of testing. After one 
week of rest the animals were tested again, although in the other open field setting.  
Drug administration 
Saline and buspirone hydrochloride (TOCRIS Cookson Inc., Missouri, USA) was 
dissolved in saline solution and injected intraperitoneally 30 min before testing in a 
volume of 1 ml/kg. We chose a dose of 3 mg/kg because this has previously been 
reported to affect anxiety-related behaviourals and no sedative effects (Grundmann et al 
2006; Hashimoto et al 1992; Mendelson et al 1990), and may interfere with the 
parameters of the tests used in this study. A week before the actual experimental testing, 
all animals received 3 times of 1 ml saline injection on alternate days to habituate to the 
injection procedure. 
Statistical analysis 
The enclosed and exposed open field arena was subdivided into 9 areas (see Fig. 2) 
and three different zones were defined (Blokland et al 2002): (i) corner zones (four 
squares each 25 cm x 25 cm), (ii) wall zones (four rectangles each 25 cm x 50 cm) and 
the (iii) center zone (one square 50 cm x 50 cm). The following measures were used for 
statistical analysis: (i) distance moved (for arena and different zones), (ii) time spent in 
each zone and (iii) frequency entry in the outer (combination of wall and corner zones) 
and inner (center zone) areas. The average of two days was calculated for statistical 
analysis.  
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Figure 2: The surface of both open-fields was virtually divided into 9 zones. These were defined 
as: corner zones (consisting of the four corner zones), wall zones (consisting of the four wall 
zones), and the center zone. 
 
 
The data were analyzed in a three-way Analysis of Variance (ANOVA) using 
Open-Field Type and Order (order of testing) as within subject factors and Treatment as a 
between-subjects factor. An LSD post hoc test was used to analyze group differences in 
more detail. To examine the relation between variables within a test and between 
different tests, Pearson correlation coefficients were calculated. All p-values < 0.05 were 
considered significant. All data are presented as mean ± S.E.M.  
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Results 
Enclosed versus exposed open field  
Firstly, the order of testing did not appear to affect the behavioural in both tests 
(distance moved: F(1,13)=0.01, ns; Time spent in different locations: all F’s< 0.34, ns). 
Consequently, we did not incorporate this factor in further analyses. To evaluate the 
differences of behaviour in the enclosed (LA) versus the exposed (HA) open field and the 
data of the saline treated animals were separately analyzed. This analysis revealed that 
the rats covered more distance in the enclosed open field or LA test as compared with the 
exposed open field or HA test (F(1,13)=86.02, p<0.001; see Fig. 3). The difference in 
distance moved was related to a decrease in the wall and corner areas (F’s>47.80, 
p<0.001; see Fig. 4) whereas the distance traveled in the centre areas was for both types 
of open field was not affected (F(1,13)=0.37, ns.). With respect to the time spent in the 
different areas of the open field, it was found that the rats spent less time in the corner of 
the HA tests as opposed to the LA (F(1,13)=17.84, p<0.001) test. Whereas, in the HA 
tests, the rats spent more time in the wall and center areas as compared with the LA test 
(F(1,13)=15.49, p<0.01 and F(1,13)=83.34, p<0.001, respectively. 
 
 
Figure 3: The effects of buspirone on the measure distance moved (fig. 3A) in both test 
conditions (LA and HA). Data represent mean (+SEM).  
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Figure 4: The effects of buspirone on the measure distance moved (cm) in the different areas of the 
open-field in both test conditions (LA and HA). Data represent mean (+SEM). * Different from 
saline 
Effects of buspirone 
Since all main effects of order of testing did not reveal statistically significant 
effects (all F’s<2.12, ns.) this factor was excluded in further analyses. Buspirone 
treatment clearly reduced the activity of the animals both in the LA and the HA tests 
(F(1,26)=96.93, p<0.001; see Fig. 3). The drug effects were greater in the LA when 
compared with the HA (F(1,26)=24.58, p<0.001). This decrease in activity was related 
with a decrease in the wall and corner areas (F(1,26)=85.73, p<0.001 and F(1,26)=66.63, 
p<0.001, respectively) whereas only a marginal drug effect was found for the activity in 
the centre zone (F(1,26)=3.58, p<0.07, ns.). The effects of buspirone on locomotor 
activity were greater in the LA than in the HA for the wall and corner (F(1,26)=25.08, 
p<0.001 and F(1,26)=14.38, p<0.001, respectively). On the other hand, the drug effect in 
the LA and the HA tests were comparable for the measure of distance moved in center 
areas (F(1,26)=0.09, ns.). 
 
A more complex picture emerged when analyzing the effects of buspirone 
treatment on the time spent of the rats in the different zones in both tests (see Fig. 5). The 
time spent of the rats in the wall zone was decreased in both tests (F(1,26)=5.40, p<0.05). 
Although no Type by Drug interaction was found (F(1,26)=1.48, ns.), post hoc analysis 
revealed that buspirone clearly reduced the time spent in the wall zone of the LA 
(p<0.001) test but not in the HA test. Besides, buspirone also significantly decreased the 
time spent in the corner squares of the HA test but not in the LA test (Type of task x 
Treatment effect: F(1,26)=4.95, p<0.05). This was confirmed by a post-hoc analysis 
showing that buspirone treatment had no effect in the corner squares of the LA test but 
only effective in the HA test. However, there was a main effect of treatment for the time 
spent in the centre squares (F(1,26)=5.62, p<0.05), indicating that the time in the centre 
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squares increased after buspirone treatment. Post hoc analysis showed that this increase 
was only significantly found in the HA test (p<0.02). 
 
 
Figure 5: The effects of buspirone on the time spent (s) in the different areas of the open field in 
both test conditions (LA and HA). Data represent mean (+SEM). * Different from saline 
 
Measures of frequency entry 
Repeated measures ANOVA revealed significant differences within 
(F(1,26)=41.125, p<0.0001) and between (F(1,26)=312.76, p<0.0001) subjects tests, and 
interaction between Group, Test and Treatment (F(1,26)=6.85, p<0.05; see Fig. 6a and 
6b). The effect of buspirone treatment significantly decreased the percentage of 
frequency entry at the outer areas in both the LA and HA tests, whereas the frequency 
entry of the inner areas was found insignificantly decreased. In the LA tests, a remarkable 
frequency entry was observed at the outer area than the inner area in both the saline and 
buspirone treated animals (see Fig. 6). Nevertheless, the HA tests also showed a similar 
effect of decreased frequency entry in both the outer and inner areas. The effect of 
buspirone treatment in the HA test showed more or less the same level of frequency entry 
in both the outer and inner areas as compared with saline which having only a slight 
decreased of frequency entry at the inner area than the outer area. Post hoc tests revealed 
significantly decrease of the frequency entry (2-tailed) at the outer areas after buspirone 
treatment in both the LA and HA tests (P<0.05). Besides, statistical analysis also showed 
a significant decrease of the frequency entry at the outer area of HA testing condition 
when compared with LA testing condition (P<0.05). 
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Figure 6: The effects of buspirone on the frequency entry into the outer and inner areas of the open-
field (LA and HA tests). Data represent mean (+SEM). # Different from outer area in the LA 
condition and † Different from outer area in the LA & HA conditions of saline treatment. 
Correlations 
Correlations within and between tests between the different variables are shown in 
Table 2. When all animals were included in the analysis a mixed picture of correlations 
was found. Within test analysis showed that the time in centre areas was negatively 
correlated with the time in the wall and corner areas. The activity of the animals was 
correlated with the time spent in the different zones and was opposite in the LA and the 
HA test. Thus, distance moved in the LA was positively correlated with the time in the 
wall zone whereas the distance moved in the HA was positively correlated with the time 
in the corners and negatively correlated with the time in the centre zone. When analyzing 
the correlations between the same parameters in different tests revealed that the distance 
moved in both tests correlated positively. Time in the centre area was also correlated 
positively. No correlation was found for the time spent in the corner and wall zones. 
 
The correlation matrix differed significantly when only analyzing the saline and 
buspirone treated animals (see Table 2B/C). In the saline group a good correlation 
between the different measures was found in the LA test. In the HA test only the time in 
the corner correlated negatively in the time in the wall and centre zones. Remarkably, no 
correlations were observed between the (similar) measures in the different tasks. In the 
analysis for the buspirone group in the LA test only negative correlations were found 
between time in the centre and the time in the corner and wall areas. There were more 
correlations found in the HA test where the activity of the rats was positively correlated 
with the time in the wall areas and negatively correlated with the time in the centre zone. 
There were occasional correlations between the measures of the different tests. No 
correlations between the same measures were observed. 
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Table 2: Pearson correlation coefficients between the different measures of the open field tests. 
Non-italic entries indicate correlations within the same test and italic entries indicate 
correlations between tests. Bold entries are statistical reliable correlations between two 
measures. 
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Discussion 
In this study, we investigated the effects of buspirone on the exploratory behaviour 
of rats in two different types of open-field settings. Buspirone treatment decreased 
animals’ behavioural activity in both variants of the test, and tended to increase the time 
spent in the less safe areas. Surprisingly, these findings may suggest both an anxiogenic 
and anxiolytic effect of buspirone in the two test models.  
 
In our laboratory, the enclosed open field test has frequently been used to measure 
strain differences and effects of treatment on anxiety. All these studies showed a very 
robust negative correlation between the time in the corner and the total distance moved 
(Blokland et al 2002; Prickaerts et al 1996; van der Staay and Blokland 1996; van der 
Staay et al 1990). Thus, a decrease in the exploratory behavioural is associated with an 
increase in time spent in the safe areas. This was replicated in the present study only in 
the enclosed open field (LA condition). In the exposed open field (HA condition), the 
correlation was not observed, supporting the idea that this test measures a different aspect 
of anxiety. Previous data have shown that these two variants of the open field test are 
models of different levels of anxiety (Ennaceur et al 2006). Our data support this notion 
whereby the exposed open field appears to induce a state of higher anxiety, as indicated 
by correlation analysis of indices of anxiety and an overall decrease in exploratory 
activity. 
 
In the open field setting the wall and corner (outer areas) are safer than the inner 
areas (Crawley 1985; Prut and Belzung 2003). Regarding the time spent of the center 
area of the open-field, our results showed that rats were more sensitive to the anxiolytic 
effect of buspirone in the HA condition than the LA condition. In addition, our frequency 
data also clearly revealed that buspirone significantly decreased the number of entries 
into the outer areas suggesting an overall anxiolytic effect. The decreased duration spent 
at the corner area of HA rats and decreased duration spent at the wall area of LA rats 
support our assumption that buspirone has anxiolytic properties. On the other hand, 
buspirone treatment also decreased the behavioural activity both in the enclosed and 
exposed open-field suggesting an anxiogenic effect. Anxiogenic-like effects of buspirone 
in a plus-maze have been reported previously (Collinson and Dawson 1997; Dawson et al 
1995). These results are consistent with our findings of a decreased distance moved in 
both variants of the open field.   
 
The reduction of locomotor activity in both the enclosed and exposed open fields 
could be interpreted as a result of a sedative effect. However, in previous reports the 
dosage of buspirone commonly varied between 0.03 mg/kg and 60 mg/kg. It is interesting 
to note that few studies demonstrated lower doses to possess any anxiolytic property. 
Some found small doses to be merely ineffective (Cervo et al 2000; Vaidya et al 2005; 
Wada and Fukuda 1991). We used a dose of 3 mg/kg of buspirone based on different 
behavioural pharmacological effects in different models  (Ettenberg and Bernardi 2006; 
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Grundmann et al 2007; Picazo and Fernandez-Guasti 1998; Warnick et al 2006). Also, 
behavioural and EEG studies have shown that buspirone does not produce sedative effect, 
motor deficits or memory impairments (Hashimoto et al 1992; Lerman et al 1986; Mattila 
et al 1982; Mendelson et al 1990; Newton et al 1982). The latter studies provide 
additional support that the decrease in behavioural activity in the open field settings is not 
likely to be interpreted in terms of a general sedation. 
 
Clinical observations have suggested that buspirone might be less effective than 
the benzodiazepines in the management of anxiety. In practice, it is used primarily for 
relief of mild to moderate generalized anxiety disorder and nervous tension, and is not 
considered effective for other types of severe anxiety disorders. However, the results 
observed in our laboratory models strongly suggest that buspirone yielded anxiolytic 
effects in both the low and high anxiety condition (enclosed and exposed open field, 
respectively) with increased time spent in the center of the open field and decreased 
frequency entries in the outer areas. Alternative explanations of the experimental data, 
such as immobility due to anxiogenic effects, or a possible role of sedative effects, appear 
unlikely.  
Conclusion 
In conclusion, buspirone seems to have anxiolytic activity in two different settings 
(enclosed and exposed) of the open fields. Buspirone therefore appears to be effective in 
both moderate and severe anxiety. Contrarily to the impressions of many clinicians, it is 
suggested that buspirone may not only be useful in reducing mild anxiety but a severe 
anxiety as well. The present data along with other experimental data leave open the 
possibility of a dual effect of buspirone on anxiety. Mechanisms responsible for the 
reduction of locomotor activity and therefore increased time spent in the center areas will 
require further elucidation. Taken together the findings suggest a complex effect of 
buspirone in an unconditional anxiety test.  
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CHAPTER 5 
 
High-frequency stimulation of the dorsolateral   
periaqueductal gray and ventromedial hypothalamus  
fails to inhibit panic-like behaviour 
  
Lee Wei Lim, Arjan Blokland, Veerle Visser-Vandewalle, Rinske Vlamings, 
Thibaut Sesia, Harry Steinbusch, Koen Schruers, Eric Griez, and Yasin Temel 
 
 
Abstract 
Electrical stimulation of the dorsolateral periaqueductal gray (dlPAG) and one of 
its target structures, the ventromedial hypothalamus (VMH), produces a typical behaviour 
in rats consisting of vigorous running and jumping which is known as “escape behaviour”. 
Escape behaviour in rodents closely mimics panic attacks in humans. Since electrical 
stimulation at higher frequencies generally inhibits the stimulated region, we tested in 
this study the hypothesis that deep brain stimulation (DBS) of the dlPAG and VMH at 
higher frequencies (> 100 Hz) would not induce escape behaviour. More specifically, we 
evaluated whether experimental DBS could be used to inhibit panic-like behaviour. Rats 
underwent implantation of DBS-electrodes at the level of the dlPAG and VMH and the 
effects of various stimulation parameters were assessed. In addition, we studied the 
neural activation pattern resulting from DBS of the dlPAG and VMH using c-Fos 
immunohistochemistry. We found that stimulation amplitude is the most important 
stimulation parameter in the induction of escape behaviour. Remarkably, stimulation 
frequency (1-300 Hz) had no effect on stimulation-induced escape behaviour and 
therefore it was not possible to prevent the induction of escape behaviour with higher 
frequencies. The neuronal activation pattern resulting from dlPAG and VMH DBS was 
similar. These findings suggest that DBS of the dlPAG and VMH induces panic-related 
behaviours even at higher frequencies.  
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Introduction 
The use of stimulation electrodes implanted in the brain to control severely 
disabling psychiatric and neurological conditions is an exciting and fast emerging area of 
clinical neuroscience (Perlmutter and Mink 2006; Schiff et al 2007; Wichmann and 
Delong 2006). Its popularity is directly related to its minimal invasiveness, reversibility 
(stimulation can be turned on and off), and adjustability (various combinations of 
stimulation parameters are possible). Currently, thousands of patients have been 
implanted with stimulating electrodes and especially in the field of psychiatric disorders 
new indications are evaluated. For instance, in case series, deep brain stimulation (DBS) 
has relieved symptoms in patients with treatment-resistant depression (Mayberg et al 
2005) and obsessive-compulsive disorder (Abelson et al 2005; Nuttin et al 1999).  
 
Before applying DBS for new indications in clinical psychiatry, it is preferred that the 
effects of DBS are evaluated systematically in animal models. In this respect, DBS could 
be considered to treat refractory panic and anxiety disorders. Panic disorder (PD) is one 
of the most frequently encountered anxiety disorder and one out of every seventy five 
people worldwide experiences panic attack (PA) once in their lives (NIH 1991 Sep 25-
27). Panic attacks are characterized by an acute moment of intense fear or 
psychologically distress with a sudden onset rapidly building to a peak level and are 
usually accompanied by somatic and psychological symptoms associated with a sense of 
impending danger and an urge to escape from the susceptible risk condition (Craske and 
Waters 2005; Griez and Schruers 1998; Klerman et al 1993). Panic disorder is recognized 
as a disabling condition and its treatment includes pharmacologic and behavioural 
therapies as well as combinations of these strategies (American-Psychiatric-Association. 
2000; Barlow et al 2000; Goisman et al 1999). In some cases, patients do not respond to 
these treatments and experience a chronic course of disease burden, usually together with 
their families (Fleet et al 1996; Reiman et al 1984; Roy-Byrne et al 1999).  
 
In preclinical experiments, electrical stimulation of the dorsolateral area of the 
Periaqueductal gray (PAG) and one of its target structures, the ventromedial 
hypothalamus (VMH), has been used to study the mechanism of PA. Electrical 
stimulation of these areas produces a typical behaviour consisting of vigorous running 
and jumping in rats (Brandao et al 1994; Jenck et al 1995; Jenck et al 1986; Schenberg et 
al 2001; Siegel et al 1997). This behaviour, also known as escape behaviour, is 
accompanied by strong emotional and autonomic activation (Bandler et al 1985a; Krieger 
and Graeff 1985; Schenberg et al 1990). Escape behaviour in rodents closely mimics PA 
in humans (Deakin 1998; Schenberg et al 2001).  The neural circuit responsible for 
stimulation-induced escape behaviour has been partly identified. Several brain structures 
interconnected with the dlPAG have been reported to show changed neuronal activity due 
to electrical or chemical stimulation. For instance, electrical and chemical stimulation 
induced significant c-Fos expression in the amygdala, thalamus, and medial prefrontal 
cortex (prelimbic, infralimbic and cingulate areas) (Borelli et al 2005a; Ferreira-Netto et 
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al 2005; Vianna et al 2003a). Another region that is strongly activated by dlPAG 
stimulation is the ventromedial hypothalamus (VMH) (de Oliveira et al 2000; Ferreira-
Netto et al 2005). 
 
In previous experiments, several stimulation paradigms have been applied to 
manipulate the dlPAG and VMH, generally aiming to evoke escape behaviour 
(Bittencourt et al 2005; Jenck et al 1983; Jenck et al 1986; Sandner et al 1982). 
Therefore, only stimulation parameters inducing escape behaviour were investigated. 
Almost all studies focused on the stimulation intensity with a fixed frequency (usually 
50-100 Hz) (de Almeida et al 2006; Schenberg et al 2002; Vargas and Schenberg 2001). 
The intensities of stimulation varied greatly among studies (Borelli et al 2004; Hassanain 
et al 2003; Martinez et al 2006; Siegel et al 1997). In this era in which electrical brain 
stimulation has become a widely applied technology in preclinical studies, a systematic 
analysis of effects of stimulation parameters on escape behaviour is needed using a 
stimulation setup similar to clinical DBS  (Belujon et al 2007; Benazzouz et al 2004; 
Kringelbach et al 2007; Temel et al 2007). The effect of stimulation frequency is of 
particular importance, since this determines whether a brain region is activated or 
inhibited (Desbonnet et al 2004; Meissner et al 2007; Temel et al 2007). For instance, it 
has been demonstrated repeatedly that high frequency stimulation (HFS) inhibits the 
target by reducing its neuronal firing by a mechanism involving either a deporalization 
blockage, neurotransmitter depletion, and/or stimulation of presynaptic terminals with 
neurotransmitter release (Benazzouz et al 2004; Filali et al 2004; Lozano and Eltahawy 
2004; Meissner et al 2005). In this study, we examined the behavioural and neuronal 
effects of dlPAG- and VMH DBS stimulation, and tested the hypothesis that HFS could 
be used to inhibit panic-like behaviour. Furthermore, the effect of stimulation parameters 
on neural activation patterns was examined in the forebrain using c-Fos 
immunohistochemistry. 
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Material and Methods  
Subjects 
Subjects were Wistar male rats ( = 24, 12 weeks old, bred and housed at the 
Central Animal Facility of Maastricht University, Maastricht, the Netherlands). Rats had 
an average body weight of 300-350 g at the time of surgery. They were housed 
individually in standard cages on sawdust bedding in an air-conditioned room (about 20 
ºC) under a 12/12-h reversed light/dark cycle. Food, standard laboratory chow 
(Hopefarms, Woerden, The Netherlands), and water were available ad libitum. All 
experimental procedures were approved by the Animal Experiments and Ethics 
Committee of Maastricht University. 
Experimental groups 
Rats were randomly assigned to one of three following experimental groups: A. 
Control (n=6); B. dlPAG stimulation (n=10); C. VMH stimulation (n=8).  
Surgical procedure 
A detailed description of the surgical procedure and the electrodes has been 
provided earlier (Temel et al 2007; Temel et al 2005). In brief, the rats were anesthetized 
throughout the entire procedure using a combination of ketamine (90 mg/kg s.c.) and 
xylazine (10 mg/kg s.c.). Rats were placed in a stereotactic apparatus (Stoelting, Wood 
Dale, USA; model 51653). After making a burr hole in the skull, rats of groups B and C 
received implantation of the electrodes at the level of the dlPAG (coordinates from 
Bregma: AP −7.6, ML 0.7, and V −4.8, approached with a coronal angle of 10°) and 
VMH (coordinates from Bregma: AP −2.5, ML 0.5, and V −9.5), respectively. A 
construction of one gold-plated needle-like electrode with an inner wire of a platinum–
iridium combination (Technomed, Beek, The Netherlands), with a tip diameter of 50 µm 
and a shaft diameter of 250 µm, was employed in this experiment. The electrodes were 
fixed in position using dental cement (Heraeus Kulzer, Hanau, Germany). Rats had a one-
week recovery period.  
Behavioural evaluation  
Rats were evaluated in an open field (OF) test. For more details of this test please 
see Hameleers et al. (Hameleers et al 2007). In summary, rats were placed in the arena 
and were connected with an external stimulator through externalized leads. The 
stimulation started approximately one minute after the rat was placed in the OF arena. 
The behaviour of the rats was videotaped (Ethovision®, Noldus Information Technology, 
Wageningen, the Netherlands). We observed three different types of behaviour during the 
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experimental procedure, consisting of ‘no effect’, ‘freezing’ behaviour characterized by 
piloerection, micturition/defaecation, and immobility, and ‘escape behaviour’ 
characterized by rigorous and aimlessly running. The stimulation procedures and 
behavioural analysis were evaluated by two researchers. 
Deep brain stimulation 
For DBS we used a variety of stimulation amplitudes (1-650 µA), and stimulation 
frequencies (1-300 Hz) at a quasi-random fashion. The pulse width was set at 100 µs 
since in previous experiments variation in pulse width did not influence behavioural 
performance (Desbonnet et al 2004). A World Precision Instruments digital stimulator 
(DS8000, WPI, Berlin, Germany) and a stimulus isolator (DLS100, WPI, Berlin, 
Germany) were used to deliver the stimuli. Real time verification of the parameters 
applied during stimulation was obtained using a digital oscilloscope (Agilent 54622D 
oscilloscope, Agilent Technologies, Amstelveen, the Netherlands).  
 
The electrical stimulation was performed with gradual increase of the current 
amplitude. At each step, stimulation duration was 15 sec followed by a stimulation off 
period of 45 s. The stimulation frequency was set at 50Hz, and pulse width at 0.1ms.  
Behavioural changes during this procedure were observed by two researchers. Freezing 
behaviour was consistently characterized by immobility (without body movement) 
accompanied by two distinctive symptoms of increased alertness (head scanning) and 
piloerection. After cessation of stimulation, freezing disappeared and animals began to 
move again.  
Histological processing 
Two hours after the final electrical stimulation procedure, rats were perfused 
transcardially with Tyrode (0.1 M) and fixative containing 4% paraformaldehyde, 15% 
picric acid and 0.05% glutaraldehyde in 0.1 M phosphate buffer (pH 7.6). Brains were 
removed and post-fixed for 2 h followed by overnight immersion in 10%, 20%, and 30% 
sucrose at 4 °C. Brain tissue was then quickly frozen with CO2 and stored at − 80 °C. 
Subsequently, the prefrontal regions of the brains were cut serially on a cryostat into 30 
µm frontal sections and again stored at − 80 °C. C-Fos immunohistochemistry was 
carried out by using an anti-c-Fos rabbit polyclonal antibody (Santa Cruz Biotechnology 
Inc., Santa Cruz, CA, USA) (diluted 1 : 20 000 in 0.1 % Bovine Serum Albumin and Tris 
Buffered Solution-Triton (TBS-T) solution).  
After overnight incubation at room temperature on a constant shaker, sections 
were rinsed with TBS-T, Tris Buffered Solution (TBS), and TBS-T and incubated with 
the secondary antibody (diluted 1: 400 in biotinylated donkey anti-rabbit biotine; Jackson 
Immunoresearch Laboratories Inc., Westgrove, USA) for ninety minutes. Subsequently, 
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the sections were incubated with an avidin-biotin-peroxidase complex (diluted 1:800, 
Elite ABC-kit, Vectastatin; Burlingame, USA) for two hours. In between steps, sections 
were washed with TBS and TBS-T. To visualize the immune complex of Horse Radish 
Peroxide reaction product, sections were incubated with 3,3’-diaminobenzidine 
tetrahydrochloride (DAB)/ Nickel Chloride (NiCL2) solution (5ml DAB solution, 5ml 
Tris/HCl, 50µl NiCL2, and 3.35 µl hydrogen peroxide). This reaction was stopped after 
10 minutes by rinsing thoroughly all the sections with TBS. All sections were then 
mounted on gelatin-coated glasses. After dehydrating, all sections were cover-slipped 
with Pertex (HistolabProducts ab, Goteborg, Sweden). Additionally, one other series of 
sections per animal was stained with standard hematoxylin–eosin (Merck, Darmstadt, 
Germany) to evaluate the localization of the electrode tips. 
Semi-quantitative evaluation of c-Fos immunoreactive cells 
Systematic cell counts were performed of c-Fos immunoreactive (c-Fos-ir) cells in 
the prelimbic (PrL), infralimbic (IL), cingulate (Cg1) and motor (M2) cortices. 
Photographs of the areas of interest were taken at 4X magnification using an Olympus 
DP70 camera connected to an Olympus AX70 bright-field microscope (analySIS; 
Imaging System, Münster, Germany). Our quantification method was similar to a 
previously reported method, with minor modifications (Lamprea et al 2002). Four 
sections from each animal were selected for quantification. The boundaries of the areas of 
interest were delineated and measured. The same light intensity and threshold conditions 
were employed for all sections. The counting of the numbers of c-Fos-ir cells was 
performed using the conventional image analysis program ‘Image J’ (version 1.38, NIH, 
USA). A cell was counted as c-Fos-ir if its density was 75% higher than the background 
density. In addition, artifacts in the sections were excluded from analysis to ensure the 
accuracy of measurements.  
 
In this study, this method of quantification was preferred to a stereological analysis 
which is laborious, since the differences were clear and therefore data about relative 
differences were sufficient for our purposes. 
Statistical analysis 
Data are presented as mean ± S.E.M and were analyzed using Analysis of 
Variance (ANOVA). Data of c-Fos-ir cell counts are expressed as number of c-Fos-ir 
cells/mm
2
. An LSD post hoc test was used to analyze group differences in more detail. P-
values lower than 0.05 were considered significant.  
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Results 
Histological evaluation of the electrode localization 
Electrode tips were located at the level of the dlPAG in 8 rats of group B, and in 5 
rats of group C electrodes were located in the VMH. In two rats of group B and 3 rats of 
group C, the electrodes were misplaced and these rats were excluded from analysis. The 
localization of the electrode tip in the PAG and VMH are illustrated in Figure 1. Based 
on the evaluation of the hematoxylin and eosin staining, no neuronal damage was 
observed except for the electrode trajectory.  
 
 
 
Figure 1: Representative low-power photomicrographs of a 30 µm-thick frontal section from the 
brain of a rat subjected to stereotactic implantation of concentric bipolar electrode to stimulate the 
dlPAG (Fig. A, scale bar = 250 µm) and VMH (Fig. B, scale bar = 500 µm) is shown. Fig. C, 
Schematic representation of the electrode sites in the dlPAG and VMH according to the Paxinos and 
Watson atlas, respectively. The symbol (▲) indicates the electrode localization in the dlPAG and (•) 
in the VMH. Abbreviation: Aquad. = aquaduct of Sylvius, 3V = third ventricle. 
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Behavioural Evaluation 
Effect of stimulation parameters 
The intensity of the electrical current applied to the dlPAG and VMH of the 
animals was based on the lowest threshold to induce escape behaviour. The current 
amplitudes necessary for inducing freezing behaviour and escape behaviour differed 
significantly between rats with dlPAG DBS and VMH DBS (F’s>351.13; P’s< 0.00). The 
current intensity applied to the dlPAG and VMH DBS to induce freezing behaviour was 
78.57 ± 4.04 µA and 540.00 ± 29.15 µA, respectively, while the current intensity to 
evoke escape behaviour was 85.71 ± 13.36 µA and 590.00 ± 29.15 µA, respectively 
(Figure 2). After confirming the current amplitudes necessary to evoke escape behaviour, 
we evaluated the effect of stimulation frequency. We found that each stimulation 
frequency applied resulted in escape behaviour (Table 1).   
 
 
Figure 2: This figure shows the current amplitudes (µA) necessary to induce freezing-
like behaviour and escape reaction. Data represent means (± SEM) of dlPAG (Fig A) and 
VMH stimulation (Fig. B) groups. 
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Effect of repeated stimulation 
Rats that showed escape behaviour in the previous session, showed no escape 
behaviour when they were stimulated again at their escape threshold on the second day. 
However, after a longer period of recovery (seven days), rats again showed escape 
behaviour when stimulating at their escape threshold. Furthermore, the rats which 
showed escape behaviour due to stimulation, showed freezing behaviour when they were 
placed in the OF arena the next day (Figure 3).   
 
 
Figure 3: Behavioural effects of sub-threshold stimulation (phase I), suprathreshold 
stimulation (phase II) and post-stimulation period (phase III). We found that stimulation 
below the escape-threshold induced freezing behaviour. In addition, rats showed freezing 
behaviour when they were placed in OF arena one day after the stimulation experiment. 
 
 
 
Table 1: This table shows the effect of stimulation parameters on behaviour. A variety of 
stimulation parameters consisting of different current amplitudes (1-650 µA) and stimulation 
frequencies (1-300 Hz) were used. The pulse width was set at 100 µs. Abbreviations: ‘LFS’ – 
Low-frequency stimulation, ‘HFS’ – High-frequency stimulation, ‘F’- Freezing response, 
‘EB’- Escape behaviour, and ‘NE’- No effect.  
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Evaluation of c-Fos-ir cells 
Since numbers of c-Fos-ir cells in the ipsilateral and contralateral regions were not 
significantly different (P’s > 0.05), we pooled these data. DBS of the dlPAG and VMH 
significantly increased the number of c-Fos-ir cells in the PrL (F’s > 53.96, P<0.00), IL 
(F’s > 90.85, P < 0.00), M2 (F’s > 77.93, P < 0.00) and Cg1 (F’s > 95.24, P < 0.00) 
regions as compared to control animals. In all regions, VMH DBS resulted in higher 
numbers of c-Fos-ir cells as compared to dlPAG DBS (F’s > 14.28, P < 0.05) (Figures 4 
and 5). 
 
 
 
Figure 4: Representative low-power photomicrographs of 30 µm-thick frontal sections from the 
brain of a control rat (Figs. A and B), a rat subjected to stereotactic implantation of concentric 
bipolar electrode to stimulate the dlPAG (Figs. C and D) and VMH (Figs. E and F). Figs A, C, and E 
at bregma level: 2.20 mm show the level of the Cg1 (Cingulate gyrus 1) and M2 (Motor cortex 2), 
and Figs. B, D, and F at bregma level: 2.20 mm show the level of PrL (Prelimbic cortex), and IL 
(Infralimbic cortex). The small dark dots represent c-Fos-ir cells. The inset in A shows a 
representative high-power photomicrograph of a c-Fos-ir cell. Scale bar = 500 µm. 
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Figure 5: Grouped data of c-Fos-ir cells per mm2. Data represents means ± S.E.M. of groups A 
(control), B (PAG stimulation) and C (VMH stimulation). Abbreviations: PrL: prelimbic cortex; IL: 
infralimbic cortex; Cg1: cingulate gyrus 1; and M2: motor cortex 2. * indicates significant difference 
between groups (P< 0.05). 
 
Discussion 
Electrical stimulation of the dlPAG and VMH produced a typical behaviour 
consisting of vigorous running and jumping in rat, referred as escape behaviour. This 
behaviour in rodents has been considered a phenomenon closely mimicking PA in 
humans (Deakin 1998; Schenberg et al 2001). Our results have revealed that the most 
important stimulation parameter for this behaviour is the stimulation amplitude. For each 
subject, a minimum amount of stimulation amplitude (escape-threshold) was necessary to 
induce escape behaviour. Interestingly, substantially higher amplitudes were required 
with VMH DBS. In addition, VMH DBS resulted in higher levels of neuronal activation 
(ie. more c-Fos ir cells) in the prefrontal areas associated with panic-reactions, which 
could be related to these high stimulation intensities. 
 
The key finding of this study is that it was not possible to prevent the induction of 
escape behaviour by PAG and VMH DBS. We have applied a wide range of frequencies 
which all induced escape behaviour. Even with 300 Hz stimulation with a threshold-
amplitude, rats showed escape behaviour. These findings suggest that both dlPAG and 
VMH are not sensitive for high frequency stimulation in the context of escape behaviour. 
This is in contrast with findings in animal models of Parkinson’s disease, Huntington’s 
disease or depression (Benazzouz et al 2004; Meissner et al 2005; Temel et al 2007; 
Temel et al 2006). In these models, low frequency stimulation usually deteriorated the 
condition, whereas HFS was effective in reducing the symptoms. However, an important 
similarity is the acute effect of dlPAG and VMH DBS on behaviour.  
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We observed two types of behaviour. Sub-threshold stimulation resulted in 
freezing behaviour and stimulations at the threshold or above induced escape behaviour. 
McNaughton and Corr (2004) have introduced the concept of two-dimensional defensive 
behaviour, categorizing behavioural reactions into avoidable and unavoidable threats 
such as the escape behaviour and panic-like freezing behaviour (McNaughton and Corr 
2004). The first dimension describes the two systems of defensive behaviour associated 
particularly with the PAG and hypothalamus in controlling defensive avoidance (fear) 
and defensive approach (anxiety). The second dimension illustrates an important 
hierarchical organization of defensive behaviour. A particular finding in this study, is that 
rats showed freezing behaviour when they were placed in the OF arena on the next day 
after a stimulation session. However, when the recovery period was extended, animals 
returned did not show this behaviour and reacted normally. This finding could be 
indicative of a fear-conditioning effect with subsequent extinction. 
 
The results of c-Fos immunohistochemistry further establishes the involvement of 
the medial prefrontal cortex in the integration of cognitive-affective information in 
response to emotional stress (Radley et al 2006).  More specifically, the Cg1 plays a role 
in autonomic functions, such as regulating blood pressure and heart rate (Allman et al 
2001). Further, the PrL, and IL cortices appear to be directly involved in cognitive 
functions, fear expression (Corcoran and Quirk 2007), and in learning and coping with 
changing contingencies in new tasks or familiar environments (Rich and Shapiro 2007). 
We have also evaluated the c-Fos expression in the motor cortex, especially in the M2 
area, to confirm the neuronal substrate of high motor activity associated with escape 
behaviour. In line with our expectation we found high levels of c-Fos-ir cells in the 
cortical motor areas. In all regions, VMH DBS resulted in more c-Fos-ir cells as 
compared to dlPAG DBS. One possible explanation could be the higher amplitudes used 
with VMH DBS which have influenced neighboring circuits and regions. Another 
explanation is that the effects of DBS of the VMH are mediated via the dlPAG. This 
explanation would corroborate the hierarchical neural levels in the two-dimensional 
defense system (see Fig. 6) (McNaughton and Corr 2004). Blanchard & Blanchard also 
described a similar hierarchy of defensive behaviour (Blanchard and Blanchard 1989a; 
Blanchard and Blanchard 1990) which was related to the neural hierarchy in the 
mechanism of defense as proposed by Deakin (Deakin 1991c) and Graeff (Graeff 1994). 
These theories explained the involvement of different levels of neuroanatomical 
structures (e.g. septo-hippocampal system, amygdala and hypothalamus) and 
neurotransmitters (e.g. acetylcholine, serotonin) in facilitating defensive behaviour 
related to rage and panic, respectively. Conceptually, the PAG has long been known as 
the primitive defensive structure commanding fight and flight reaction and accordingly 
higher current amplitudes were necessary with VMH DBS to influence the dlPAG in 
order to induce such defensive response. Nevertheless, the results obtained with c-Fos 
immunohistochemistry should be interpreted carefully, since c-Fos is only a general 
marker of neuronal activity. Consequently, the c-Fos experssion may reflect direct and 
indirect effects, and excitation and inhibition. 
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Figure 6: Schematic illustration of the upstream connections of the periaqueductal gray 
matter in defensive behaviour based on McNaughton and Corr’s two-dimensional defense 
system (McNaughton and Corr 2004).  Abbreviations: PAG: periaqueductal gray, VMH: 
ventromedial hypothalamus, Amyg: amygdala, AC: anterior cingulate gyrus, PFC: 
prefrontal cortex, and M: motor cortex. 
Conclusion 
In conclusion, the main finding of the present study is that both low- and high 
frequency stimulation of the dlPAG and VMH DBS induced escape behaviour. In 
addition, different current amplitudes produced different behaviours consisting of 
freezing and escape. Furthermore, we found simple fear-conditioning with subsequent 
extinction in the post-stimulation period.  
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CHAPTER 6 
 
Buspirone induced acute and chronic changes of  
neural activation in the periaqueductal gray of rats 
 
Lee Wei Lim, Yasin Temel, Thibaut Sesia, Rinske Vlamings, 
Veerle Visser-Vandewalle, Harry Steinbusch, and Arjan Blokland  
Abstract 
5-Hydroxytryptamine1A (5-HT1A) modulation within the midbrain periaqueductal 
gray (PAG) is closely associated with anxiety- or panic-like behaviour. Several findings 
have demonstrated that the properties of buspirone (a 5-HT1A partial agonist) would 
function as either anxiolytic or panicolytic in both clinical and laboratory animal research. 
In this study, we have investigated the neuronal activity occurring within the different 
regions of the PAG induced by buspirone treatment. Twenty-eight albino Wistar rats 
(350-400g) were injected with either acute or chronic saline/buspirone (each, n=7), 
respectively. Our results show that buspirone treatment reduced locomotor activity, body 
weight and fecal boli, particularly in the chronic buspirone group. Two-way ANOVA 
revealed a significant decrease of c-Fos-ir cells expression in all regions of the rostral 
PAG after both acute- and chronic buspirone (AB and CB, respectively) treatment. 
However, no effects on c-Fos-ir were detected in the caudal lPAG and vlPAG in both the 
AB and CB groups, and in the dlPAG of the CB group. Interestingly, c-Fos-ir cells in the 
dmPAG column were reduced consistently in both the rostral and caudal PAG in both AB 
and CB groups. Besides, in all regions the number of c-Fos-ir cells was higher in the AB 
than in the CB group with exception of the rostral lPAG. In conclusion, the main 
anxiolytic effect of buspirone was specifically localized in all regions of the rostral PAG 
and in the caudal dmPAG. However, the caudal dlPAG, lPAG and vlPAG were found to 
be ineffective to buspirone treatment, probably due to their distinctive function in 
mediating higher level of anxiety in defensive behaviour. This indicates that the 
longitudinal anatomical structure of the PAG possesses a different level of receptor 
sensitivity of 5-HT1A in the pathophysiology of anxiety and panic disorder.   
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Introduction 
Buspirone, a 5-Hydroxytryptamine1A  (5-HT1A) partial agonist, is an efficacious 
anxiolytic drug in the treatment of clinically generalized anxiety disorder (GAD) 
(Jacobson et al 2007), and ineffective for severe anxiety (Ninan 2004b; Sramek et al 
2002), and panic disorder (PD) (Charney et al 1986; Sheehan et al 1990). The most 
common side effects, which occur approximately in 10% of the patients, are drowsiness, 
and headache. Occasionally, patients may complain of fatigue, nervousness, insomnia, 
and light-headedness. Nevertheless, the main advantage of buspirone as compared with 
the typical benzodiazepine anxiolytic is that it does not produce addiction, withdrawal 
syndrome, or mental confusion (Gorman 2003). Most clinical data have shown that the 
anxiolytic activity begins from one to three weeks after starting the therapy and that 
single doses are not very effective (Goldberg 1979). However, in the laboratory animal 
studies, buspirone was found to be effective in both the acute- and chronic treatment 
conditions, as well as the anxiolytic effects in the mild and severe anxiety conditions 
during the open-field tests (Clement et al 1996; Cole and Rodgers 1993; Lim et al 2008f; 
Liu et al 2004). Some authors even consider that the chronic nature of GAD is severe and 
debilitating which requires a long-term treatment and therefore buspirone seems to be 
more adapted to such therapeutic approach (Boulenger 1995; Brawman-Mintzer 2001). 
 
The experimental evidence of 5-HT1A modulation in defensive behaviour within 
the midbrain periaqueductal gray (PAG) is closely related with PD and anxiety-like 
behaviour (Beckett and Marsden 1997; de Bortoli et al 2006; Graeff 2004). In line with 
the clinical findings, buspirone showed no effects on the ‘escape behaviour’, a defensive 
behaviour which is generally known as the ‘panic-like’ reaction in the experimental 
animal models (Connor and Davidson 1998; Den Boer and Slaap 1998; Poltronieri et al 
2003). Interestingly, in some preclinical studies the administration of 5-HT1A agonist into 
the dorsal PAG have been shown to inhibit such escape reaction during the electrical 
stimulation which is generally considered not relevant in the clinical practice (de Bortoli 
et al 2006; Nogueira and Graeff 1995). On the contrary, several investigations have also 
demonstrated that the administration of buspirone was even possible to induce panic 
attacks as reported in the clinical studies (Lechin et al 2002; Norman and Judd 1989; Pols 
et al 1989). Such contradictory findings have stirred considerable excitement over this 
unsolved puzzle in the inhibitory or excitatory mechanism for “panic-like” behaviour. 
However, it is still a matter of investigation whether buspirone may have a relevant role 
in the regulation of defensive responses in association with anxiety disorder. 
 
There is empirical evidence showing that the different regions of the PAG play 
some specific roles in the modulation of anxiety and defensive behaviour. In particular, 
the dorsolateral PAG (dlPAG) and lateral PAG (lPAG) are involved mainly in the 
facilitation of  panic-like behaviour, a behaviour known as escape or flight reaction 
(Borelli et al 2004; Vianna et al 2003a). In contrast to the stimulation of dPAG or lPAG, 
the ventrolateral PAG (vlPAG) stimulation produced passive reactions of 
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quiescence/immobility, decreased vigilance and hyporeactivity with hypotension and 
bradycardia, not responding to any external environmental stimuli (Keay and Bandler 
2001; McNaughton and Corr 2004). The similar effects of hypotensive responses without 
significant heart rate changes were also observed during the stimulation in the 
dorsomedial PAG (dmPAG) (Pajolla and de Aguiar Correa 2004; Pajolla et al 2005). 
Thus, excitation of the vlPAG region elicits anxiety-like reaction characterized by 
freezing behaviour. It has been proposed that the vlPAG is exclusively involved in the 
passive emotional coping reaction during the inescapable events such as muscle and 
visceral pain. Such events have been shown to consistently evoke c-Fos expression in the 
vlPAG column selectively (Clement et al 1996; Keay et al 1994).  
 
Besides, the active emotional coping which responsible for the confrontational 
defensive reaction (fight and flight) when an animal is facing the stress or threat, 
activates either the dlPAG or lPAG columns (Keay and Bandler 2001). Thus, the 
different somatic and autonomic reactions with respect to either active or passive 
emotional coping in the different columns of the PAG, has provided an appropriate 
defensive strategy to any arising threats and levels of anxiety. Furthermore, various 
behavioural animal studies have indicated that either the administration of anxiolytic or 
anxiogenic drug alter the number of c-Fos immunoreactivity (c-Fos-ir) expression in the 
different regions of the PAG (Netto and Guimaraes 2004; Singewald and Sharp 2000). 
Therefore, morphological and anatomical studies of the neuronal activation in the PAG 
are necessary to evaluate the fundamental changes resulting from these anxiolytic drugs 
before proceeding further into its complexity.  
 
It is known that c-Fos expression is an accepted marker for the neural activation 
based on its function in regulating the immediate early transcription of genes (Malkani 
and Rosen 2000; Muller et al 1983). In this study, we investigated the effects of acute and 
chronic buspirone treatment using this c-Fos marker to study the differential pattern of 
neural activation particularly focused on the different regions of the PAG.  
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Material and methods  
Subjects 
Twenty-eight male albino Wistar rats (Harlan, Horst, The Netherlands) weighing 
approximately 350-400g were used in this study. They were housed individually in the 
standard transparent polypropylene cages on sawdust bedding in an air-ventilated room 
under a 12/12-h reversed light/dark cycle with the room temperature 20-22 °C and 
humidity 60-70%. Food, standard laboratory chow (Hopefarms, Woerden, the 
Netherlands) and acidified water were available ad libitum. The home cages of the 
animals were changed once a week as well as their food and water supply. All the 
animals were handled daily in order to habituate them to being picked up in order to 
reduce handling stress during the injection procedure. The experimental protocol and 
procedures were approved by the Animal Experiments and Ethics Committee of 
Maastricht University, the Netherlands. 
Experimental groups 
Animals were divided randomly into the following four experimental groups: 
Acute saline (AS, n=7), Acute buspirone (AB, n=7), Chronic saline (CS, n=7), and 
Chronic buspirone (CB, n=7). The rats with acute treatment received only one time 
injection, whereas the rats in the chronic treatment group were injected continuously for 
twenty one days with either saline or buspirone hydrochloride, respectively. 
Drug administration 
Buspirone hydrochloride (TOCRIS Cookson Inc., Missouri, USA) was dissolved 
in saline solution and injected subcutaneously. We used a dose of 3 mg/kg because this 
has previously been reported to influence anxiety-related behaviour and produce no 
sedative effects (Clement et al 1996; Hashimoto et al 1992; Lim et al 2008f; Ninan 
2004b). A week before the actual experimental injection, all animals received 3 times of 
1 ml saline injection on alternate days to habituate the animals to the injection procedure. 
Chronic treatment with saline and buspirone consisted of 21 daily routine injections. The 
acute treatment with saline or buspirone (one time injection) was performed at day 21, so 
that all animals achieved the same age/body weight at the end of the experimental stage. 
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Behavioural analysis 
Behavioural observation of the mobility of rats started after the injection with 
either saline or buspirone. Once the rats were placed back into their individual home 
cages (20 x 25 x 45cm), their mobility was measured by two independent researchers, of 
which one was blind to the treatment condition. The immobility was operationally 
interpreted as the total absence of body movement and it was scored through a time-
sample procedure. Firstly, the activity was rated every 1 min for the total of 10 min, and 
then subsequently every 10 min till the end of 180 min. The mobility of the rat was 
defined as simultaneous present of movement such as grooming and walking within the 
home-cage. The measurement of rat’s behaviour was conducted in the usual dim-light 
condition with no interference of objects such as videotapes recording and procedural 
manipulation. One researcher was blind with respect to the experimental condition during 
the behavioural observation.  
 
This procedure was repeated and performed randomly on five successive days (day 
1, day 5, day 10, day 15, and day 20). Additionally, the body weight of all rats was 
measured one week before treatment started, and also during the 3 weeks chronic 
treatment. After the injection on day 14, the fecal boli of all animals were collected from 
the cage and weighted accordingly. 
Histological processing 
Two hours after the final procedure of injection, rats were perfused transcardially 
with Tyrode (0.1 M) and fixative containing 4% paraformaldehyde, 15% picric acid and 
0.05% glutaraldehyde in 0.1 M phosphate buffer (pH 7.6). Brains were removed and 
post-fixed for 2 h followed by overnight immersion in 10%, 20% and 30% sucrose at 
4 °C. Brain tissue was then quickly frozen with CO2 and stored at − 80 °C. Subsequently, 
the prefrontal regions of the brains were cut serially on a cryostat (MICROM HM 520, 
Neuss, Germany) into 30 µm frontal sections and again stored at − 80 °C.  
c-Fos protein immunohistochemisty 
c-Fos immunohistochemistry was carried out by using anti-cFos, rabbit polyclonal 
lgG (diluted 1:20,000 in 0.1% Bovine Serum Albumin (BSA) and Tris Buffered Solution-
Triton (TBS-T) solution; Santa Cruz Biotechnology Inc., Santa Cruz, CA) as primary 
antibody for an overnight incubation at room temperature on a constant shaker. Next, 
after the rinsing steps with TBS-T, Tris Buffered Solution (TBS), and TBS-T; all the 
sections were incubated with the secondary antibody (diluted 1: 400 in biotinylated 
donkey anti-rabbit biotine; Jackson Immunoresearch Laboratories Inc., Westgrove, USA) 
for one hour and subsequently the sections were incubated with an avidin-biotin-
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peroxidase complex (diluted 1:800 in Elite ABC-kit, Vectastatin; Burlingame, USA) for 
two hours. In between steps, sections were washed with TBS and TBS-T. To visualize 
the immune complex of Horse Radish Peroxide (HRP) reaction product, the sections 
were incubated with 3,3’-diaminobenzidine tetrahydrochloride (DAB)/ Nickel Chloride 
(NiCL2) solution (5ml DAB solution, 5ml Tris/HCl, 50µl NiCL2, and 3.35 µl hydrogen 
peroxide (H2O2)). This reaction was stopped within the duration of 10 minutes by rinsing 
thoroughly all the sections with TBS. Finally sections were then rinsed, dehydrated, and 
cover-slipped. 
Quantitative evaluation of c-Fos immunoreactive cells 
Systematic cell counts of c-Fos immunoreactive (c-Fos-ir) cells were performed in 
two separate parts of the PAG: A. Rostral PAG (dmPAG, dlPAG, and lPAG; Bregma -
6.04mm, -6.30mm, -6.72mm, -6.80mm, and -7.30mm) and B. Caudal PAG (dmPAG, 
dlPAG, lPAG, and vlPAG; Bregma -7.64mm, -7.80mm, -8.00mm, -8.30mm, and -
8.72mm) parts, respectively. Photographs of the areas of interest were taken at 4X 
magnification using an Olympus DP70 camera connected to an Olympus AX70 bright-
field microscope (analySIS; Imaging System, Münster, Germany). Our quantification 
method was similar to a previously reported method, with minor modifications (Lamprea 
et al 2002; Lim et al 2008b). Four sections from each of the rostral (n=4) and caudal (n=4) 
PAG in each animal (n=6 in each group) were selected for quantification. The boundaries 
of the areas of interest were delineated and measured. The same light intensity and 
threshold conditions were employed for all sections. The counting of the numbers of c-
Fos-ir cells was performed using the conventional image analysis program ‘Image J’ 
(version 1.38, NIH, USA). A cell was counted as c-Fos-ir if its density was 75% higher 
than the background density. In addition, artifacts in the sections were excluded from 
analysis to ensure the accuracy of measurements. Since we observed marked differences 
between groups, we preferred the present method of quantification instead of a 
stereological method.   
Statistical analysis 
 All data are presented as means ± S.E.M and were analyzed using a two-way 
Analysis of Variance (ANOVA) using Treatment (saline vs. buspirone) and Duration of 
treatment (acute and chronic) as between-subject factors. All statistical analyses were 
performed with SPSS 13.0 version for Windows. Data of c-Fos-ir cell counts are 
expressed as number of c-Fos-ir cells per mm
2
.  An LSD post hoc test was used to 
analyze group differences in more detail. P-values lower than 0.05 were considered 
significant.  
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Results 
Behavioural evaluation 
 After injection, rats in the buspirone injected groups were more immobile in their 
home cages as compared to the control groups (Day 1, F(3,24)=2064.094, p<0.001; Day 
5, F(3,24)=41040.353, p<0.001; Day 10, F(3,24)=4320.288, p<0.001; Day 15, 
F(3,24)=4109.152, p<0.001; Day 20, F(3,24)=3823.978, p<0.001). The rats with acute 
treatment of buspirone were immobile for a period of 3 to 20 minutes, whereas the 
duration of immobility in the chronically treated rats lasted 3-80 minutes on the fifth day 
of injection (See Fig 1). However, on days 10, 15 and 20 the immobility of CB rats lasted 
3-100 minutes. Some rats began to show slight activity after 100 minutes of injection, and 
the mobility was returned to normal after approximately 130 minutes.  
 
 
Figure 1: The graph represents the duration of immobility of rats during the period of 
injection on the day 1 of acute treatment; and day 5, day 10, day 15, and day 20 of 
chronic treatment conditions.  The animals with acute and chronic saline treatment 
demonstrated no immobility throughout the entire experiment. Data are presented as 
means ± S.E.M. * indicates significant difference as compared to the day 1 of acute 
treatment, # indicates significant difference of day 10, day 15 and day 20 in comparison 
to day 5 and day 1, respectively (P< 0.05). 
 
 
Additionally, the body weight of all rats was measured continuously on week 1, 
week 2, week 3, and week 4. No significant effect on weight change was found in all 
groups in week 1 (F(3, 19)=0.314, n.s.) and week 2 (F(3,19)=0.914, n.s.). However, the 
body weight was lower in the CB group in week 3 (F(3,19)=6.693, p<0.001) and week 4 
(F(3,19)=5.709, p<0.001) (See Fig 3). Interestingly, in line with loss of body weight in 
the CB rats, the fecal mass production of the CB group also showed a significant decrease 
in week 3 as compared to the other groups (F(3, 27)=36.696, p<0.001; see Figure 2).          
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Figure 2: The effect of acute and chronic buspirone treatment in comparison to 
saline treated animals. The total mean weight of fecal boli (per week) was 
measured on the Day 14 of injection during the experimental procedure within 
the animal home cages. Data are presented as means ± S.E.M. * indicates 
significant difference as compared to the saline injected groups, acute and 
chronic treatment, respectively (P< 0.05).  
 
 
 
Figure 3: The graph shows the mean body weight (g) of animals during the acute and chronic 
buspirone and saline treatments. Data are presented as means ± S.E.M. * indicates significant 
difference as compared to the saline injected groups, acute and chronic treatment, respectively (P< 
0.05). 
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Evaluation of c-Fos-ir cells 
Two-way ANOVA showed a significant difference between groups in all regions 
of the rostral PAG, dmPAG (F(3,15)=66.855, P<0.001), dlPAG (F(3,15)=34.408, 
p<0.001), and lPAG (F(3,15)=285.207, P<0.001). In the caudal PAG, a significant 
difference between groups was found in the dmPAG (F(3,15)=189.591, P<0.001), dlPAG 
(F(3,15)=8.244, p<0.001), lPAG (F(3,15)=4.524, P<0.001), and vlPAG (F(3,15)=66.992, 
P<0.001). Post-hoc analysis revealed significantly decrease of c-Fos-ir cells expression in 
the entire region of the rostral PAG of both the AB and CB treated rats. In the caudal 
PAG, a significant decrease in the number of c-Fos-ir cells was found in the dmPAG 
region of both the AB and CB groups, as well as in the dlPAG of AB group but not the 
CB group. No significant effect was detected in the caudal lPAG and vlPAG of both the 
AB and CB groups. Interestingly, a consistent effect on the decrease of c-Fos-ir cells 
expression was significantly found at the dmPAG column in both the rostral and caudal 
PAG of AB and CB groups, respectively. The acute treatment conditions of AS resulted 
in higher number of c-Fos-ir cells as compared to CS treated condition, except for the 
rostral lPAG.      
 
 
Figure 4: Grouped data of c-Fos-ir cells per mm2 in the rostral PAG region. Data represent means 
± S.E.M. of groups A (acute saline), B (acute buspirone), C (chronic saline) and D (chronic 
buspirone). Abbreviations: dmPAG: dorsomedial periaqueductal gray; dlPAG: dorsolateral 
periaqueductal gray; and lPAG: lateral periaqueductal gray. * indicates significant difference as 
compared to the saline injected groups, acute or chronic treatment, respectively (P< 0.05). 
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Figure 5: Grouped data of c-Fos-ir cells per mm2 in the caudal PAG region. Data represents means ± 
S.E.M. of groups A (acute saline), B (acute buspirone), C (chronic saline) and D (chronic buspirone). 
Abbreviations: dmPAG: dorsomedial periaqueductal gray; dlPAG: dorsolateral periaqueductal gray; 
lPAG: lateral periaqueductal gray, and vlPAG: ventrolateral periaqueductal gray. * indicates significant 
difference as compared to the saline injected groups, acute or chronic treatment, respectively (P< 0.05). 
 
 
Figure 6: Schematic drawing of the rostral PAG regions based on the Atlas of the rat brain by Paxinos 
and Watson (4th Edition, 1998, Academic Press Inc, California, USA). Boxed areas are shown in the 
high-magnification photomicrographs of Fig. 6 (A, B, C). Representative high-power 
photomicrographs of a 30 µm-thick section from the brain of the rostral PAG regions, see fig.6 (A): 
dmPAG, (B): dlPAG, and (C) lPAG. Abbreviation: Aq= Aquaduct, dmPAG= dorsomedial 
periaqueductal gray, dlPAG= dorsolateral periaqueductal gray, and lPAG= lateral periaqueductal gray. 
The small dark dots represent c-Fos-ir cells at 4X magnification power. The inset in A shows a 
representative high-power photomicrograph of a c-Fos-ir cell at 100X magnification.  
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Figure 7: Schematic drawing of the caudal PAG regions based on the Atlas of the rat brain by Paxinos 
and Watson (4th Edition, 1998, Academic Press Inc, California, USA). Boxed areas are shown in the 
high-magnification photomicrographs of Fig. 7 (A, B, C, D). Representative high-power 
photomicrographs of a 30 µm-thick section from the brain of the caudal PAG regions, see fig.7 (A): 
dmPAG, (B): dlPAG, (C) lPAG, and (D) vlPAG. Abbreviation: dmPAG= dorsomedial periaqueductal 
gray, dlPAG= dorsolateral periaqueductal gray, lPAG= lateral periaqueductal gray, vlPAG= 
ventrolateral PAG, Aq= Aquaduct, DRD= dorsal raphe dorsal, DRV= dorsal raphe ventral, and DRVL= 
dorsal raphe ventrolateral. The small dark dots represent c-Fos-ir cells at 4X magnification power.  
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Discussion 
The main objective of this experiment was to evaluate the neuronal activity 
occurring within the different regions of the PAG after acute and chronic treatment of 
buspirone. Besides, we have also measured the effects of these treatments on behavioural 
mobility. It was found that the treatment with buspirone decreased behavioural activity 
particularly in the CB group which showed a significant longer duration of immobility as 
compared with the other groups. Additionally, the reduction of body weight was clearly 
observed in the CB rats as measured on the second and third week of chronic treatment. 
The latter group also showed a decrease in the total weight of fecal boli production on the 
second week of treatment. Two-way ANOVA revealed a significant decrease in the 
number of c-Fos-ir cells in all regions of the rostral PAG, and in the dorsal regions of the 
caudal PAG. It has to be noted that buspirone treatment did not affect the number of c-
Fos-ir cells in the caudal lPAG and vlPAG regions of both AB and CB groups, as well as 
the dlPAG of the CB group. Accordingly, the most consistent effect of buspirone on c-
Fos expression was found in the dmPAG column in both the rostral and caudal part of the 
PAG. The differential pattern of c-Fos-ir expression in the different regions of the PAG 
after buspirone treatment may indicate that the longitudinal anatomical structure of the 
PAG possesses a different level of receptor sensitivity towards 5-HT1A mechanism in the 
pathophysiology of anxiety and panic disorder. 
Behavioural effects of buspirone treatment 
The effects of locomotor activity suppression in the acute- and chronically-
buspirone treated rats suggest that the pharmacological interaction of 5-HT1A does not 
only induce a complex mechanism of action on neurotransmitters, but also involve in the 
modulation of anxiety disorder (de Bortoli et al 2006). The immobility of rats in the home 
cages is usually interpreted as a result of sedative effect which may possibly reflect the 
dopamine D2 antagonism-induced sedation or locomotor suppressant induced by alpha-2 
adrenoceptor antagonist action (Collinson and Dawson 1997). However, comparative 
studies on the behavioural and EEG changes have confirmed that buspirone with the 
dosage varied between 10-20 mg does not produce any sedative effect, motor disturbance 
and memory impairments (Lerman et al 1986; Mattila et al 1982; Newton et al 1982). For 
instance, buspirone was reported to reduce both the REM (rapid eye movement) sleep 
and non-REM latency when compared to those sedative anxiolytic agents, e.g. diazepam 
which increased the non-REM sleep and caused severe motor disturbance (Hashimoto et 
al 1992; Mendelson et al 1990). Considering these effects, Grundmann et al. also showed 
that a single injection of 10 mg/kg buspirone treatment did not produce any significant 
overt behavioural change or motor dysfunction in the elevated pluz-maze and open field 
test, indicating that the observed effects were not due to sedation (Grundmann et al 2006; 
Grundmann et al 2007). The latter studies support the hypothesis that buspirone with 
dosages as used in this experiment produced no sedative properties unlike 
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benzodiazepines. On the other hand, Collinson and Dawson showed that buspirone 
increased substantially the production of glucocorticoid hormone which eventually 
suppressed the locomotor activity as induced by alpha-2 adrenoceptor antagonist action 
(Collinson and Dawson 1997). In view of this, one study had demonstrated that the 
locomotor suppressant effect of buspirone after 1 hour but not 4 hours was correlated 
significantly with glucocorticoid production suggesting that the acute glucocorticoid-
releasing effect of buspirone initially suppressed locomotor activity and thereby masking 
the anxiolytic action of the compound (McNaughton et al 1996). However, the present 
study had revealed more specifically the exact time frame of such immobility activity in 
both the acute and chronic treatment. It has been reported that the immobility with the 
reduction of locomotor activity could be the result of an anxiogenic effect, but at the 
same time the authors also found evidence for an anxiolytic effect (Clement et al 1996; 
Lim et al 2008f). Taken together these behavioural findings concerning the dual effects of 
buspirone, a complex mechanism of 5-HT1A interaction might probably take place within 
the different regions of PAG for the modulation of anxiety disorder that eventually 
affects the emotional response and autonomic nervous system. 
Reduction of body weight and fecal boli 
In human studies, buspirone has been well established typically in the treatment of 
GAD. In consideration of the side effects, buspirone does not induce any sedation or 
cognitive dysfunction as compared to other anxiolytic compounds such as the 
benzodiazepines. However, other adverse effects such as vertigo, headaches, anorexia, 
and nausea, have been frequently encountered in patients after buspirone administration 
(Goldberg 1979; Goldberg and Finnerty 1979; Gorman 2003). Interestingly, it has been 
reported previously that after chronic buspirone treatment, the body weight was 
significantly reduced (Andersen et al 2005; Larsson et al 1990; Schechter et al 1990). In 
contrast, some studies have also demonstrated that buspirone did not cause any increase 
or decrease of the average body weight (Eison 1986; Okazawa et al 1999), while one 
study even showed the effect of weight gain (Goudie and Leathley 1991). Nevertheless, 
there are a number of mechanisms involved such as the genetic and environmental factors 
or drug interaction to play a role for the alteration of body weight. Thus, the reduction of 
the mean weight on body mass and fecal boli in the CB group, one could possibly explain 
that the side effects (ie. nausea and anorexia) were probably due to the decreased appetite 
and gastrointestinal disturbances.  
Effects of c-Fos-ir expression on acute and chronic saline treatment 
Interestingly, the number of c-Fos-ir cells in the AS condition was found to be 
significantly higher than the CS treated condition even though all the rats had received 3 
injections prior to the experiment. The pattern of c-Fos-ir cells expression in this 
condition could not be possibly explained by the experimental stress as it was 
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demonstrated in a previous study that a single restraint or injection would induce stress-
like behaviour but not in the repeated injection procedure due to the habituation effects 
(Fernandes et al 2002; Melia et al 1994). Nevertheless, the procedural stress manipulation 
cannot be ruled out as the leading factor for such pattern of c-Fos-ir expression. In this 
respect, our assumption is that the animals might require a longer period in order to 
achieve its habituation effects as it was observed in the case of chronic conditions. 
Another possible explanation could be that the PAG is sensitive to the procedural 
injection since the PAG has been generally known to be involved in the regulation of fear 
and anxiety. Our finding show that the PAG is activated differently in the acute and 
chronic saline conditions which might suggest a modulatory role of 5-HT1A in the fear 
and anxiety condition.   
Effects of buspirone on the rostral and caudal periaqueductal gray  
The major finding in this study was that the number of c-Fos-ir cells was 
significantly reduced in all regions of the rostral PAG, whereas the caudal PAG showed a 
rather complex picture of c-Fos-ir cells expression in its different regions. It has been 
proposed that different areas of the PAG play a different role in mediating defensive 
behaviour during an aversive or stressful situation. We know from electrical or chemical 
stimulation studies, that dlPAG stimulation evokes a typical response known as defensive 
behaviour which is closely related to panic and anxiety like behaviour (Bandler and Keay 
1996; Borelli et al 2005a; Brandao et al 1994; Brandao et al 1982). This panic-like 
behaviour was further investigated in our laboratory and a simple fear-conditioning effect 
with anxiety-like behaviour was found during the post-stimulation period in the caudal 
dlPAG of electrical stimulated animals (Lim et al 2008b). Additionally, there are data 
showing that the dlPAG and lPAG are involved mainly in the facilitation of panic-like 
behaviour (Borelli et al 2004; Vianna et al 2003a), whereas the vlPAG stimulation 
produced freezing- or fear-like behaviour (Keay and Bandler 2001; McNaughton and 
Corr 2004). In recent years, most clinical and preclinical studies have indicated that 
buspirone is only used for mild anxiety (e.g. GAD) and it is considered ineffective for 
other anxiety conditions (e.g. panic disorder) (Connor and Davidson 1998; Ninan 2004b). 
Accordingly, the present study has demonstrated no significant effect of c-Fos-ir 
expression in the caudal dlPAG, lPAG, and vlPAG regions, which is in line with the 
clinical findings that buspirone was effective only in mild anxiety (i.e GAD) and not for 
the severe anxiety such as fear and panic disorder. Therefore, buspirone plays no 
significant role in preventing the spontaneous occurrence of panic attacks. Furthermore, it 
has been shown that intra-dorsal-PAG injection of buspirone produced no effect on 
escape reaction (de Bortoli et al 2006) whereas a panicolytic compound such as 5-HT1A 
receptor agonists 8-OH-DPAT and BAY-R-1532 decreased the aversive behaviour 
induced by the stimulation of the same structure (Nogueira and Graeff 1995). It is 
therefore possible that the caudal dlPAG, lPAG and vlPAG are mainly responsible for 
intense and aversive behaviours such as panic-like reaction, whereas the rostral PAG is 
involved more in the regulation of mild anxiety-like behaviour. 
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Effects of buspirone on the dorsomedial periaqueductal gray  
Several experimental findings have demonstrated that the 5-HT1A receptors in the 
PAG are involved in anxiety and panic disorder (Graeff 2004; Nogueira and Graeff 1995; 
Pobbe and Zangrossi 2005; Zanoveli et al 2005). However, the specific role played by the 
different regions of the PAG in the regulation of anxiety is still poorly understood, 
though it has been the focus of interest for decades. A recent study with microinjection of 
ovian corticotropin-releasing factor (oCRF, a nonspecific CRF receptor agonist that 
produces anxiogenic-like effects) into the dmPAG, dlPAG, and lPAG showed that a 
difference effect of columnar specificity for the oCRF in the PAG was obtained using the 
exploratory behavioural of rats in the elevated plus-maze (EPM) test (Borelli and 
Brandao 2008). It was found that the oCRF intra-dmPAG reduced entries and time spent 
in the open arms and decreased end-arm exploration and head-dipping. On the other hand, 
the oCRF intra-dlPAG and lPAG produced no effect on the exploratory behavioural of 
the animals in the EPM. Besides, Fontanesi et al., have observed the increase of c-Fos-ir 
expression in the dPAG of rats during the withdrawal period of prolonged treatment with 
diazepam which lead to a withdrawal syndrome characterized by increased level of 
anxiety (Fontanesi et al 2007). Since our findings have revealed that a consistent effect 
was obtained in the dorsomedial column of both the rostral and caudal PAG in acute and 
chronic buspirone treated animals, it is most likely the anxiolytic effect is mainly 
localised in the dmPAG.  
Effects of buspirone on the dorsolateral periaqueductal gray  
Many studies have shown that neural activation within the different regions of the 
PAG (i.e. high levels of c-Fos-ir expression) was related either to the experimental 
anxiogenic testing condition or the administration of anxiogenic drugs to the animals 
(Netto and Guimaraes 2004; Singewald and Sharp 2000; Zienowicz et al 2007). One 
study showed that the administration of anxiogenic drugs, for instance the m-
chlorophenyl piperazine (mCPP; non-selective 5-hydroxytryptamine 5-HT2C receptor 
agonist), carboxy-terminal tetrapeptide of cholecystokinin (CCK4; CCKB agonist), and 
yohimbine (α2-adrenoceptor antagonist) increased the number of c-Fos-ir cells in the 
rostral dlPAG regions but not the caudal dlPAG (Singewald and Sharp 2000).  However, 
the present study of buspirone treatment showed that the decrease in the number of c-Fos-
ir cells of the PAG which also supports the hypothesis that the pharmacological property 
of buspirone is anxiolytic. Moreover, the present study revealed that buspirone decreased 
the number of c-Fos-ir cells in the rostral dlPAG and caudal dlPAG in the AB group but 
not the caudal dlPAG in the CB group. This suggests that the rostral dlPAG plays a role 
in anxiety, while the caudal dlPAG showed somehow rather complex or no effect in the 
regulation of anxiety. One possible explanation is that buspirone appears to play a dual 
role in the regulation of anxiety either as anxiolytic or anxiogenic within the different 
brain regions. Such result of dual effect was also reported in many studies across 
different experimental paradigms and animal models (Graeff 2002). Another possibility 
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would be the complexity of mechanism of action between the pharmacological properties 
of buspirone along with different regions of the PAG as it was well established that the 
different anatomical column of the PAG possesses different and specific functional role 
in the regulation of defensive behaviour including the panic- and anxiety-like response 
(Borelli and Brandao 2008; LeDoux et al 1988; Vianna et al 2003a).   
Role of periaqueductal gray 5-HT1A receptors in anxiety  
To our knowledge, the PAG contains a large quantity of 5-HT-ir nerve terminals 
that originate from the 5-HT containing cells bodies located in the dorsal raphe nucleus 
(Beitz et al 1986; Clements et al 1985; Lovick et al 2000). The obtained results from 
different studies on electrophysiological and autoradiographical mapping of 5-HT 
receptors have demonstrated that the PAG is relatively rich in 5-HT1A, 5-HT1B, 5-HT2A, 
and other receptor subtypes (Brandao et al 1991; Pazos and Palacios 1985; Pompeiano et 
al 1992). Of interest for the 5-HT1A receptor, the receptor-binding data have shown 
that >65% of neurons within the PAG regions were highly responsive to 5-HT1A agonists 
(Behbehani et al 1993). Nogueira and Graeff have shown that the microinjections of 5-
HT1A receptor agonist, 8-OH-DPAT and BAY-R-1532 into the dPAG decreased 
remarkably the escape reaction (Nogueira and Graeff 1995). It was also reported that the 
activation of both the 5-HT1A and 5-HT2A receptors within the dPAG inhibited the escape 
reaction when rats were exposed to the open arms of an anxiety test (Zanoveli et al 2003). 
On the other hand, a contradictory result was found on the chronic administration of 
buspirone, a compound non-effective for PD, which did not inhibit the escape reaction as 
compared to those of clinically effective panicolytic drugs such as the selective serotonin 
reuptake inhibitor (SSRI) imipramine and fluoxetine (de Bortoli et al 2006; Poltronieri et 
al 2003). Thus, the differential effects of 5-HT1A agonists as either anxiolytic or 
panicolytic actions in the PAG suggest that the increase of 5-HT level within the PAG 
plays a role on either the anti-aversive or –anxiety or both actions (Behbehani et al 1993; 
Nogueira and Graeff 1991). In addition, the interaction of 5-HT1A with other receptor 
subtypes or neurotransmitters (e.g. 5-HT2A, GABAergic interneurons) at the cellular level 
could also possibly influence the PAG neuronal activity involving the mechanism of 
panicolytic or anxiolytic action (Conn and Sanders-Bush 1987; Griffiths and Lovick 
2002). Taken together, these studies along with our findings may explain the relative 
importance of 5-HT1A agonists on the regulation of panic and anxiety disorders in the 
different regions of the PAG. 
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Conclusion 
 In conclusion, the present findings demonstrated that stimulation of 5-HT1A 
receptors induced different neuronal activation pattern in the different regions of the PAG 
in both the acute- and chronic buspirone treatment. In view of these results, the main 
effect of anxiolytic action was specifically localized in all regions of the rostral PAG and 
in the caudal dmPAG. However, the caudal dlPAG, lPAG and vlPAG were found to be 
ineffective to buspirone treatment, probably due to their distinctive function in mediating 
higher level of anxiety in defensive behaviour. This indicates that the longitudinal 
anatomical structure of the PAG possesses a different level of receptor sensitivity of 5-
HT1A in the pathophysiology of anxiety and panic disorder.   
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CHAPTER 7 
 
Electrical stimulation of the dorsolateral periaqueductal gray 
evokes escape response followed by fear behaviour in rats: 
Reversal by SSRI treatment 
 
Lee Wei Lim, Arjan Blokland, Sonny Tan, Rinske Vlamings, Thibaut Sesia, 
Veerle Visser-Vandewalle, Koen Schruers, Harry Steinbusch, and Yasin Temel  
 
 
Abstract 
Electrical stimulation of the dorsolateral periaqueductal gray (dlPAG) has been 
shown to induce escape and freezing responses which mimic the panic- and fear-like 
behaviour. In the present study, we tested the hypothesis whether the freezing behaviour 
could be attenuated by acute and chronic administration of escitalopram and buspirone. 
Additionally, the levels of blood corticosterone were measured in the different 
experimental conditions. Our results demonstrated that escitalopram treatment was 
effective in attenuating the stimulation induced fear when compared to buspirone and 
saline treated animals after acute and chronic treatment. The stimulation amplitudes to 
evoke escape behaviour were significantly higher after chronic buspirone and 
escitalopram treatment. The levels of blood corticosterone were increased after 
stimulation and the open-field testing conditions when compared to the baseline level. In 
conclusion, the current study shows that the escape reaction generated intrinsically within 
the dlPAG was followed by freezing behaviour 12 h later. This fear-like behaviour was 
reversed by escitalopram treatment while buspirone or vehicle treated groups did not 
attenuate fear behaviour. Our data also confirm the elevation of blood corticosterone 
level during the panic and fear-like behaviour. Future research of fear should be focused 
on the underlying neural mechanism within the dlPAG. 
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Introduction 
Fear is an emotional activation of defensive behavioural system that protects an 
organism from potentially threatening stimuli. The behavioural response to such threats 
can be either innate (unconditioned) or learned (conditioned) (Blanchard and Blanchard 
1972; Klemenhagen et al 2006; Stiedl et al 2000). Innate fear depends on stimuli that 
naturally evoke fear when animals are exposed to a novel place (Blanchard et al 1991) or 
natural predators (Montgomery 1955; Montgomery and Monkman 1955). While learned 
fear is a form of Pavlovian conditioning when an animal is trained to associate a neutral 
stimulus (tone, light) with an external aversive stimulus, usually an electric foot-shock 
(Brown et al 1951; Davis et al 1993), noxious thermal stimuli (Finn et al 2006; Harris and 
Westbrook 1994) or predatory odor (Blanchard et al 1990; Dielenberg et al 1999). In this 
respect, the most frequently used animal models of fear-conditioning have a common 
behavioural phenotype as the exhibition of freezing response with high levels of 
immobility and vigilant scanning of the environment (Bandler and Shipley 1994; Carrive 
1993). Despite these animal models were generally used to investigate the underlying 
mechanisms of fear memory acquisition and consolidation (Dayan et al 2000; Schiller et 
al 2008), the neural substrate that responsible for the origin of fear expression in the brain 
is still poorly understood. In other words, the acquisition of fear involves a complex 
neural circuitry and neurochemistry in the overall integration of fearful impulses from the 
higher levels of fear circuit in the thalamic and amygdaloid nuclei complex relays to the 
lower levels (i.e., at hypothalamic and mesencephalic levels; see (LeDoux 1993; LeDoux 
1995; Panksepp 1998).  
 
Recently, electrical stimulation of the midbrain dorsal periaqueductal gray (PAG) 
induces defensive behaviour and a wealth of evidence also suggesting that it plays an 
important role for the generation of fear and anxiety (Bandler and Shipley 1994; Lovick 
et al 2000). Interestingly and unexpectedly, we have observed a similar behaviour in rats 
who had received electrical stimulation of the dorsolateral periaqueductal gray (dlPAG). 
Immediately after the onset of stimulation rats show vigorous running and jumping in the 
open-field arena (Lim et al 2008a; Lim et al 2008b). This behaviour is known as escape 
behaviour and is generally accepted as a model for panic attacks (Graeff 1990; Schenberg 
et al 2001). When the stimulated rats were placed in the same open-field arena after 12 h 
of escape behaviour, they became immobile and showed head scanning, indicative of 
fear. Here, we have investigated this phenomenon more in detail. We hypothesized that 
electrical stimulation of the dlPAG (unconditioned stimulus, US) would induce such kind 
of innate fear response after evoking escape behaviour in an enclosed open-field 
environment (conditioned stimulus, CS).   
 
In the first part of the present study, we recorded the behaviour of the subjects 
after having received dlPAG stimulation with parameters evoking fear behaviour in the 
open-field arena. Subsequently, the effects of acute and chronic escitalopram treatment 
on fear behaviour were tested in the same group of animals. We expected that this 
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selective serotonin reuptake inhibitor (SSRI) would attenuate the fear response induced 
by dlPAG stimulation based on its efficacy in the treatment of panic disorders (APA 
1998; Hogg et al 2006; Hollander and Simeon 2003). Another group of animals was 
treated with buspirone, again tested after a single-dose and chronic treatment. Buspirone, 
a classical 5-HT1A receptor agonist, is effective in the treatment of generalized anxiety 
disorder but not for other severe anxiety (Ninan 2004). Therefore, we reasoned that 
buspirone would not be effective in reducing dlPAG stimulation–induced fear response. 
This pharmacological approach was used to further characterize the behavioural 
phenotype induced by dlPAG stimulation. Finally, corticosterone levels were measured at 
different phases of the experiment to examine the relation between the behavioural 
changes and treatment effects. The present study would allow us to further elucidate the 
intrinsic properties of dlPAG as a substrate for the expression of fear responses, and the 
modulation by 5-HT treatment. 
Material and Methods  
Subjects  
Subjects were male albino Wistar rats ( = 40, 12 weeks old), bred and housed at 
the Central Animal Facility of Maastricht University (Maastricht, the Netherlands). Rats 
had an average body weight of 300-350 g at the time of surgery. They were housed 
individually in standard cages on sawdust bedding in an air-conditioned room (about 20 
ºC) under a 12/12-h reversed light/dark cycle. Food, standard laboratory chow 
(Hopefarms, Woerden, the Netherlands), and water were available ad libitum. This study 
was approved by the Animal Experiments and Ethics Committee of Maastricht 
University.  
Experimental groups 
Rats were randomly divided into the following six experimental groups: A. dlPAG 
stimulation and treatment with saline (STIM-SAL, n=7); B. dlPAG stimulation and 
treatment with buspirone (STIM-BUSP, n=7); C. dlPAG stimulation and treatment with 
escitalopram (STIM-ESCIT n=7); D. dlPAG sham surgery and saline treatment (SHAM-
SAL, n=6); E. dlPAG sham surgery and buspirone treatment (SHAM-BUSP, n=6); and F. 
dlPAG sham surgery and escitalopram treatment (SHAM-ESCIT, n=7). 
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A flowchart of the experiment is shown in figure 1. All animals were handled daily 
in order to habituate them to being picked up and reduce stress during behavioural testing.  
 
 
 
Figure 1. Design of the experimental procedures. 
Surgical procedures 
A detailed description of the surgical procedure has been reported previously 
(Temel et al 2007). In brief, the rats were anesthetized throughout the entire procedure 
using a combination of ketamine (90 mg/kg) and xylazine (10 mg/kg) injected 
subcutaneously (s.c.). Rats were placed in a stereotactic apparatus (Stoelting, Wood Dale, 
USA; model 51653). After making a burr hole in the skull, rats received implantation of 
the electrode at the level of the dlPAG (coordinates from Bregma: anteroposterior, −7.6; 
mediolateral, + 0.7; and ventral, −4.8; approached with a coronal angle of 10°). A 
construction of one gold-plated needle-like electrode with an inner wire of a platinum–
iridium combination (Technomed, Beek, the Netherlands) with a tip diameter of 50 µm 
and a shaft diameter of 250 µm, was employed in this experiment. The electrodes were 
fixed in position using dental cement (Heraeus Kulzer, Hanau, Germany). After the 
operation, rats were injected with Temgesic (0.1 mg/kg, s.c.) and allowed to recover for 
two weeks.  
Electrical dlPAG Stimulation 
All animals in the dlPAG stimulation group underwent a stimulation session in 
their home cages to determine the level of the escape threshold. The stimulation 
amplitudes were gradually increased till the escape behaviour (ie. rigorously running with 
aimless direction) was observed (Lim et al 2008a). The stimulation duration was 15 s 
followed by a stimulation-off period of 45 s. After this the cable was removed. The 
stimulation frequency was set at 50 Hz, and pulse width at 0.1 ms based on previous 
experience (Lim et al 2008a). Animals which required stimulation amplitudes above 100 
µA were discarded from analysis. Remarkably, when rats were stimulated for the second 
time in the open field (see Fig. 1), rats from the STIM BUS and STIM ESCIT groups did 
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not show an escape response at the amplitude as determined at the first stimulation 
session. The amplitudes were increased in a stepwise manner until an escape response 
was observed. This stepwise increase was achieved within 1-2 min in the open field. A 
World Precision Instruments (WPI) digital stimulator (DS8000, WPI, Berlin, Germany) 
and a stimulus isolator (DLS100, WPI, Berlin, Germany) were used to deliver the stimuli. 
Real time verification of the parameters applied during stimulation was obtained using a 
digital oscilloscope (Agilent 54622D oscilloscope, Agilent Technologies, Amstelveen, 
the Netherlands). After the threshold determination session, all rats were given a recovery 
period of two weeks. The sham animals were similarly connected to the stimulator but no 
current was delivered to the dlPAG.  
Drug administration 
Escitalopram oxalate (ESCIT) (H. Lundbeck A/S, Copenhagen, Denmark) and 
Buspirone hydrochloride (BUSP) (TOCRIS, Cookson Inc., Missouri, USA) were freshly 
prepared and dissolved in saline 0.9% NaCl (Braun, Melsungen, Germany). ESCIT (10 
mg/kg) and BUSP (3 mg/kg) were injected (s.c. in a volume of 1 ml/kg) 60 min and 120 
min before behavioural testing, respectively. These doses were chosen based on previous 
experimental studies. A week before the actual experimental testing, all animals received 
1 ml saline injection 3 times on alternating days in order to habituate to the injection 
procedure. A single-dose acute treatment was performed before the open-field 
experiment. After recording the behaviour and collecting blood samples, the subjects 
entered into the chronic experiment. They received 21 daily injections of either ESCIT, 
BUSP, or SAL.  
Behavioural testing  
The apparatus consisted of an enclosed open-field (square: 100 cm x 100 cm, and 
height: 40 cm), clear Plexiglas box with an open top and a dark floor (Lim et al 2008d). 
All open-field testing was conducted in the same room in a dimly lit condition from 
08:00 till 10:00 h. On the first day of stimulation in the open field, rats were placed in the 
open-field arena and connected with the external stimulator through externalized leads. 
The electrical stimulation was performed based on the previously determined escape 
threshold level and started 1 min after the rat was placed in the open-field arena. Once the 
escape reaction was evoked, the cable connected to the rat was detached and the animal 
was left in the open-field for approximately 30 s.  
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Next day, after 12 h of escape behaviour rats were placed again in the open-field. 
The behaviour of each rat was recorded using an automated system consisting of a 
camera connected to a computer with the Ethovision tracking software (Ethovision, 
Noldus Information Technology, Wageningen, the Netherlands). At the time of open field 
testing the researchers were blind with respect to treatment and stimulation conditions. A 
trial was stopped after 5 min and the rat was removed from the arena. Of note, behaviour 
was not analyzed during the first open field test since the escape response after STIM was 
assumed not to produce open field data that could be interpreted in a reliable manner. 
Blood sampling and corticosterone radioimmunoassay 
Blood sample collections were taken at different time points (see Fig 1). All rat tail 
blood samples were withdrawn and directly put into heparinized blood collection tubes 
(Microvette, CB300, Sarstedt, Germany) in a cold ice box. Blood samples were 
centrifuged at 3000 rpm for 5 min at 4°C and the supernatant was thereafter stored at 
−80°C until analysis. 50 µl of plasma was extracted with 3 ml dichloromethane and 
vortexed for one minute in order to determine the concentration of plasma corticosterone. 
The corticosterone was then measured directly on 1 ml dried dichloromethane and 
extracted for radioimmunoassay using corticosterone-
125
I. The radioimmunological 
reaction was performed overnight at 4°C, after which a secondary antibody system was 
used to separate bound and unbound steroid. The entire procedure has been described in 
detail previously (Sulon et al 1978; Van den Hove et al 2006).  
Histological processing 
After the final experiment, rats were under generalized anesthesia with Nembutal 
(75 mg/kg) and perfused transcardially with Tyrode (0.1 M) and fixative solution 
containing 4% paraformaldehyde, 15% picric acid and 0.05% glutaraldehyde in 0.1 M 
phosphate buffer (pH 7.6). The rat brains have been post-fixed for 2 hours in the same 
fixative used for perfusion. Hereafter, the brains were cryprotected by overnights sucrose 
treatment at 4 °C. Brain tissue was then quickly frozen with CO2 and stored at − 80 °C. 
Subsequently, the brains were cut serially on a cryostat into 30 µm frontal sections and 
again stored at − 80 °C. The sections were stained with standard hematoxylin–eosin 
(Merck, Darmstadt, Germany) to examine the localization of the electrode tips. 
Statistical analysis 
All data are presented as mean ± S.E.M and were analyzed using two-way 
ANOVA using Treatment and Stimulation as between-subjects factors. A Duncan post 
hoc test was used to analyze group differences in more detail. Pearson correlation 
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coefficients were calculated to examine the relation between variables within a test and 
between different tests of corticosterone and behavioural open-field data. All p-values < 
0.05 were considered significant. 
Results 
Histological evaluation of the electrode localization 
In all rats, except for four, the electrode tips were located within the dlPAG. One 
rat in group STIM-SAL and STIM-ESCIT, two rats in SHAM-ESCIT, electrodes were 
placed outside the dlPAG. The required current to induce an escape reaction in the rats of 
STIM-SAL and STIM-ESCIT was > 100 µA and they were discarded from analysis. The 
final group sizes were six animals per group for SHAM-SAL, SHAM-BUSP, STIM-SAL, 
STIM-ESCIT and seven animals for groups STIM-BUSP, and SHAM-ESCIT. 
 
The localization of the electrode tip in the dlPAG is illustrated in Fig. 2. Except for 
the electrode trajectory, we observed no additional tissue damage due to repeated 
stimulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Representative low-power photomicrographs of a 30 µm-thick coronal section from the 
brain of a rat subjected to stereotactic implantation of concentric bipolar electrode to stimulate the 
dlPAG (Fig. 2B, scale bar = 250 µm) is shown. Fig. 2A, schematic representation of the electrode 
sites in the dlPAG according to the Paxinos and Watson atlas, respectively. The symbol (•) 
indicates the electrode localization in the dlPAG. Abbreviation: Aq = aqueduct of Sylvius; dlPAG 
= dorsolateral periaqueductal gray; dmPAG = dorsomedial periaqueductal gray; lPAG = lateral 
periaqueductal gray; vlPAG = ventrolateral periaqueductal gray; DRD = dorsal raphe nucleus, 
dorsal part; DRVL = dorsal raphe nucleus, ventrolateral part; and DRV = dorsal raphe nucleus, 
ventral part.  
 
 
 
 163 
Threshold dlPAG stimulation 
The intensity of stimulation current applied to the dlPAG of the animals was based 
on the lowest threshold to induce escape behaviour. There were no group differences 
before acute treatment (F(2,17)=0.02, n.s.; see Fig. 3). The stimulation amplitudes to 
evoke escape behaviour were significantly higher for the second phase for animals in 
STIM-BUSP and STIM-ESCIT group (F(2, 17)=26.07, p<0.001).  
 
 
Figure 3. This figure shows the current amplitudes (µA) necessary to induce escape 
reaction. Data represent means ± S.E.M. of dlPAG group. Indication: * Significant 
difference from the STIM-SAL group during the stimulation phase II. 
Open field behaviour after dlPAG stimulation 
The open field behaviour was comparable in the acute and chronic phases of the 
study (Treatment, Stimulation and all interactions with Time, for the distance moved, 
time in corner and mean velocity: all F’s < 1.45 n.s.). However, there was an overall 
increase in the time the rats spent in the corner areas in the chronic phase (Time: 
F(1,31)=11.38, p<0.01), which was independent of stimulation or treatment conditions 
(all F’s < 1.45 n.s.). 
 
Twelve hours after dlPAG stimulation the rats were put in the same open field, and 
the behaviour of the animals was scored. STIM rats showed a significant reduction in 
distance moved and mean velocity and an increased time spent in corner areas as 
compared to the SHAM animals (all F’s>4.67, p<0.05; see Fig. 4). Acute treatment 
attenuated these effects (all F’s>3.54, p<0.05; and a marginal Treatment by Stimulation 
interaction: all F’s>2.88, p<0.07). Post hoc analysis of treatment effects in the STIM 
groups revealed that only ESCIT attenuated the effects of dlPAG stimulation on all three 
open field measures. 
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Figure 4. A set of bar graphs showing the behavioural data of acute treatment with 
saline, buspirone, and escitalopram for the dlPAG stimulation, and dlPAG sham rats. 
The data of distance moved (Fig. 4A), time spent in the corner zones (Fig. 4B), and 
mean velocity (Fig. 4C) in the open-field are expressed as means ± S.E.M.  Indication: * 
Significant difference from the STIM-SAL and STIM-BUSP. 
 
 
After chronic treatment, the animals were stimulated to induce an escape response 
for the second time in the open-field. Later, they were again tested in the open-field after 
12 h of escape reaction. Similar to the acute treatment, STIM rats showed a significant 
reduction in distance moved and mean velocity and an increased time spent in corner 
areas as compared to the SHAM animals (all F’s>10.58, p<0.01). There was no 
indication of treatment effects (all F’s>2.06, n.s.). However, there were marginal 
Treatment by Stimulation effects for all three open field measures (all F’s>2.91, p<0.07). 
Post hoc analysis of treatment effects in the STIM group revealed that only ESCIT 
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attenuated the effects of dlPAG stimulation on all three open field measures (Fig. 4). No 
effects of treatment was found in the SHAM group (Treatment: all F’s<1.13, n.s.). 
 
 
Figure 5. A set of bar graphs showing the behavioural data of chronic treatment with saline, 
buspirone, and escitalopram for the dlPAG DBS, and dlPAG sham rats. The data of distance moved 
(Fig. 5A), time spent in the corner zones (Fig. 5B), and mean velocity (Fig. 5C) in the open-field 
are expressed as means ± S.E.M.  Indication: * Significant difference from the STIM-SAL.  
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Effects of dlPAG stimulation on blood corticosterone level 
Corticosterone levels were similar in the pre- (baseline) and post open-field 
periods (Time: F(1,15)=2.65, ns). Comparison of STIM-SAL and SHAM-SAL groups 
showed that STIM increased corticosterone levels after open field testing in the acute 
(t(10)=8.00, p<0.01) and chronic treatment condition (t(10=3.73, p<0.01; see Figure 6 
A/B). One-way ANOVA showed that there was treatment effect in the SHAM animals, 
acutely (F(2,17)=4.44, p<0.05) and marginally after chronic treatment (F(2,17)=3.34, 
p<0.07). Post hoc analysis showed that after acute BUSP treatment corticosterone levels 
were increased. After chronic treatment both BUSP and ESCIT increased the 
corticosterone levels after the rats were placed in the open field.  
 
Thirty minutes after the rats were stimulated corticosterone levels were higher as 
compared to base line levels (see Fig. 6A). However, there were no differences between 
the treatment groups at the first time and second time the rats were stimulated (F’s<1.71, 
ns.). After acute treatment the corticosterone response was less pronounced in the STIM-
ESCIT group as compared to the other STIM groups (F(2,17)=6.96, p<0.01). Chronic 
treatment also affected the corticosterone response (F(2,17)=9.67, p<0.01), but now the 
post hoc analysis revealed that BUSP treatment increased the response and the STIM-
ESCIT did not differ from the STIM-SAL group.  
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Figure 6 (A) and 6 (B). The chart of lines with markers showing the plasma level of blood 
corticosterone (ng/ml) for the dlPAG stimulation, and dlPAG sham rats. The data are expressed as 
means ± S.E.M demonstrating the condition during the pre open-field period, stimulation phase I, 
open-field testing with acute treatment, post open-field period, stimulation phase II, and open-
field testing with chronic treatment. The inset in 6 (A) shows the levels of blood corticosterone 
during the first and second stimulation periods in the open-field conditions. Indication:  STIM-
SAL;  STIM-BUSP;  STIM-ESCIT;  SHAM-SAL;  SHAM-BUSP; and  SHAM-
ESCIT. * Significant difference from the STIM- or SHAM-SAL group.   
 
Correlation between corticosterone level and open-field behavioural effects 
The correlation between the behavioural measures and the corticosterone levels 
(taken 30 min after open-field behaviour) are presented in figures 7, 8, and Table 1. 
When all animals were included in the analysis, significant correlations were found 
between the corticosterone level and the open-field behaviour (rp> .50). In table 1, within 
test analysis showed that the corticosterone level was negatively correlated with the 
distance moved and mean velocity; and positively correlated with the time spent in corner 
zone of the open-field in both acute and chronic testing conditions. Additionally, the time 
spent in the corner zone of the rats was found to be negatively correlated with the 
distance moved and mean velocity in the open-field (see Table 1). Figure 7A shows that 
the pattern of correlations for distance moved and corticosterone of STIM-SAL and 
STIM-BUSP were concentrated in the region with little distance moved and high 
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corticosterone levels (upper right area). On the other hand, a shift to the lower right area 
(more distance moved and lower coricosterone levels) was observed in the SHAM groups 
and the STIM ESCIT group with almost no overlap between these set of groups. A 
similar picture emerged for the relation between time spent in the corner areas and 
corticosterone, although the shift was from upper right to lower left side of the figure (see 
Figure 7B). After chronic treatment the correlations were comparable although the 
correlations were somewhat lower (See Figures 8A/B and Table 1). 
 
 
 
Table 1: Pearson correlation coefficients between the levels of blood corticosterone and the different 
measures of the open-field in both the acute (Table 1A), and chronic (Table 1B) treatments. Indication: 
** Correlation is significant at the 0.01 level (2-tailed), * Correlation is significant at the 0.05 level (2-
tailed). 
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Figure 7: Pearson correlation coefficients between the levels of blood corticosterone and the 
distanced moved (Fig. 7 A) and the time spent in the corner zone (Fig. 7 B) of the open-field 
in acute treatment. Indication:  STIM-SAL;  STIM-BUSP;  STIM-ESCIT;  SHAM-
SAL;  SHAM-BUSP; and  SHAM-ESCIT. 
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Figure 8: Pearson correlation coefficients between the levels of blood corticosterone and the 
distanced moved (Fig. 8 A) and the time spent in the corner zone (Fig. 8 B) of the open-field 
in chronic treatment. Indication:  STIM-SAL;  STIM-BUSP;  STIM-ESCIT;  
SHAM-SAL;  SHAM-BUSP; and  SHAM-ESCIT. 
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Discussion 
In this study, electrical stimulation of the dlPAG evoked escape reactions 
subsequently followed by freezing response when animals were placed back to the open-
field 12 h later. These findings indicate that dlPAG stimulation induces long lasting (at 
least 12 h) fear which is probably associated with the open field context. Further, it was 
shown that escitalopram, but not buspirone, treatment was effective in attenuating the 
freezing behaviour in both the acute and chronic treatment condition. Interestingly, the 
stimulation amplitudes to evoke escape behaviour were increased after chronic treatment 
with ESCIT and BUSP. Further, the present study shows that dlPAG stimulation elevated 
blood corticosterone levels which were associated with changes in open field behaviour. 
Altogether these data indicate that dlPAG stimulation induced behavioural and 
physiological changes which could even be observed 12 h after stimulation. These 
findings suggest that dlPAG stimulation not only induces escape behaviour but that 
stimulation also leads to fear conditioning. Since there are no other stimuli than the 
context during dlPAG stimulation, the observed freezing behaviour in the open field 
context is considered to model internal generated fear. 
 
It could be argued that the freezing behaviour observed 12 h after stimulation 
could be regarded as generalized fear after stimulation. However, before the rats were 
tested in the open field no freezing was observed in the home cage. The rats showed a 
normal behavioural repertoire in their home cage and the freezing behaviour was 
observed as soon as they were placed in the open field. In the present study we did not 
test whether the fear was also expressed in another context.  Previous data have shown 
that fear induced by dlPAG stimulation generalizes to other contexts (Vianna et al 2001). 
It should be noted that in this latter study relative small boxes were used in which the 
context was modified. To what extend this dlPAG stimulation induced fear generalizes to 
other contexts needs to be investigated in further studies.  
Effects of treatment 
The electrophysiological and microdialysis studies have demonstrated that the 
somatodendritic 5-HT1A receptors become desensitized after prolonged administration of 
SSRIs (Dawson et al 2000; Hamon et al 1990; Invernizzi et al 1994). The therapeutic 
effect of ESCIT as antidepressant and panicolytic drug can be achieved either via the 
stimulation of 5-HT1A receptors indirectly through increased availability of synaptic 5-HT 
or possibly mediated by activation of 5-HT1A receptors (De Vry 1995). The behavioural 
effect observed herein after fear conditioning exposure was in accordance with previous 
reports showing the panicolytic properties of ESCIT in the electrical stimulated dorsal 
PAG (Hogg et al 2006). The latter authors reported that ESCIT significantly reduced the 
escape behaviour and fear-like sensation indicating the potential therapeutic efficacy for 
fear and panic disorders. Based on these findings, it was hypothesized that the activation 
 172
of 5-HT1A receptors in dlPAG produces inhibitory of aversive responses, an anti-aversive 
effects (Brandao et al 1991). Furthermore, Graeff also suggested that the increase of 5-
HT availability within the midbrain decreases the magnitude of anxiety (Graeff 2004). In 
agreement with previous studies, the present study of ESCIT treatment did not only 
increase the aversive threshold response but also attenuate the freezing or fear-like 
behaviour in the open-field environment.  
 
In addition, our study shows that the current intensity for the escape threshold was 
remarkably increased in the groups of STIM-BUSP and STIM-ESCIT. This data 
replicated previous studies on the reduction of aversive response when animals were 
subjected to the dorsal PAG stimulation using anti-panic agents such as alprazolam, 
clonazepam, zimelidine, (Jenck et al 1990; Jenck et al 1995) escitalopram, fluoxetine, 
paroxetine and the benzodiazepine (Hogg et al 2006). It was proposed that the anti-
aversive effects were obtained by increasing the extracellular synaptic availability of 
serotonin in the brain (Jenck et al 1995; Schutz et al 1985) as well as through the 
activation of 5-HT2c receptors (Jenck et al 1998). However, the present study showed that 
buspirone was able to increase the aversive threshold for escape reaction but not reducing 
the freezing behaviour in the open-field testing. One possible explanation could be the 
complexity of mechanism of action of BUSP in the different regions of the PAG. In this 
respect, our previous findings have revealed that BUSP induced different patterns of c-
Fos immunoreactivity in the rostral and caudal dlPAG, which suggest that the rostral 
dlPAG plays a role for anxiety while the caudal dlPAG is more towards aversive 
behaviour such as panic-like behaviour (Lim et al 2008c).  
 
The morphological property of PAG is considerably rich in 5-HT immunoreactive 
nerve terminals that originated mainly from the serotonin-containing neuron in the dorsal 
raphe nucleus (Beitz et al 1986; Lovick et al 2000). Many studies on the 5-HT1A receptor 
subtype have indicated that this subsystem plays an important role in the modulation of 
fear conditioning (Ceglia et al 2004; Pobbe and Zangrossi 2005; Quartermain et al 1993). 
Recent findings on the 5-HT1A receptor subtype have indicated that this structure is 
highly involved in the modulatory function underlying generalized anxiety disorder and 
defensive behaviour (Argyropoulos et al 2004; Quartermain et al 1993). Furthermore, our 
previous results have shown that BUSP treatment induced a different pattern of neuronal 
activation in the different PAG region, indicating a different level of receptor sensitivity 
of 5-HTIA in the pathophysiology of anxiety and panic disorder. (Lim et al 2008c). 
 
It has been established that BUSP is clinically known to be effective only for mild 
anxiety (e.g. generalized anxiety disorder) but not for severe anxiety (e.g. panic disorder) 
condition (Ninan 2004). Previous experimental evidences have also demonstrated no 
effects on the escape behaviour, a panic-like reaction in the dlPAG stimulated animals 
(Connor and Davidson 1998; Poltronieri et al 2003). However, some contradictory results 
showed that the administration of 5-HT1A agonist into the dorsal PAG was possible to 
inhibit this escape reaction during the electrical stimulation of this structure (de Bortoli et 
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al 2006; Nogueira and Graeff 1995). It is of interest to note that the present study of 
BUSP treatment produced no effects on the conditioned fear in the open-field testing but 
it increased the intensity of stimulation of escape reaction after chronic treatment. On the 
other hand, there seemed to be a trend that after chronic treatment BUSP showed some 
beneficial effects. It could be argued that longer treatment periods are required to obtain 
an effect of BUSP treatment in this model. 
Corticosterone and defensive behaviour 
In consideration of the stress hormone, corticosterone/cortisol is thought to be an 
important neuroendocrinological hormone for stress response and defensive behaviour. 
There are some controversial issues concerning the involvement of stress hormones for 
panic attacks (PAs) in which the hypothalamic-pituitary-adrenal (HPA) axis was not 
activated during the naturally occurring PAs and in the experimental induced panic-like 
attacks by selective panicogenic agents such as lactate and carbon dioxide (Graeff and 
Del-Ben 2008; Schenberg et al 2001). However, several contradictory findings have 
demonstrated that the plasma cortisol level was elevated in the naturally occurring PAs, 
as well as in the experimental studies with 35% CO2 inhalation, or administration of 
pharmacological agents with α2-adrenergic antagonist yohimbine, the serotonergic agents 
1-(m-chlorophenyl) piperazine (mCPP) and fenfluramine (Argyropoulos et al 2002; 
Davidson 2000; Nutt and Ballenger 2003; van Duinen et al 2005). PAs are generally 
regarded as severe traumatic stressors, nevertheless other findings of naturally occurring 
PAs show no marked elevation of cortisol or adreno-cortico-tropin hormone (ACTH) 
though (McNally and Lukach 1992). Further, recent studies with 35% CO2 challenge and 
pharmacological substances (m-CKK, yohimbine, caffeine) showed that the HPA axis 
was activated in these experimental panic-like responses (Charney et al 1987; Graeff et al 
2005; van Duinen et al 2005; van Duinen et al 2007).  
 
The present data show that corticosterone levels were increased after dlPAG 
stimulation and after open field testing in the STIM animals. Also, an increase of the 
corticosterone levels was found after acute and chronic ESCIT and BUSP treatment in 
the open field testing of sham animals. Previous studies have demonstrated that HPA 
activation was associated with a 5-HT1A agonistic function by increasing the plasma 
corticosterone levels in order for the animal to cope with this stressful/fearful condition 
(McAllister-Williams et al 2001; Takao et al 1997; Tsuji et al 2001; Young et al 1994). 
Thus, the elevation of corticosterone level by BUSP and SSRIs treatment in the present 
study was in agreement with previous observations (Bundgaard et al 2007; Lorens and 
Van de Kar 1987; Matheson et al 1988). Nevertheless, in STIM animals a reduction of 
corticosterone level was observed after ESCIT treatment (as opposed to BUSP) when 
compared to STIM-SAL animals in the open field. Yet, these animals still showed a 
considerably high level of corticosterone as compared to the SHAM-SAL group. 
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In this study, it is important to note that, the levels of corticosterone did not mimic 
the behavioural effects as observed in the open field testing of both the acute and chronic 
treatment. It could be anticipated that the attenuation of fear-like response in the open 
field testing would lead to a reduction of corticosterone level. However, the results 
obtained in this study were not the one we expected. One possible explanation could be 
that the administration of SSRI activates the HPA axis through the post-synaptic 5-HT 
receptors in the paraventricular nucleus of the hypothalamus, which results in 
adrenocorticotropin release at the pituitary levels (Dinan 1996; Fuller et al 1996). At the 
same time, SSRI treatment also enhances the serotonergic activity by increasing the 
extracellular 5-HT levels in the central nervous system (Hjorth et al 2000; Pineyro and 
Blier 1999). Therefore, our data show for the first time that SSRI treatment produces 
phobiolytic activity with elevation of corticosterone level during the open field testing in 
the animal model of internal fear generated by dlPAG stimulation.   
eural mechanism of fear  
Recent evidence indicated that the amygdala is a center where convergence of 
various types of fearful sensations and perceptions that animals experienced. The 
amygdala-PAG connection provides an essential defensive behavioural system in the 
overall integration of fearful information. Previous studies demonstrated that the lateral 
amygdaloid nucleus (LA) connects directly to the central amygdaloid nucleus (CA), 
which projects its axons downward via the ventral amygdalofugal pathway, through the 
anterior and medial hypothalamus, and finally down to the lower reaches of the PAG 
(LeDoux 1994; LeDoux 1995; Swanson and Petrovich 1998). In this study, the electrical 
stimulation was used as an unconditioned fear stimulus (US) generated within the dlPAG 
in an enclosed open-field environment (as condition stimulus, CS). During stimulation, 
rats immediately displayed spontaneous flight response and this condition was considered 
as intense forms of fear/panic. As such, the CS cue was generated and fearful information 
of the open-field environment arrived at the thalamic nuclei, and later through a direct 
thalamic-amygdaloid connection, where information was conveyed to the LA (see Figs. 
9A and 9B). This pathway is known as the primitive mechanism of defense or “low-road” 
in the defensive behavioural system as described previously by LeDoux in which a fear-
response is activated in animals. During this moment, CS and US information converge 
onto the LA where plasticity was formed to mediate the process of acquisition of fear 
learning. Therefore, 12 h later after the stimulation rats exhibited freezing behaviour 
when they were placed back into the same open-field environment. Interestingly, Vianna 
et al showed that electrical stimulation of the dlPAG produced no freezing behaviour in 
the same/different context environment 24 h later (Vianna et al 2001). However, the 
present study demonstrated that freezing behaviour was observed after 12 h of escape 
reaction when rats were tested again in the same open field condition. This suggests that 
fear conditioning generated within the dlPAG was confined to a specific time frame 
which followed by subsequent extinction.  
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Figure 9 (A) and (B): Illustration of freezing behaviour in the open-field after the induction of 
escape behaviour by electrical stimulation of the dlPAG – a substrate for the expression of fear.     
 
In conclusion, the current study shows that the freezing behaviour generated 
intrinsically within the dlPAG was confined to a specific time frame after the induction of 
escape behaviour. This fear-like response was attenuated by ESCIT treatment while 
BUSP was not effective. Interestingly, the stimulation amplitudes to evoke escape 
behaviour were significantly higher for animals chronically treated with buspirone and 
escitalopram. Further, our data also confirm the activation of the HPA axis during the 
panic and fear-like behaviour. Future research of fear should be focused on the 
underlying neural substrate of fear generated by dlPAG stimulation. 
Acknowledgement 
The authors are thankful to H. Lundbeck A/S for the donation of Escitalopram 
Oxalate. This research was supported by a grant from the FP6 Marie Curie Fellowship 
(MEST-CT-2005-020589).  
 
 
 
 176
References 
APA (1998): Practice guidelines for the treatment of patients with panic disorder. Am J 
Psychiatry:155:151-134. 
Argyropoulos SV, Bailey JE, Hood SD, Kendrick AH, Rich AS, Laszlo G, et al (2002): Inhalation of 35% 
CO(2) results in activation of the HPA axis in healthy volunteers. Psychoneuroendocrinology 
27:715-729. 
Argyropoulos SV, Hood SD, Adrover M, Bell CJ, Rich AS, Nash JR, et al (2004): Tryptophan depletion 
reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. 
Biol Psychiatry 56:503-509. 
Bandler R, Shipley MT (1994): Columnar organization in the midbrain periaqueductal gray: modules for 
emotional expression? Trends eurosci 17:379-389. 
Beitz AJ, Clements JR, Mullett MA, Ecklund LJ (1986): Differential origin of brainstem serotoninergic 
projections to the midbrain periaqueductal gray and superior colliculus of the rat. J Comp eurol 
250:498-509. 
Blanchard DC, Blanchard RJ (1972): Innate and conditioned reactions to threat in rats with amygdaloid 
lesions. J Comp Physiol Psychol 81:281-290. 
Blanchard RJ, Blanchard DC, Agullana R, Weiss SM (1991): Twenty-two kHz alarm cries to presentation 
of a predator, by laboratory rats living in visible burrow systems. Physiol Behav 50:967-972. 
Blanchard RJ, Blanchard DC, Weiss SM, Meyer S (1990): The effects of ethanol and diazepam on 
reactions to predatory odors. Pharmacol Biochem Behav 35:775-780. 
Brandao ML, Lopez-Garcia JA, Graeff FG, Roberts MH (1991): Electrophysiological evidence for 
excitatory 5-HT2 and depressant 5-HT1A receptors on neurones of the rat midbrain tectum. Brain 
Res 556:259-266. 
Brown JS, Kalish HI, Farber IE (1951): Conditioned fear as revealed by magnitude of startle response to 
an auditory stimulus. J Exp Psychol 41:317-328. 
Bundgaard C, Larsen F, Jorgensen M, Mork A (2007): Pharmacokinetic/pharmacodynamic feedback 
modelling of the functional corticosterone response in rats after acute treatment with escitalopram. 
Basic Clin Pharmacol Toxicol 100:182-189. 
Carrive P (1993): The periaqueductal gray and defensive behaviour: functional representation and 
neuronal organization. Behav Brain Res 58:27-47. 
Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi RW (2004): Effects of chronic 
treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: 
role of 5-HT1A receptors. Br J Pharmacol 142:469-478. 
Charney DS, Woods SW, Goodman WK, Heninger GR (1987): Neurobiological mechanisms of panic 
anxiety: biochemical and behavioural correlates of yohimbine-induced panic attacks. Am J 
Psychiatry 144:1030-1036. 
Connor KM, Davidson JR (1998): Generalized anxiety disorder: neurobiological and pharmacotherapeutic 
perspectives. Biol Psychiatry 44:1286-1294. 
Davidson RJ (2000): Anxiety, Depression, and Emotion: anxiety, Depression Sas C. Oxford University 
Press:77-78. 
Davis M, Falls WA, Campeau S, Kim M (1993): Fear-potentiated startle: a neural and pharmacological 
analysis. Behav Brain Res 58:175-198. 
Dawson LA, Nguyen HQ, Smith DI, Schechter LE (2000): Effects of chronic fluoxetine treatment in the 
presence and absence of (+/-)pindolol: a microdialysis study. Br J Pharmacol 130:797-804. 
Dayan P, Kakade S, Montague PR (2000): Learning and selective attention. at eurosci 3 Suppl:1218-
1223. 
de Bortoli VC, Nogueira RL, Zangrossi H, Jr. (2006): Effects of fluoxetine and buspirone on the 
panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat 
dorsal periaqueductal gray. Psychopharmacology (Berl) 183:422-428. 
De Vry J (1995): 5-HT1A receptor agonists: recent developments and controversial issues. 
Psychopharmacology (Berl) 121:1-26. 
 177 
Dielenberg RA, Arnold JC, McGregor IS (1999): Low-dose midazolam attenuates predatory odor 
avoidance in rats. Pharmacol Biochem Behav 62:197-201. 
Dinan TG (1996): Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sci 
58:1683-1694. 
Finn DP, Jhaveri MD, Beckett SR, Madjd A, Kendall DA, Marsden CA, et al (2006): Behavioural, central 
monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in 
rats. euroscience 138:1309-1317. 
Fuller RW, Perry KW, Hemrick-Luecke SK, Engleman E (1996): Serum corticosterone increases reflect 
enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat 
hypothalamus. J Pharm Pharmacol 48:68-70. 
Graeff FG (1990): Brain defense systems and anxiety. In: Roth M, Burrows GD, Noyes R (eds) Handbook 
of Anxiety. The neurobiology of anxiety. Elsevier, Amsterdam:307-354. 
Graeff FG (2004): Serotonin, the periaqueductal gray and panic. eurosci Biobehav Rev 28:239-259. 
Graeff FG, Del-Ben CM (2008): Neurobiology of panic disorder: From animal models to brain 
neuroimaging. eurosci Biobehav Rev. 
Graeff FG, Garcia-Leal C, Del-Ben CM, Guimaraes FS (2005): Does the panic attack activate the 
hypothalamic-pituitary-adrenal axis? An Acad Bras Cienc 77:477-491. 
Hamon M, Gozlan H, el Mestikawy S, Emerit MB, Bolanos F, Schechter L (1990): The central 5-HT1A 
receptors: pharmacological, biochemical, functional, and regulatory properties. Ann  Y Acad Sci 
600:114-129; discussion 129-131. 
Harris JA, Westbrook RF (1994): Effects of midazolam and naloxone in rats tested for 
sensitivity/reactivity to formalin pain in a familiar, novel or aversively conditioned environment. 
Psychopharmacology (Berl) 115:65-72. 
Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB (2000): Serotonin autoreceptor 
function and antidepressant drug action. J Psychopharmacol 14:177-185. 
Hogg S, Michan L, Jessa M (2006): Prediction of anti-panic properties of escitalopram in the dorsal 
periaqueductal grey model of panic anxiety. europharmacology 51:141-145. 
Hollander E, Simeon D (2003): Anxiety disorders. In Textbook of Clinical Psychiatry. American 
Psychiatric Publishing, Washington, DC 4th Ed:543-565. 
Invernizzi R, Bramante M, Samanin R (1994): Chronic treatment with citalopram facilitates the effect of a 
challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. Eur J 
Pharmacol 260:243-246. 
Jenck F, Broekkamp CL, Van Delft AM (1990): The effect of antidepressants on aversive periaqueductal 
gray stimulation in rats. Eur J Pharmacol 177:201-204. 
Jenck F, Moreau JL, Berendsen HH, Boes M, Broekkamp CL, Martin JR, et al (1998): Antiaversive 
effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. Eur 
europsychopharmacol 8:161-168. 
Jenck F, Moreau JL, Martin JR (1995): Dorsal periaqueductal gray-induced aversion as a simulation of 
panic anxiety: elements of face and predictive validity. Psychiatry Res 57:181-191. 
Klemenhagen KC, Gordon JA, David DJ, Hen R, Gross CT (2006): Increased fear response to contextual 
cues in mice lacking the 5-HT1A receptor. europsychopharmacology 31:101-111. 
LeDoux JE (1993): Emotional networks in the brain. In Handbook of emotions (M. Lewis &J. M. 
Haviland, eds.) ew York: Guilford Press:109-118. 
LeDoux JE (1994): Emotion, memory and the brain. Sci Am 270:50-57. 
LeDoux JE (1995): Emotion: clues from the brain. Annu Rev Psychol 46:209-235. 
Lim LW, Blokland A, Visser-Vandewalle V, Vlamings R, Sesia T, Steinbusch H, et al (2008a): High-
frequency stimulation of the dorsolateral periaqueductal gray and ventromedial hypothalamus 
fails to inhibit panic-like behaviour. Behav Brain Res 193:197-203. 
Lim LW, Temel Y, Blokland A, Visser-Vandewalle V, Steinbusch H (2008b): Fos immunoreactivity in 
the rat forebrain induced by electrical stimulation of the dorsolateral periaqueductal gray matter. J 
Chem euroanat (In press). 
Lim LW, Temel Y, Sesia T, Vlamings R, Visser-Vandewalle V, Steinbusch HW, et al (2008c): Buspirone 
induced acute and chronic changes of neural activation in the periaqueductal gray of rats. 
euroscience 155:164-173. 
 178
Lim LW, Temel Y, Visser-Vandewalle V, Steinbusch H, Schruers K, Hameleers R, et al (2008d): Effect 
of buspirone on the behavioural regulation of rats in low versus high anxiety conditions. 
Arzneimittelforschung 58:269-276. 
Lorens SA, Van de Kar LD (1987): Differential effects of serotonin (5-HT1A and 5-HT2) agonists and 
antagonists on renin and corticosterone secretion. euroendocrinology 45:305-310. 
Lovick TA, Parry DM, Stezhka VV, Lumb BM (2000): Serotonergic transmission in the periaqueductal 
gray matter in relation to aversive behaviour: morphological evidence for direct modulatory 
effects on identified output neurons. euroscience 95:763-772. 
Matheson GK, Gage D, White G, Dixon V, Gipson D (1988): A comparison of the effects of buspirone 
and diazepam on plasma corticosterone levels in rat. europharmacology 27:823-830. 
McAllister-Williams RH, Anderson AJ, Young AH (2001): Corticosterone selectively attenuates 8-OH-
DPAT-mediated hypothermia in mice. Int J europsychopharmacol 4:1-8. 
McNally RJ, Lukach BM (1992): Are panic attacks traumatic stressors? Am J Psychiatry 149:824-826. 
Montgomery KC (1955): The relation between fear induced by novel stimulation and exploratory 
behaviour. J Comp Physiol Psychol 48:254-260. 
Montgomery KC, Monkman JA (1955): The relation between fear and exploratory behaviour. J Comp 
Physiol Psychol 48:132-136. 
Ninan PMS (2004): Buspirone and gepirone. In: Schatzberg AF, Nemeroff CB, editors.  Textbook of 
psychopharmcology 3rd ed Washington, DC. . American Psychiatric Publishing:391-404. 
Nogueira RL, Graeff FG (1995): Role of 5-HT receptor subtypes in the modulation of dorsal 
periaqueductal gray generated aversion. Pharmacol Biochem Behav 52:1-6. 
Nutt DJ, Ballenger JC (2003): Anxiety Disorders. Blackwell Publishing:280-281. 
Panksepp J (1998): Affective Neuroscience: The foundations of human and animal emotions. Oxford 
University Press:206-222. 
Pineyro G, Blier P (1999): Autoregulation of serotonin neurons: role in antidepressant drug action. 
Pharmacol Rev 51:533-591. 
Pobbe RL, Zangrossi H, Jr. (2005): 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal 
gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the 
dorsal raphe nucleus. Psychopharmacology (Berl) 183:314-321. 
Poltronieri SC, Zangrossi H, Jr., de Barros Viana M (2003): Antipanic-like effect of serotonin reuptake 
inhibitors in the elevated T-maze. Behav Brain Res 147:185-192. 
Quartermain D, Clemente J, Shemer A (1993): 5-HT1A agonists disrupt memory of fear conditioning in 
mice. Biol Psychiatry 33:247-254. 
Schenberg LC, Bittencourt AS, Sudre EC, Vargas LC (2001): Modeling panic attacks. eurosci Biobehav 
Rev 25:647-659. 
Schiller D, Cain CK, Curley NG, Schwartz JS, Stern SA, Ledoux JE, et al (2008): Evidence for recovery 
of fear following immediate extinction in rats and humans. Learn Mem 15:394-402. 
Schutz MT, de Aguiar JC, Graeff FG (1985): Anti-aversive role of serotonin in the dorsal periaqueductal 
grey matter. Psychopharmacology (Berl) 85:340-345. 
Stiedl O, Misane I, Spiess J, Ogren SO (2000): Involvement of the 5-HT1A receptors in classical fear 
conditioning in C57BL/6J mice. J eurosci 20:8515-8527. 
Sulon J, Demey-Ponsart L, Beauduin P, Sodoyez JC (1978): Radioimmunoassay of corticosterone, 
cortisol and cortisone: their application to human cord and maternal plasma. J Steroid Biochem 
9:671-676. 
Swanson LW, Petrovich GD (1998): What is the amygdala? Trends eurosci 21:323-331. 
Takao K, Nagatani T, Kitamura Y, Yamawaki S (1997): Effects of corticosterone on 5-HT1A and 5-HT2 
receptor binding and on the receptor-mediated behavioural responses of rats. Eur J Pharmacol 
333:123-128. 
Temel Y, Boothman LJ, Blokland A, Magill PJ, Steinbusch HW, Visser-Vandewalle V, et al (2007): 
Inhibition of 5-HT neuron activity and induction of depressive-like behaviour by high-frequency 
stimulation of the subthalamic nucleus. Proc atl Acad Sci U S A 104:17087-17092. 
Tsuji M, Takeda H, Matsumiya T (2001): Protective effects of 5-HT1A receptor agonists against 
emotional changes produced by stress stimuli are related to their neuroendocrine effects. Br J 
Pharmacol 134:585-595. 
 179 
Van den Hove DL, Steinbusch HW, Bruschettini M, Gazzolo D, Frulio R, Scheepens A, et al (2006): 
Prenatal stress reduces S100B in the neonatal rat hippocampus. euroreport 17:1077-1080. 
van Duinen MA, Schruers KR, Maes M, Griez EJ (2005): CO2 challenge results in hypothalamic-
pituitary-adrenal activation in healthy volunteers. J Psychopharmacol 19:243-247. 
van Duinen MA, Schruers KR, Maes M, Griez EJ (2007): CO2 challenge induced HPA axis activation in 
panic. Int J europsychopharmacol 10:797-804. 
Vianna DM, Landeira-Fernandez J, Brandao ML (2001): Dorsolateral and ventral regions of the 
periaqueductal gray matter are involved in distinct types of fear. eurosci Biobehav Rev 25:711-
719. 
Young AH, Goodwin GM, Dick H, Fink G (1994): Effects of glucocorticoids on 5-HT1A presynaptic 
function in the mouse. Psychopharmacology (Berl) 114:360-364. 
 
 
 
 
 
 
 
 180
 
 
 
 
 
 
 181 
CHAPTER 8 
 
CONCLUSION 
 
 
 
  
 
 
 
 
 
 182
 
 183 
Conclusion 
 
In the present study, we first tested the hypothesis whether electrical stimulation of 
the dlPAG at higher frequencies (>100Hz) would prevent rats showing escape or panic-
like behaviour in the open-field arena. Secondly, we hypothesized that SSRI treatment 
would attenuate the fear-like behaviour after escape reaction of dlPAG stimulation during 
the post-stimulation periods. Furthermore, we also investigated the modulatory role and 
treatment effects of buspirone in the different regions of the PAG and different settings of 
the open-field arenas. Altogether, the experimental data presented in this thesis are 
concluded as follows. 
  
Chapter 2: The PAG is composed of different anatomical columns with functional 
differentiation. The PAG is considered a key structure to coordinate behaviour in 
response to threatening stimuli. It has been demonstrated that stimulation of this area in 
rats initiate different defensive behaviours such as fight, flight and freeze in response to 
aversive external and internal stimuli. Besides, it also eliminates the perception of pain by 
stimulation which is called stimulation produced analgesia. Several physiological 
changes have been observed in the alteration of blood circulation, respiration, pain 
perception, autonomic movement and postural adjustment with complex behaviour 
during and after the stimulation or lesions of the PAG. In addition, the PAG also 
modulates several biological functions such as reproductive or sexual behaviour, 
maternal behaviour, vocalization, anxiety, cardiovascular, and respiratory activities 
 
Chapter 3: The integration of cognitive-affective information for defensive 
behaviour involves different neuroanatomical structures. We found that electrical 
stimulation of the dlPAG produced different patterns of neuronal activation in specific 
parts of the forebrain which are involved in panic- or fear-like behaviour. Importantly, 
the range of neuroanatomical structures (e.g. cortical areas, septo-hippocampal system, 
amygdala and hypothalamus) and neurotransmitters (e.g. acetylcholine, serotonin) 
matched the two-dimensional defense system of McNaughton and Corr.  
 
Chapter 4: To further investigate the effects of buspirone, two different 
conditions of the open-field were used which were the enclosed and exposed open-fields 
(distinguished as low and high anxiety). Our results showed that buspirone has an 
anxiolytic action in these two open-field settings suggesting that buspirone may not only 
be useful in reducing mild anxiety but also severe anxiety as well. However, in clinical 
practice buspirone is typically used for mild anxiety such as generalized anxiety disorder 
and not for other severe anxiety conditions. Besides, the reduced activity and increase 
time spent in the center areas of the open-field setting are indicative of both an 
anxiogenic and anxiolytic effect, respectively. This data appears to show a dual effect of 
buspirone on anxiety.   
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Chapter 5: It was demonstrated that electrical stimulation of the dlPAG and VMH 
at higher-frequencies (>100Hz) was not able to prevent the induction of escape 
behaviour. The intensity of stimulation amplitude turned out to be the most important 
stimulation parameter for evoking escape behaviour. Furthermore, we also observed that 
the neuronal activation pattern in the medial prefrontal cortex resulting from dlPAG and 
VMH stimulation was similar. These findings suggest that electrical stimulation of the 
dlPAG and VMH induces panic-related behaviours even at higher frequencies.  
 
Chapter 6: In this study, it was shown that the modulatory roles of 5-HT1A 
receptors induced different neuronal activation patterns in the different regions of the 
PAG in both the acute and chronic buspirone treatment conditions. In view of these 
results, the main effect of anxiolytic action was specifically localized in all regions of the 
rostral and caudal dmPAG. However, the caudal dlPAG, lPAG and vlPAG were found to 
be ineffective to buspirone treatment, probably due to their distinctive function in 
mediating higher level of anxiety in defensive behaviour. This indicates that the 
longitudinal anatomical structure of the PAG possesses a different level of receptor 
sensitivity of 5-HT1A in the pathophysiology of anxiety and panic disorder. 
 
Chapter 7: Here, we have shown that the escape reaction generated intrinsically 
within the dlPAG was followed by freezing behaviour on the next day. This fear-like 
response was attenuated by escitalopram treatment while buspirone or vehicle treated 
groups showed no effect. Interestingly, the stimulation amplitudes to evoke escape 
behaviour were significantly higher for animals chronically treated with buspirone and 
escitalopram. In addition, our data also confirm the activation of the HPA axis during the 
panic and fear-like behaviour after dlPAG stimulation.  
 
The results obtained from these experiments as outlined in this thesis show that the 
dlPAG plays an important role in defensive behaviour. The electrical stimulation of the 
dlPAG shows a similar fearful emotional activation in both animals and humans. Thus, 
the use electrical stimulation of the PAG as an animal model of neuropsychiatric 
disorders is a promising tool which can be used in the development of novel therapies. In 
addition, our findings also suggest the combination of drugs and neurostimulatory 
therapies in the management of experimental models of pathological fear. The question 
whether neurostimulatory therapies can be used in the treatment of pathological fear 
remains not fully answered. From this study, we can state that this is not possible using 
the PAG as target. However, these new clues from an old concept can lead us to find the 
optimal target.   
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